,Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
0,CHEMBL100086,P46098,,OSVMSQACZRYAPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12482441.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,Development of a presynaptic 5-HT1A antagonist.,Bioorg. Med. Chem. Lett.,2003.0,13.0,2.0,"Mattson RJ, Catt JD, Sloan CP, Gao Q, Carter RB, Gentile A, Mahle CD, Matos FF, McGovern R, VanderMaelen CP, Yocca FD",,3062.0,DTCT0023221,1489397,DTCC00263953,917398,5847
1,CHEMBL104700,P46098,,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478126,DTCC00272114,931177,48255
2,CHEMBL1079079,P46098,,WGIPGQAPFNVWIX-XXFZXMJFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19767206.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 (receptor) at 10 uM by scintillation counting,,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,2009.0,19.0,21.0,"Donohue SR, Varnäs K, Jia Z, Gulyás B, Pike VW, Halldin C",,619795.0,DTCT0023221,3267809,DTCC00632772,857661,37697
3,CHEMBL108,P46098,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849452,DTCC00144764,229550,34292
4,CHEMBL1082723,P46098,NITD609,CKLPLPZSUQEDRT-WPCRTTGESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20813948.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant serotonin 5HT3 receptor,,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,2010.0,329.0,5996.0,"Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT",,658586.0,DTCT0023221,3467863,DTCC00031143,1686650,40818
5,CHEMBL1083485,P46098,,YOCUJVXRRWEPDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345977,DTCC00645978,1654372,39082
6,CHEMBL1083787,P46098,,LMGUUVWYFJIKCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345978,DTCC00645979,1395966,39082
7,CHEMBL1083788,P46098,,DFBQTBNRGSIKHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345979,DTCC00645980,652015,39082
8,CHEMBL1084363,P46098,,MMXFWZCBTFHARB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345974,DTCC00645913,716354,39082
9,CHEMBL1084364,P46098,,FWCCJDYYJWWQOS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345975,DTCC00645914,1525122,39082
10,CHEMBL1084365,P46098,,HCBWAWNFHVHMOV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345976,DTCC00645915,652014,39082
11,CHEMBL1084631,P46098,,FTPAKCBSUUBRFU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,5800.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345972,DTCC00645911,554947,39082
12,CHEMBL1084876,P46098,,UPVXJFQSDLKQRB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345973,DTCC00645912,1428308,39082
13,CHEMBL1085379,P46098,,OXIAXPOOKVTTDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,5700.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345971,DTCC00645849,1492825,39082
14,CHEMBL1086332,P46098,,MUIUUGJVKFYPIF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,7900.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345969,DTCC00645847,587120,39082
15,CHEMBL1086333,P46098,,HSWHSJUFDDMBTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,7800.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345970,DTCC00645848,197801,39082
16,CHEMBL1086577,P46098,,SLMFOVKWAUVQPC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345980,DTCC00645981,1330901,39082
17,CHEMBL1098230,P46098,,PQPVHIHIJVIEQG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20384344.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.,J. Med. Chem.,2010.0,53.0,9.0,"Ishikawa M, Shinei R, Yokoyama F, Yamauchi M, Oyama M, Okuma K, Nagayama T, Kato K, Kakui N, Sato Y",,630142.0,DTCT0023221,3336761,DTCC00641534,631300,38886
18,CHEMBL11,P46098,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849456,DTCC00132703,11935,34292
19,CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,0.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553852,DTCC00258915,1310663,41528
20,CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-1.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825.0,DTCT0023221,5035411,DTCC00258915,1316308,42619
21,CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,2.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035400,DTCC00258915,1316308,42619
22,CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,0.5,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035391,DTCC00258915,1316308,42619
23,CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,0.5,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709627,DTCC00258915,1301532,58772
24,CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678639,DTCC00258915,1304123,65052
25,CHEMBL1112,P46098,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329312.0,DTCT0023221,13582408,DTCC00106550,1580612,39761
26,CHEMBL111639,P46098,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11512051.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736677,DTCC00281815,2106040,69642
27,CHEMBL11608,P46098,TYRAMINE,DZGWFCGJZKJUFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium at 10 uM by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478754.0,DTCT0023221,2354067,DTCC00139782,1458834,26306
28,CHEMBL11608,P46098,TYRAMINE,DZGWFCGJZKJUFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,EC50,=,26000.0,NM,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478755.0,DTCT0023221,2354068,DTCC00139782,1458834,26306
29,CHEMBL1163015,P46098,,HFOUMBDMIJJHCK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,2800.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114452,DTCC00650396,1232455,36218
30,CHEMBL116913,P46098,,CEOCEXSTLLSYBV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12540230.0,KI,=,53.2,NM,,,,,,,,,,,,,,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,5-HT4 receptor ligands: applications and new prospects.,J. Med. Chem.,2003.0,46.0,3.0,"Langlois M, Fischmeister R",,3473.0,DTCT0023221,1066965,DTCC00290242,1774449,17663
31,CHEMBL1169707,P46098,,GCWNAFLHJNJVCV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20541425.0,ACTIVITY,=,-7.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 1 uM by radioligand displacement assay,,"Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.",Bioorg. Med. Chem.,2010.0,18.0,14.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Kovalenko SM, Mitkin OD, Okun IM, Ravnyeyko IM, Tkachenko SE, Zaremba OV",,642506.0,DTCT0023221,3393561,DTCC00655086,1536915,39618
32,CHEMBL1170237,P46098,,DICVBGGIAAPPNV-ZSUDRMHPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,1000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643656,DTCC00655623,481040,56290
33,CHEMBL1171434,P46098,,XVOYSCVBGLVSOL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737634,DTCC00655109,2106368,69159
34,CHEMBL117287,P46098,PRUCALOPRIDE,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,3981.07,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613773,DTCC00290884,823881,33265
35,CHEMBL1173578,P46098,,AFEOLFPUJYURJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20541425.0,ACTIVITY,=,-3.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 1 uM by radioligand displacement assay,,"Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.",Bioorg. Med. Chem.,2010.0,18.0,14.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Kovalenko SM, Mitkin OD, Okun IM, Ravnyeyko IM, Tkachenko SE, Zaremba OV",,642506.0,DTCT0023221,3393573,DTCC00656645,1504596,39618
36,CHEMBL1178,P46098,,UIJIQXGRFSPYQW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720913,DTCC00292803,2102127,68163
37,CHEMBL1189234,P46098,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475977,DTCC00667938,1780157,51935
38,CHEMBL1189234,P46098,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12600286,DTCC00667938,1780916,55935
39,CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20724042.0,KI,=,0.0316,NM,,,,,,,,,,,,,,Binding affinity to 5HT3A receptor,,Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.,Eur. J. Med. Chem.,2010.0,45.0,11.0,"Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC",,685540.0,DTCT0023221,3563563,DTCC00668368,1396273,41807
40,CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-2.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035402,DTCC00668368,1413958,42619
41,CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-2.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825.0,DTCT0023221,5035413,DTCC00668368,1413958,42619
42,CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813.0,IC50,=,0.83,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human wild type 5-HT3A receptor expressed in HEK293 cells assessed as inhibition of 5-HT-induced response after 45 mins by FLIPR assay,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278336.0,DTCT0023221,12951310,DTCC00668368,1419159,56549
43,CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813.0,KD,=,0.32,NM,,cell_based,,,,,,,,,,,,Binding affinity to human wild type 5-HT3A receptor expressed in HEK293 cells after 24 hrs by liquid scintillation counting analysis,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278482.0,DTCT0023221,12952197,DTCC00668368,1419159,56549
44,CHEMBL120055,P46098,,DWSOZYFSYVOVOC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,IC50,>,10000.0,NM,,,,,,,,,,,,,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,7.0,,,3460.0,DTCT0023221,875262,DTCC00296622,109540,1553
45,CHEMBL1204203,P46098,,GQQHPWHBHFNFFC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11170628.0,KI,>,1000.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.,J. Med. Chem.,2001.0,44.0,2.0,"López-Rodríguez ML, Morcillo MJ, Fernández E, Porras E, Orensanz L, Beneytez ME, Manzanares J, Fuentes JA",,3471.0,DTCT0023221,1564868,DTCC00681707,808331,16410
46,CHEMBL1208883,P46098,,LMMXCOUUSOBOAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20638843.0,ACTIVITY,=,8.4,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human 5HT3 receptor expressed in CHO cells at 10 uM,,Discovery of novel alpha7 nicotinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,16.0,"Peng Y, Zhang Q, Snyder GL, Zhu H, Yao W, Tomesch J, Papke RL, O'Callaghan JP, Welsh WJ, Wennogle LP",,645017.0,DTCT0023221,3415698,DTCC00685727,716438,39883
47,CHEMBL1210154,P46098,,CQUWKHKELQQYRI-KGENOOAVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591666.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL 43694 from human recombinant 5HT3 receptor expressed in CHO cells,,A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.,Bioorg. Med. Chem. Lett.,2010.0,20.0,15.0,"Gattinoni S, Simone CD, Dallavalle S, Fezza F, Nannei R, Battista N, Minetti P, Quattrociocchi G, Caprioli A, Borsini F, Cabri W, Penco S, Merlini L, Maccarrone M",,643635.0,DTCT0023221,3413129,DTCC00686944,241890,39814
48,CHEMBL1210515,P46098,,RPQHJWKLRRXKIS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591663.0,IC50,=,7943.28,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor,,Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.,Bioorg. Med. Chem. Lett.,2010.0,20.0,15.0,"Capelli AM, Castelletti L, Salvagno C, Oliosi B, Di Lenarda E, Virginio C, Lightfoot A, Kew JN, Teague S",,643571.0,DTCT0023221,3412864,DTCC00687304,1557285,35708
49,CHEMBL1210703,P46098,,AJTVQZWUKUPHIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591663.0,IC50,=,1000.0,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor,,Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.,Bioorg. Med. Chem. Lett.,2010.0,20.0,15.0,"Capelli AM, Castelletti L, Salvagno C, Oliosi B, Di Lenarda E, Virginio C, Lightfoot A, Kew JN, Teague S",,643571.0,DTCT0023221,3412900,DTCC00687492,328485,35708
50,CHEMBL1224034,P46098,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20692833.0,INHIBITION,=,-8.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human 5HT3 receptor at 10 uM,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010.0,20.0,18.0,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652353.0,DTCT0023221,3449407,DTCC00692765,716520,40427
51,CHEMBL1224527,P46098,,FKYWSGYMKJUZEP-ZOBUZTSGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20709559.0,KI,=,870000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Facile synthesis of octahydrobenzo[h]isoquinolines: Novel and highly potent D(1) dopamine agonists.,Bioorg. Med. Chem.,2010.0,18.0,18.0,"Bonner LA, Chemel BR, Watts VJ, Nichols DE",,652920.0,DTCT0023221,3442398,DTCC00693196,1666088,40467
52,CHEMBL123137,P46098,,HNDAZSYDBSRFST-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,4.68,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422326,DTCC00299255,1656132,51459
53,CHEMBL1241348,P46098,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20823284.0,INHIBITION,=,5.0,%,,,,,,,,,,,,,,Inhibition of human H3 receptor at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010.0,54.0,11.0,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724392.0,DTCT0023221,5127076,DTCC00126282,118904,43507
54,CHEMBL1242923,P46098,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20684563.0,KI,>=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659608.0,DTCT0023221,3460952,DTCC00697046,1200707,40772
55,CHEMBL1242950,P46098,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20684563.0,KI,>=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659608.0,DTCT0023221,3460953,DTCC00032233,1972874,40772
56,CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,EMAX,=,15.0,%,,,,,,,,,,,,,,Agonist activity at human 5HT3A at 100 uM relative to control,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851022.0,DTCT0023221,11361502,DTCC00701194,1189842,50968
57,CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,INHIBITION,=,25.0,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851023.0,DTCT0023221,11361500,DTCC00701194,1189842,50968
58,CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,25.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452775,DTCC00701194,1170043,51687
59,CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human 5HT3R,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877364.0,DTCT0023221,11452733,DTCC00701194,1170043,51687
60,CHEMBL1258223,P46098,,WKWADEWWLCVVLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20812727.0,KI,=,1072.0,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664931.0,DTCT0023221,3532944,DTCC00701398,1168405,41144
61,CHEMBL1258452,P46098,,DZZIAERGLDKTBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20812727.0,KI,=,3511.0,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664931.0,DTCT0023221,3532988,DTCC00701623,716604,41144
62,CHEMBL1258614,P46098,,IUEKKZWRWOFGRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664299.0,DTCT0023221,3527811,DTCC00701782,911256,41064
63,CHEMBL1258671,P46098,,WLHFUBIRAHRPHA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20812727.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664931.0,DTCT0023221,3533032,DTCC00701836,911257,41144
64,CHEMBL1258843,P46098,,VHENJOBTWCOIPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664299.0,DTCT0023221,3527894,DTCC00702004,1265966,41064
65,CHEMBL1270261,P46098,,XILQKEHRYUALQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5HT3A receptor expressed in Xenopus oocyte,Not Active,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010.0,53.0,17.0,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675557.0,DTCT0023221,3545611,DTCC00703499,631664,41410
66,CHEMBL1270261,P46098,,XILQKEHRYUALQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351.0,INHIBITION,=,1.7,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 20 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010.0,53.0,17.0,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675555.0,DTCT0023221,3545610,DTCC00703499,631664,41410
67,CHEMBL1270361,P46098,,XILQKEHRYUALQZ-SNVBAGLBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351.0,INHIBITION,=,34.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 9 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010.0,53.0,17.0,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675554.0,DTCT0023221,3545609,DTCC00703596,1633942,41410
68,CHEMBL1270457,P46098,,XILQKEHRYUALQZ-JTQLQIEISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351.0,INHIBITION,=,29.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 9 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010.0,53.0,17.0,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675554.0,DTCT0023221,3545608,DTCC00703690,1212287,41410
69,CHEMBL1271520,P46098,,ORJWZBKFHYBQDC-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,165.0,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553829,DTCC00704734,631676,41528
70,CHEMBL1271790,P46098,,ABIDZKZAFOTHFB-GRDNDAEWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,6.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553838,DTCC00704993,1472476,41528
71,CHEMBL1272016,P46098,,QZEXFNKCPOFGAE-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,47.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553847,DTCC00705207,469940,41528
72,CHEMBL1272072,P46098,,OUENCNZMGZDHGX-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,32.7,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553849,DTCC00705263,890297,41528
73,CHEMBL1272121,P46098,,IMXFSNJHDBFECE-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,36.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553856,DTCC00705310,242106,41528
74,CHEMBL1272122,P46098,,ZCUBEQCDRQOEAQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,12.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553853,DTCC00705311,1854887,41528
75,CHEMBL1272123,P46098,,PBZNWDCSSPCDNF-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,66.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553854,DTCC00705312,1569073,41528
76,CHEMBL1272176,P46098,,AJOIVAKMJVSBOV-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,18.2,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553855,DTCC00705363,1019144,41528
77,CHEMBL1272177,P46098,,UYMMSSRZDUEJKE-GFCCVEGCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,36.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553857,DTCC00705364,275022,41528
78,CHEMBL1272178,P46098,,MNODGVITNFISIZ-LLVKDONJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,13.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553858,DTCC00705365,1727628,41528
79,CHEMBL1272232,P46098,,IATGNHOMUXVGCQ-LLVKDONJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,4.7,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553859,DTCC00705417,502570,41528
80,CHEMBL1276832,P46098,,VWVPNALHKWLANG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,48.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587057,DTCC00706551,1557482,41871
81,CHEMBL1276833,P46098,,MYBMSIDXODXJBU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,50.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587058,DTCC00706552,296048,41871
82,CHEMBL1276834,P46098,,SMZVQCAMELNWOP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,62.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587072,DTCC00706553,555234,41871
83,CHEMBL1276835,P46098,,LQAYFYWMQKQPPJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,84.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587090,DTCC00126685,490852,41871
84,CHEMBL1276919,P46098,,YURHTDCTHANLFV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587487,DTCC00706630,133751,41871
85,CHEMBL1276920,P46098,,YZHWETPHARDZQM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,87.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587094,DTCC00706631,619766,41871
86,CHEMBL1276921,P46098,,ZNOMCTSKVJJIMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,46.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587054,DTCC00706632,1072234,41871
87,CHEMBL1276922,P46098,,MLNBDGCWHJVZAI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,22.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587036,DTCC00706633,878675,41871
88,CHEMBL1277005,P46098,,MPEGWVZSANJAMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587474,DTCC00706713,780906,41871
89,CHEMBL1277006,P46098,,OHXKHPFEXVDLQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,24.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587039,DTCC00706714,1810952,41871
90,CHEMBL1277007,P46098,,QZHACJCMCCGZRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,59.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587069,DTCC00706715,1072235,41871
91,CHEMBL1277098,P46098,,IQKPITCNSNNYNB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587475,DTCC00706802,684307,41871
92,CHEMBL1277099,P46098,,JIWMRJSKGUAANW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,41.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587046,DTCC00706803,133752,41871
93,CHEMBL1277100,P46098,,LZVLTVPNYIRFTB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587488,DTCC00706804,2005627,41871
94,CHEMBL1277101,P46098,,ZRMKLDGEAIPBEE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587489,DTCC00706805,1331198,41871
95,CHEMBL1277186,P46098,,DWCWRMNZCYONIV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587476,DTCC00706886,942829,41871
96,CHEMBL1277187,P46098,,LLZLRXCVMYYKBH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,44.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587051,DTCC00706887,1493079,41871
97,CHEMBL1277188,P46098,,VTHVGLORMDHGGF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587490,DTCC00706888,1039843,41871
98,CHEMBL1277189,P46098,,WOXCQSXEHWXACS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587491,DTCC00706889,652302,41871
99,CHEMBL1277280,P46098,,HLMKBCUKQMBYDR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,69.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587081,DTCC00706972,1460605,41871
100,CHEMBL1277281,P46098,,OJNSMLDRVFFVJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,63.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587076,DTCC00706973,1810956,41871
101,CHEMBL1277282,P46098,,DQFJTXJCMDYWKL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,52.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587061,DTCC00706974,942831,41871
102,CHEMBL1277283,P46098,,QCJPMOOSRAYGGE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587492,DTCC00706975,328677,41871
103,CHEMBL1277371,P46098,,WCGCGRZZPCFDSO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587477,DTCC00707056,1428595,41871
104,CHEMBL1277372,P46098,,SPBSBKPLXWUEGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,61.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587071,DTCC00707057,1200798,41871
105,CHEMBL1277373,P46098,,UGLUCZYCHYWOCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,55.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587062,DTCC00707058,1525423,41871
106,CHEMBL1277374,P46098,,HGUUKRWUSHWXTH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,86.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587092,DTCC00707059,780910,41871
107,CHEMBL1277462,P46098,,YHOYHBANAWEKNE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,64.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587078,DTCC00707139,1493081,41871
108,CHEMBL1277463,P46098,,MDDLXKDIADSAQA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587112,DTCC00707140,1200799,41871
109,CHEMBL1277464,P46098,,XYQXSKXZFRFXOW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587493,DTCC00707141,1972994,41871
110,CHEMBL1277465,P46098,,WCNGVFDLZVYEJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587494,DTCC00707142,716655,41871
111,CHEMBL1277558,P46098,,OMACXBJTMXFHCQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,77.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587085,DTCC00707232,1331202,41871
112,CHEMBL1277559,P46098,,FEPROLQKWGDFKU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,26.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587040,DTCC00707233,1493086,41871
113,CHEMBL1277560,P46098,,OPVPOKBFTBDGTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587495,DTCC00707234,684313,41871
114,CHEMBL1277561,P46098,,WXWOIPIEFSEMLN-OYRHEFFESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,INHIBITION,=,19.6,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 100 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684898.0,DTCT0023221,3587034,DTCC00707235,1266030,41871
115,CHEMBL1277561,P46098,,WXWOIPIEFSEMLN-OYRHEFFESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,INHIBITION,=,87.3,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 1000 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684899.0,DTCT0023221,3587093,DTCC00707235,1266030,41871
116,CHEMBL1277651,P46098,,GTIKAAJNYPWELX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,45.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587053,DTCC00707320,69163,41871
117,CHEMBL1277652,P46098,,UFZPJSNEEQOZFZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,50.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587059,DTCC00707321,2070192,41871
118,CHEMBL1277653,P46098,,WXWOIPIEFSEMLN-MEMLXQNLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,INHIBITION,=,1.4,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 100 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684898.0,DTCT0023221,3586994,DTCC00707322,1972997,41871
119,CHEMBL1277653,P46098,,WXWOIPIEFSEMLN-MEMLXQNLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,INHIBITION,=,18.4,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 1000 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684899.0,DTCT0023221,3587031,DTCC00707322,1972997,41871
120,CHEMBL1277745,P46098,,CFOHOEGJDCNBCR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,99.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587110,DTCC00707410,133756,41871
121,CHEMBL1277746,P46098,,PWVBQEUMVVPFJT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587478,DTCC00707411,1810959,41871
122,CHEMBL1277832,P46098,,ASIIZNZQUBPOJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587479,DTCC00707495,1746576,41871
123,CHEMBL1277833,P46098,,TZSHYDBBXRRBCE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587480,DTCC00707496,14899,41871
124,CHEMBL1277913,P46098,,PYCJRTFNOGPLEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587481,DTCC00707572,587403,41871
125,CHEMBL1277914,P46098,,XVBPOYYIPRSULQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,83.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587089,DTCC00707573,101390,41871
126,CHEMBL1277995,P46098,,RSUQRWJJGYXXCP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587482,DTCC00707651,1007415,41871
127,CHEMBL1277996,P46098,,GSEARIWHWZTSPV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,45.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587052,DTCC00707652,426610,41871
128,CHEMBL1278087,P46098,,BSCUUFDNCBQNPG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,15.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587028,DTCC00707741,684323,41871
129,CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,8.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587017,DTCC00707742,716661,41871
130,CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,8.93,NM,,,,,,,,,,,,,,Displacement of [3H]BRL-43694 from human recombinant 5HT3 receptor,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684926.0,DTCT0023221,3587018,DTCC00707742,716661,41871
131,CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,KI,=,4.72,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684895.0,DTCT0023221,3587005,DTCC00707742,716661,41871
132,CHEMBL1278174,P46098,,HOABLJVFGVOCMM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587473,DTCC00707823,684327,41871
133,CHEMBL1278175,P46098,,GERBCOZLRREKHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,48.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587056,DTCC00707824,2070202,41871
134,CHEMBL1278176,P46098,,FCQFXDREOPQEAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,97.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587109,DTCC00707825,166107,41871
135,CHEMBL128,P46098,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7752204.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding activity radioligand.,,"Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.",J. Med. Chem.,1995.0,38.0,10.0,"Street LJ, Baker R, Davey WB, Guiblin AR, Jelley RA, Reeve AJ, Routledge H, Sternfeld F, Watt AP, Beer MS",,3126.0,DTCT0023221,520894,DTCC00154636,658692,13017
136,CHEMBL128,P46098,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9357515.0,IC50,=,9.3,NM,,,,,,,,,,,,,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,"Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.",J. Med. Chem.,1997.0,40.0,22.0,"MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG",,3459.0,DTCT0023221,712596,DTCC00154636,659675,14385
137,CHEMBL1289626,P46098,WMS-1410,KKLZGWQBNXJWGZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20965739.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]-GR-65630 from 5-HT3 receptor at 1 to 3 uM,Not Active,"Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.",Bioorg. Med. Chem.,2010.0,18.0,22.0,"Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wünsch B",,686785.0,DTCT0023221,3613342,DTCC00032749,40842,41994
138,CHEMBL133455,P46098,,VVHJUSGIUWQPIT-VIFPVBQESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12954071.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003.0,46.0,19.0,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,3472.0,DTCT0023221,1106904,DTCC00315452,2045939,17506
139,CHEMBL1336,P46098,SORAFENIB,MLDQJTXFUGDVEO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22694093.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor after 1.5 hrs by scintillation counter,Not Active,Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.,J. Med. Chem.,2012.0,55.0,12.0,"Lin X, Huang XP, Chen G, Whaley R, Peng S, Wang Y, Zhang G, Wang SX, Wang S, Roth BL, Huang N",,858212.0,DTCT0023221,11389507,DTCC00361295,782470,51215
140,CHEMBL133868,P46098,,VVHJUSGIUWQPIT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12954071.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003.0,46.0,19.0,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,3472.0,DTCT0023221,1109511,DTCC00315451,173712,17506
141,CHEMBL1365455,P46098,,MNJNPLVXBISNSX-PBWFPOADSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801.0,IC50,=,6.9,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016.0,24.0,8.0,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559795.0,DTCT0023221,117199,DTCC00772276,517084,66408
142,CHEMBL13823,P46098,N-(3-CHLOROPHENYL)GUANIDINE,DWLMIHRZURMFAQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337.0,KI,=,32.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin) expressed in mouse/rat NG108-15 cells after 30 mins by by liquid scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988339.0,DTCT0023221,12618342,DTCC01738849,1877872,56006
143,CHEMBL1382868,P46098,,BGMSTNYJYPSLHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,1300.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14713107,DTCC00788480,2098974,68163
144,CHEMBL138458,P46098,,IJKYJDDNDXAREJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002.0,45.0,2.0,"Maier CA, Wünsch B",,3461.0,DTCT0023221,1330607,DTCC00323189,65365,16958
145,CHEMBL138809,P46098,,RZZAEVQHACUOGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002.0,45.0,2.0,"Maier CA, Wünsch B",,3461.0,DTCT0023221,1325461,DTCC00323057,1489511,16958
146,CHEMBL141209,P46098,,POOPPNNSPMKABZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002.0,45.0,2.0,"Maier CA, Wünsch B",,3461.0,DTCT0023221,1333323,DTCC00322694,1360188,16958
147,CHEMBL1417859,P46098,,GEIHZHQRXYKYAE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,9000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718733,DTCC00821177,2101711,68163
148,CHEMBL142852,P46098,RS-33800,JKCPJPRSHXMMGA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3476.0,DTCT0023221,534954,DTCC01743500,1404383,1973
149,CHEMBL142852,P46098,RS-33800,JKCPJPRSHXMMGA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,19.95,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3475.0,DTCT0023221,534956,DTCC01743500,1404383,1973
150,CHEMBL14376,P46098,ILOPERIDONE,XMXHEBAFVSFQEX-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11750183.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14732054,DTCC00143788,2104585,69484
151,CHEMBL1448856,P46098,,XJIAFXBLMMIRJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714397,DTCC00849945,2099633,68163
152,CHEMBL145033,P46098,RS-16456,OGXMGJGFLBSEJW-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.138,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3476.0,DTCT0023221,525499,DTCC01743499,369324,1973
153,CHEMBL145033,P46098,RS-16456,OGXMGJGFLBSEJW-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,602.56,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3475.0,DTCT0023221,525501,DTCC01743499,369324,1973
154,CHEMBL145725,P46098,RS-16566,OGXMGJGFLBSEJW-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.145,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3475.0,DTCT0023221,528403,DTCC01743488,1883313,1973
155,CHEMBL145725,P46098,RS-16566,OGXMGJGFLBSEJW-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.537,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3476.0,DTCT0023221,528401,DTCC01743488,1883313,1973
156,CHEMBL148204,P46098,ACRIDIN-3-YLAMINE,GHCKERHPOQWERJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,1000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090033,DTCC01743566,296720,45760
157,CHEMBL148489,P46098,N-(3-PYRIDYLMETHYL)PYRROLIDINE,YFCWBKBNFCDPDF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10337083,DTCC00339052,2026783,48255
158,CHEMBL15056,P46098,,IBPWGZKZWJYGLA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565.0,KI,=,0.33,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008.0,51.0,3.0,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123.0,DTCT0023221,2280966,DTCC00144504,585453,25139
159,CHEMBL1516176,P46098,,PDNJLMZEGXHSCU-VKHMYHEASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14742333,DTCC00912618,2108018,69159
160,CHEMBL1545368,P46098,,RVXFERDBNJSQDX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14717934,DTCC00939726,2101285,68163
161,CHEMBL1548,P46098,,VBKOTIVQMCTTAQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17998160.0,KI,=,172.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.,Bioorg. Med. Chem. Lett.,2008.0,18.0,1.0,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,463654.0,DTCT0023221,2290840,DTCC00502474,1636476,25254
162,CHEMBL1586599,P46098,,WHCWGLIMIAJMOY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,12000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720929,DTCC00978021,2102135,68163
163,CHEMBL1614664,P46098,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739995,DTCC01003548,2107269,69275
164,CHEMBL1623875,P46098,,UMWDYBZXNCMBRO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14717956,DTCC01011635,2101297,68163
165,CHEMBL1632158,P46098,,RNXYMZNGMNWKMC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21075638.0,KI,=,2511.89,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010.0,18.0,24.0,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697187.0,DTCT0023221,5017352,DTCC01017945,1445751,42157
166,CHEMBL1632174,P46098,,ODMLUIATXKBXOW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21075638.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010.0,18.0,24.0,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697187.0,DTCT0023221,5017418,DTCC01017961,1185873,42157
167,CHEMBL1641625,P46098,,AGVRILRKGQDLBR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,2.4,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035385,DTCC01020566,604835,42619
168,CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,22.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035398,DTCC01020556,798453,42619
169,CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,71.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825.0,DTCT0023221,5035410,DTCC01020556,798453,42619
170,CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,5.4,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635.0,DTCT0023221,5035394,DTCC01020556,798453,42619
171,CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,9.2,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700639.0,DTCT0023221,5035406,DTCC01020556,798453,42619
172,CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,35.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035399,DTCC01020557,313577,42619
173,CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,97.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 1 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700640.0,DTCT0023221,5035416,DTCC01020557,313577,42619
174,CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,14.5,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635.0,DTCT0023221,5035395,DTCC01020557,313577,42619
175,CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,4.4,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035375,DTCC01020557,313577,42619
176,CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,0.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 1 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700636.0,DTCT0023221,5035397,DTCC01020558,960317,42619
177,CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,0.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 1 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700636.0,DTCT0023221,5035408,DTCC01020558,960317,42619
178,CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,84.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 1 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700640.0,DTCT0023221,5035417,DTCC01020558,960317,42619
179,CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,4.9,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035376,DTCC01020558,960317,42619
180,CHEMBL1643883,P46098,,FDKJLUOOFWBTDY-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,6.9,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700639.0,DTCT0023221,5035407,DTCC01020559,215490,42619
181,CHEMBL1643883,P46098,,FDKJLUOOFWBTDY-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,12.6,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635.0,DTCT0023221,5035396,DTCC01020559,215490,42619
182,CHEMBL1643883,P46098,,FDKJLUOOFWBTDY-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,1.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035377,DTCC01020559,215490,42619
183,CHEMBL1643884,P46098,,FDKJLUOOFWBTDY-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-2.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 10 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700637.0,DTCT0023221,5035409,DTCC01020560,2087653,42619
184,CHEMBL1643884,P46098,,FDKJLUOOFWBTDY-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-2.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 10 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700641.0,DTCT0023221,5036540,DTCC01020560,2087653,42619
185,CHEMBL1643884,P46098,,FDKJLUOOFWBTDY-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,0.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035378,DTCC01020560,2087653,42619
186,CHEMBL1643885,P46098,,ZCOOWPLAEBRGOA-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,2.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035379,DTCC01020561,1024849,42619
187,CHEMBL1643886,P46098,,JOEZRUWANPRMKY-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,2.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035380,DTCC01020562,183378,42619
188,CHEMBL1643887,P46098,,JOEZRUWANPRMKY-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,1.6,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035381,DTCC01020563,734130,42619
189,CHEMBL1643888,P46098,,CKWOZHIVNRGMQI-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,3.6,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035382,DTCC01020564,1671980,42619
190,CHEMBL1643889,P46098,,CKWOZHIVNRGMQI-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,2.3,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035384,DTCC01020565,475832,42619
191,CHEMBL1643890,P46098,,QOGFHRRNPRRNAI-NRFANRHFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,7.1,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035386,DTCC01020567,378849,42619
192,CHEMBL1643891,P46098,,JCMOIELRWILJKV-FQEVSTJZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,23.4,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035387,DTCC01020569,798454,42619
193,CHEMBL1643892,P46098,,JCMOIELRWILJKV-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,7.9,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035388,DTCC01020570,669627,42619
194,CHEMBL1643893,P46098,,RZKMGDNFMYZIER-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,0.9,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035389,DTCC01020571,1703834,42619
195,CHEMBL1643894,P46098,,RZKMGDNFMYZIER-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,0.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035390,DTCC01020572,1185896,42619
196,CHEMBL1643894,P46098,,RZKMGDNFMYZIER-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635613,DTCC01020572,1161836,64307
197,CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-1.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035401,DTCC01020573,540450,42619
198,CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-1.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825.0,DTCT0023221,5035412,DTCC01020573,540450,42619
199,CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,KI,=,0.06,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634.0,DTCT0023221,5035392,DTCC01020573,540450,42619
200,CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.06,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678640,DTCC01020573,528395,65052
201,CHEMBL1643899,P46098,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885.0,DTCT0023221,5036630,DTCC01020576,166198,42620
202,CHEMBL1643899,P46098,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584703,DTCC01020576,168448,55935
203,CHEMBL1643900,P46098,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885.0,DTCT0023221,5036660,DTCC01020577,942929,42620
204,CHEMBL1643900,P46098,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584700,DTCC01020577,945255,55935
205,CHEMBL1643901,P46098,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885.0,DTCT0023221,5036692,DTCC01020578,1460729,42620
206,CHEMBL1643901,P46098,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584718,DTCC01020578,1463030,55935
207,CHEMBL1643902,P46098,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885.0,DTCT0023221,5036724,DTCC01020579,619871,42620
208,CHEMBL1643902,P46098,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584714,DTCC01020579,622243,55935
209,CHEMBL1651095,P46098,PULICATIN A,ZVWPMYHMXUXIMC-IONNQARKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21028889.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand displacement assay,Not Active,"Pulicatins A-E, neuroactive thiazoline metabolites from cone snail-associated bacteria.",J. Nat. Prod.,2010.0,73.0,11.0,"Lin Z, Antemano RR, Hughen RW, Tianero MD, Peraud O, Haygood MG, Concepcion GP, Olivera BM, Light A, Schmidt EW",,714929.0,DTCT0023221,5076871,DTCC01023403,1907820,43120
210,CHEMBL1651208,P46098,,DWTYHCYVKJONSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23009245.0,INHIBITION,=,10.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human 5HT3 at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012.0,55.0,22.0,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876176.0,DTCT0023221,11437734,DTCC01023515,317585,51586
211,CHEMBL1651219,P46098,,ZQBPXBADOJMCRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23009245.0,INHIBITION,=,-13.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human 5HT3 at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012.0,55.0,22.0,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876176.0,DTCT0023221,11437685,DTCC01023526,1675972,51586
212,CHEMBL1668584,P46098,,YPVOSIDECMYMTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21333408.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2011.0,46.0,4.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I",,740251.0,DTCT0023221,5907271,DTCC01025412,943137,44130
213,CHEMBL1669669,P46098,RO-5212773,KLFVWQCQUXXLOU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21237643.0,INHIBITION,=,9.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL 43694 from human recombinant 5HT3 receptor expressed in CHO cells,,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,2011.0,21.0,4.0,"Stalder H, Hoener MC, Norcross RD",,716516.0,DTCT0023221,5105748,DTCC00033580,1557659,43309
214,CHEMBL1672288,P46098,,LVXAMCKZCLWWTF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21207959.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,2011.0,54.0,3.0,"Siméon FG, Wendahl MT, Pike VW",,718858.0,DTCT0023221,5116559,DTCC01026954,798550,43561
215,CHEMBL1702607,P46098,,ADVPTQAUNPRNPO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14733126,DTCC01037443,2104825,69159
216,CHEMBL1738699,P46098,,YVPGZQLRPAGKLA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207.0,DTCT0023221,5974923,DTCC01070772,735160,44781
217,CHEMBL1748,P46098,NORCISAPRIDE,OMLDMGPCWMBPAN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,EC50,=,2300.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598658.0,DTCT0023221,3115582,DTCC00604523,715932,36218
218,CHEMBL1748,P46098,NORCISAPRIDE,OMLDMGPCWMBPAN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1600.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114457,DTCC00604523,715932,36218
219,CHEMBL1764,P46098,LEVOMEPROMAZINE,VRQVVMDWGGWHTJ-CQSZACIVSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849464,DTCC00609202,1745673,34292
220,CHEMBL1765683,P46098,,ZVRXOXFSMYJETP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21428406.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011.0,54.0,8.0,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743825.0,DTCT0023221,5918941,DTCC01078226,652599,44302
221,CHEMBL1765684,P46098,,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21428406.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011.0,54.0,8.0,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743825.0,DTCT0023221,5918942,DTCC01078227,975211,44302
222,CHEMBL1770373,P46098,PF-3246799,CZWQBSKNHUVZLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21195614.0,IC50,=,2300.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor,,"Pyrimido[4,5-d]azepines as potent and selective 5-HT(2C) receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.",Bioorg. Med. Chem. Lett.,2011.0,21.0,9.0,"Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, Af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA",,744884.0,DTCT0023221,5933236,DTCC00033971,69510,44351
223,CHEMBL17740,P46098,,GVOCXQUIZNWEMU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,PKI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,Not Active,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090027,DTCC00147787,263506,45760
224,CHEMBL1774991,P46098,,YTOGOMGUCNEXIR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21520940.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011.0,54.0,10.0,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747437.0,DTCT0023221,5943668,DTCC01083260,1575851,44583
225,CHEMBL1774995,P46098,,IUEHDTRLKKNLDW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21520940.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011.0,54.0,10.0,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747437.0,DTCT0023221,5943667,DTCC01083264,1252166,44583
226,CHEMBL177611,P46098,PNU-282987,WECKJONDRAUFDD-ZDUSSCGKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24901260.0,KI,=,930.0,NM,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin),,Recent developments in novel antidepressants targeting a4ß2-nicotinic acetylcholine receptors.,J. Med. Chem.,2014.0,57.0,20.0,"Yu LF, Zhang HK, Caldarone BJ, Eaton JB, Lukas RJ, Kozikowski AP",,1454480.0,DTCT0023221,13901941,DTCC00379668,1846517,60704
227,CHEMBL1783889,P46098,,DSNALXIKDKGHLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496643.0,DTCT0023221,14434907,DTCC01087435,1615288,62611
228,CHEMBL1784671,P46098,,NVCJMYLJSSPEKR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207.0,DTCT0023221,5974922,DTCC01088207,184448,44781
229,CHEMBL1784673,P46098,,CPOQTXKWWFQYCF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207.0,DTCT0023221,5974921,DTCC01088209,314586,44781
230,CHEMBL1784685,P46098,,APARPRRWRUIPGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207.0,DTCT0023221,5976390,DTCC01088221,1764905,44781
231,CHEMBL1784694,P46098,,USRJTKDRTOTPRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207.0,DTCT0023221,5976391,DTCC01088230,347293,44781
232,CHEMBL180101,P46098,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849458,DTCC00383453,1362971,34292
233,CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434.0,KI,=,0.7,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990.0,33.0,10.0,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470.0,DTCT0023221,1071794,DTCC00149028,1196464,10392
234,CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,0.95,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14756850,DTCC00149028,2110980,68446
235,CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,5.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14756852,DTCC00149028,2110980,68446
236,CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14756851,DTCC00149028,2110980,68446
237,CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159.0,KI,=,0.39,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847.0,DTCT0023221,12984063,DTCC00149028,1223430,56928
238,CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159.0,KI,=,0.398,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847.0,DTCT0023221,12984028,DTCC00149028,1223430,56928
239,CHEMBL1812545,P46098,,JDBSZVDIUIRSDG-DAFODLJHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21726069.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human 5HT3 receptor at 10 uM relative to control,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011.0,54.0,15.0,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,762041.0,DTCT0023221,6053735,DTCC01099864,1959018,45491
240,CHEMBL1813065,P46098,,DNVBBWNTRFFIHW-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649960,DTCC01100346,898549,47502
241,CHEMBL1824046,P46098,,NRJJRVIMKKANAW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,PKI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,Not Active,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090029,DTCC01105796,2006347,45760
242,CHEMBL1824047,P46098,,WIPPGLNWEIAUEV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,794.33,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090034,DTCC01105797,134433,45760
243,CHEMBL1824048,P46098,,LZFIKFXIHTZOJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,1.58,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090040,DTCC01105798,2006348,45760
244,CHEMBL1824228,P46098,,RWBFCYZFACUBIZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,1258.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090045,DTCC01105973,166727,45760
245,CHEMBL1824777,P46098,,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207.0,DTCT0023221,6091857,DTCC01106515,961498,45468
246,CHEMBL1824778,P46098,,LPAMOYXJLQSGRI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207.0,DTCT0023221,6091856,DTCC01106516,1058448,45468
247,CHEMBL1824784,P46098,,HXOMGUPFBWZKBK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207.0,DTCT0023221,6091855,DTCC01106522,638709,45468
248,CHEMBL1824785,P46098,,ZILQWXOKQUVSTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207.0,DTCT0023221,6091854,DTCC01106523,1640941,45468
249,CHEMBL182721,P46098,,XCKMSIBEVNAANY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283.0,KI,=,5248.07,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004.0,14.0,16.0,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007.0,DTCT0023221,1764678,DTCC00387104,98387,18177
250,CHEMBL1829335,P46098,IRDABISANT,XUKROCVZGZNGSI-CQSZACIVSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,2.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649959,DTCC01107613,1577250,47502
251,CHEMBL1834350,P46098,,XEWOFIPWWSYNAY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21866910.0,KI,=,10000.0,NM,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor,,"N'-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT(6)R) Antagonists with Unique Structural Features.",J. Med. Chem.,2011.0,54.0,20.0,"van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG",,771214.0,DTCT0023221,6116220,DTCC01109859,1655306,46048
252,CHEMBL183776,P46098,,QOTYCLIFPPZNAZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004.0,14.0,16.0,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007.0,DTCT0023221,1765138,DTCC00387156,325640,18177
253,CHEMBL183776,P46098,,QOTYCLIFPPZNAZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013.0,22.0,2.0,,,932184.0,DTCT0023221,11740304,DTCC00387156,350771,51606
254,CHEMBL184238,P46098,URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16352709.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14740684,DTCC00000860,2107472,69711
255,CHEMBL184770,P46098,,IOUSMYRYFCYRJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004.0,14.0,16.0,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007.0,DTCT0023221,1764687,DTCC00387182,1036895,18177
256,CHEMBL184770,P46098,,IOUSMYRYFCYRJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013.0,22.0,2.0,,,932184.0,DTCT0023221,11740306,DTCC00387182,1061574,51606
257,CHEMBL18772,P46098,QUIPAZINE,XRXDAJYKGWNHTQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,3.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125159,DTCC00149768,905225,23555
258,CHEMBL18772,P46098,QUIPAZINE,XRXDAJYKGWNHTQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125160,DTCC00149768,905225,23555
259,CHEMBL1885748,P46098,,JQSJAVBMIMDUFO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23642479.0,INHIBITION,=,2.0,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM relative to control,,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,2013.0,23.0,12.0,"Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J",,965555.0,DTCT0023221,12471656,DTCC01135294,545285,54833
260,CHEMBL189676,P46098,SURINABANT,HMXDWDSNPRNUKI-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15131245.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14758281,DTCC00396917,2111237,69827
261,CHEMBL19215,P46098,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20451398.0,ACTIVITY,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human cloned 5HT3 receptor,,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,2010.0,18.0,22.0,"Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C",,681128.0,DTCT0023221,3577597,DTCC00150357,296043,41784
262,CHEMBL1922537,P46098,USABAMYCIN A,VRTIPIUNHQTBEU-JVOXIWMLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22001031.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 25 uM,Not Active,Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.,Bioorg. Med. Chem. Lett.,2011.0,21.0,23.0,"Sato S, Iwata F, Yamada S, Kawahara H, Katayama M",,791000.0,DTCT0023221,7549228,DTCC01163372,749872,46551
263,CHEMBL1922538,P46098,USABAMYCIN B,YZASJELCRXLHII-LFJXOHPOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22001031.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 25 uM,Not Active,Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.,Bioorg. Med. Chem. Lett.,2011.0,21.0,23.0,"Sato S, Iwata F, Yamada S, Kawahara H, Katayama M",,791000.0,DTCT0023221,7549229,DTCC01163373,814229,46551
264,CHEMBL1922539,P46098,USABAMYCIN C,MGYWULAVXWGTIC-JVOXIWMLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22001031.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 25 uM,Not Active,Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.,Bioorg. Med. Chem. Lett.,2011.0,21.0,23.0,"Sato S, Iwata F, Yamada S, Kawahara H, Katayama M",,791000.0,DTCT0023221,7549230,DTCC01163374,653111,46551
265,CHEMBL1922614,P46098,,UKQMQTGGUNTZKM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22029285.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of serotonin 5-HT3 receptor at 1 uM by ligand displacement assay,Not Active,"Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.",J. Med. Chem.,2011.0,54.0,23.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM",,790139.0,DTCT0023221,7548685,DTCC01163436,1512917,46592
266,CHEMBL193016,P46098,,TYAGAVRSOFABFO-VIFPVBQESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,INHIBITION,=,2.5,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851023.0,DTCT0023221,11361592,DTCC00398972,155272,50968
267,CHEMBL1939222,P46098,,HTSQRRQNKJNSLH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22191331.0,INHIBITION,=,7.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor at 10 uM by radioligand displacement assay,,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,2012.0,55.0,1.0,"Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante RJ, Silverman RB",,858163.0,DTCT0023221,11390346,DTCC01170899,931965,51183
268,CHEMBL1939782,P46098,,LRBQTFPUUPFJQW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22222034.0,INHIBITION,=,54.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 at 10 uM,,"The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.",Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Ho GD, Yang SW, Smotryski J, Bercovici A, Nechuta T, Smith EM, McElroy W, Tan Z, Tulshian D, McKittrick B, Greenlee WJ, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R",,798417.0,DTCT0023221,7606602,DTCC00129329,1234141,47151
269,CHEMBL194305,P46098,,ZQZWLJUKYOXRPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331.0,IC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005.0,15.0,19.0,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408.0,DTCT0023221,1847927,DTCC00405026,337540,19721
270,CHEMBL1945843,P46098,,HBDLBTSITBUDIR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,EC50,=,1.1,NM,,,,,,,,,,,,,,Antagonist activity at human recombinant 5HT3 receptor assessed as inhibition of RAMH-induced [35S]GTPgammaS binding,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805907.0,DTCT0023221,7650077,DTCC01173747,962719,47502
271,CHEMBL1945843,P46098,,HBDLBTSITBUDIR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KB,=,0.3,NM,,,,,,,,,,,,,,Antagonist activity at human recombinant 5HT3 receptor assessed as inhibition of RAMH-induced [35S]GTPgammaS binding,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805907.0,DTCT0023221,7650079,DTCC01173747,962719,47502
272,CHEMBL1945843,P46098,,HBDLBTSITBUDIR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649971,DTCC01173747,962719,47502
273,CHEMBL1949930,P46098,,IKXSPLZKOZXPFB-RQBPZYBGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22226656.0,INHIBITION,=,25.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 at 10 uM,,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,2012.0,22.0,3.0,"Tripathy R, McHugh RJ, Bacon ER, Salvino JM, Morton GC, Aimone LD, Huang Z, Mathiasen JR, DiCamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Qian J, Angeles TS, Connors T, Spais C, Holskin B, Duzic E, Schaffhauser H, Rossé GC",,804658.0,DTCT0023221,7639569,DTCC01175384,653195,47384
274,CHEMBL195241,P46098,,ACKJXXOVSOCBPX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565.0,KI,=,5.6,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008.0,51.0,3.0,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123.0,DTCT0023221,2280967,DTCC00400878,1555590,25139
275,CHEMBL1958132,P46098,,ZSXVTCQOHADCFY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,19.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649961,DTCC01179816,1092624,47502
276,CHEMBL1958133,P46098,,QJAUWCVZCCDKQC-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,1.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649962,DTCC01179817,444872,47502
277,CHEMBL1958134,P46098,,IQDHHFRBYSXXIU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,13.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649963,DTCC01179818,1830967,47502
278,CHEMBL1958135,P46098,,FSIKVHPOLUUBDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,8.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649964,DTCC01179819,2025907,47502
279,CHEMBL1958322,P46098,,SRWDXYXZNVIWLX-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,2.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649965,DTCC01179982,414258,47502
280,CHEMBL1958323,P46098,,OVNSLCAMMBQZNV-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,1.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649966,DTCC01179983,315936,47502
281,CHEMBL1958324,P46098,,ZLVGQXFVHCGGPY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,7.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649967,DTCC01179984,1027328,47502
282,CHEMBL1958325,P46098,,PNKGJBPTSCNELU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,4.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649968,DTCC01179985,833451,47502
283,CHEMBL1958326,P46098,,FVBMQXFSNPPRRM-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,2.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649969,DTCC01179986,88882,47502
284,CHEMBL1958327,P46098,,ZDCLGHCQWVFXJS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,8.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649970,DTCC01179987,1734325,47502
285,CHEMBL1958328,P46098,,HBDLBTSITBUDIR-SFHVURJKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,11.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649972,DTCC01179988,414259,47502
286,CHEMBL1958329,P46098,,XBRKSAQXTGMBRJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,7.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649973,DTCC01179989,898552,47502
287,CHEMBL1958330,P46098,,YNRFAWWXOCTZKF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,5.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649974,DTCC01179990,1513083,47502
288,CHEMBL1958331,P46098,,ZKBYTERDWDMGKM-LJQANCHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,1.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649975,DTCC01179991,704211,47502
289,CHEMBL1958332,P46098,,DLAXWULAMBVPFO-LJQANCHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,2.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649976,DTCC01179992,348692,47502
290,CHEMBL1958333,P46098,,ZROXYPDPKXBHHW-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649977,DTCC01179993,1253593,47502
291,CHEMBL1958334,P46098,,DACDBRYFJUJEAA-LJQANCHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017.0,KI,=,3.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012.0,55.0,1.0,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903.0,DTCT0023221,7649978,DTCC01179994,1609817,47502
292,CHEMBL2012728,P46098,,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22342142.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012.0,22.0,6.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811304.0,DTCT0023221,10426504,DTCC01227134,427664,47711
293,CHEMBL2012737,P46098,,NFEVAAXMHCVVQF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22342142.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012.0,22.0,6.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811304.0,DTCT0023221,10426503,DTCC01227143,620872,47711
294,CHEMBL2024087,P46098,,FQIJPHXWIONJLF-JKOKRWQUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22171543.0,INHIBITION,=,38.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815922.0,DTCT0023221,10457767,DTCC01232472,1365032,48063
295,CHEMBL2024089,P46098,,HGSHFGWWOPXUPH-WHOFXGATSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22171543.0,INHIBITION,=,23.5,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815922.0,DTCT0023221,10457768,DTCC01232474,102538,48063
296,CHEMBL2024094,P46098,,NMIIKXFGCKOYRV-WHOFXGATSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22171543.0,INHIBITION,=,42.4,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815922.0,DTCT0023221,10457769,DTCC01232479,1008460,48063
297,CHEMBL2027925,P46098,CAPESEROD,MDBNTXARNGRHEV-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12130738.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737750,DTCC01233125,2106409,69654
298,CHEMBL2030622,P46098,,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10477991,DTCC01235111,1610661,48255
299,CHEMBL2030623,P46098,,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478032,DTCC01235112,382111,48255
300,CHEMBL2030624,P46098,,MFKYGKXYJBKSQN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478079,DTCC01235113,218663,48255
301,CHEMBL2030625,P46098,,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818146.0,DTCT0023221,10478181,DTCC01235114,53054,48255
302,CHEMBL2030626,P46098,,TWUZJTIHFYRNSV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818146.0,DTCT0023221,10478230,DTCC01235115,1735130,48255
303,CHEMBL2030627,P46098,,JJTSIVODPMDGBG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478269,DTCC01235116,1417143,48255
304,CHEMBL2030628,P46098,,URNOPSHFIGOPOJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478609,DTCC01235117,1221331,48255
305,CHEMBL2030629,P46098,,SRRZEMVAQOSBLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478656,DTCC01235118,963513,48255
306,CHEMBL2030630,P46098,,LCBQDWKMNGEPLD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10471507,DTCC01235119,1961153,48255
307,CHEMBL2030631,P46098,N-BENZYLPYRROLIDINE,CWEGCQIIDCZZED-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478728,DTCC00041635,1993939,48255
308,CHEMBL2030632,P46098,N-(3-FLUOROBENZYL)PYRROLIDINE,PRKCBGIXZFUCEF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10331361,DTCC00041636,1417144,48255
309,CHEMBL2030633,P46098,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",MIZXZRHARATZMK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10478813,DTCC00041637,801620,48255
310,CHEMBL2030634,P46098,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,ADGIWWYGVBZYMC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818146.0,DTCT0023221,10479209,DTCC00041638,769521,48255
311,CHEMBL2030635,P46098,N-(2-PHENYLETHYL)PYRROLIDINE,KLUCWWVQVUXBSE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10479252,DTCC00041639,995674,48255
312,CHEMBL2030636,P46098,,PXBKRGXXBYALIH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10479296,DTCC00129963,1156787,48255
313,CHEMBL2030637,P46098,,VBKWQJLSFFFYLC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10479379,DTCC00129964,834331,48255
314,CHEMBL2031737,P46098,,GPZMWOXSIRVXQW-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22313227.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012.0,55.0,5.0,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818810.0,DTCT0023221,10474250,DTCC01236182,1106160,48153
315,CHEMBL203627,P46098,,PUDDOANNCQNPJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125164,DTCC00417389,1345649,23555
316,CHEMBL203627,P46098,,PUDDOANNCQNPJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125165,DTCC00417389,1345649,23555
317,CHEMBL2047561,P46098,,NBIWTPBSAFCSRX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762.0,INHIBITION,=,10.6,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288.0,DTCT0023221,10528259,DTCC00130266,167263,48646
318,CHEMBL2047570,P46098,,QXCOEFGWAUGVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762.0,INHIBITION,=,8.3,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288.0,DTCT0023221,10528278,DTCC00130275,1429720,48646
319,CHEMBL2047571,P46098,,JYIMWQCCVNSNJW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762.0,INHIBITION,=,0.5,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288.0,DTCT0023221,10528297,DTCC01242745,1332453,48646
320,CHEMBL2047573,P46098,,JZHYJRPFUZJBQH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762.0,INHIBITION,=,14.1,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288.0,DTCT0023221,10528316,DTCC01242747,1138570,48646
321,CHEMBL2047574,P46098,,NQXSFBZVBLPNCG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762.0,INHIBITION,=,25.1,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288.0,DTCT0023221,10528336,DTCC01242748,524316,48646
322,CHEMBL2058415,P46098,,GBAMAYLRKACPQW-IZZDOVSWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,5916.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643574,DTCC01245405,545513,56290
323,CHEMBL2058416,P46098,,WNMPRXNFNSOTPV-LFYBBSHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,6178.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643572,DTCC01245406,545514,56290
324,CHEMBL2058419,P46098,,IQJBDRJDMXGXFH-OSNXYGPASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,656.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643680,DTCC01245409,1062308,56290
325,CHEMBL2058420,P46098,,MDTKNEDEHYXCRY-OSNXYGPASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,1223.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643652,DTCC01245410,739193,56290
326,CHEMBL2058426,P46098,,ORMRVPRSUUACQQ-ZLJHMRGVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,591.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643683,DTCC01245413,1963125,56290
327,CHEMBL2058427,P46098,,ZBFOHUZFNZHQKR-QYRFSWOLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,2624.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643606,DTCC01245414,1354102,56290
328,CHEMBL2059590,P46098,,ZQMXTDPQEHZTBG-KOUNCHBCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22683222.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor at 10 uM,,"Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.",Bioorg. Med. Chem. Lett.,2012.0,22.0,14.0,"Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum AA, Humphrey PP, Marquess DG, Shaw JP, Smith JA, Derek Turner S, Vickery RG",,829453.0,DTCT0023221,10537716,DTCC01246534,912602,48889
329,CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125494,DTCC00417470,1410574,23555
330,CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125495,DTCC00417470,1410574,23555
331,CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125172,DTCC00417470,1410574,23555
332,CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125173,DTCC00417470,1410574,23555
333,CHEMBL2086404,P46098,,VENCMHFMVFASKV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599866,DTCC01254431,1974296,50457
334,CHEMBL2086582,P46098,WAY-361789,LKMWIEHGNOUIAH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599886,DTCC00042481,1655940,50457
335,CHEMBL2086582,P46098,WAY-361789,LKMWIEHGNOUIAH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599354,DTCC00042481,1655940,50457
336,CHEMBL2086583,P46098,,AWJOXQPKTMMFHH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599887,DTCC01253699,1494444,50457
337,CHEMBL2086584,P46098,,KELGFUJORMNBDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599888,DTCC01253700,1234562,50457
338,CHEMBL2086584,P46098,,KELGFUJORMNBDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599355,DTCC01253700,1234562,50457
339,CHEMBL2086585,P46098,,JJJIVUQWUUXQLP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599889,DTCC01253701,847574,50457
340,CHEMBL2087337,P46098,VELUSETRAG,HXLOHDZQBKCUCR-WOZUAGRISA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959244.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor at 10 uM,,"Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Genov D, Goldblum AA, Humphrey PP, Jiang L, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,841635.0,DTCT0023221,10607097,DTCC01254336,154809,49752
341,CHEMBL2087421,P46098,,TYDKAHFZLFMNQX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22369198.0,INHIBITION,=,1.0,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 5 uM by cell based assay,,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,2012.0,55.0,6.0,"Barth M, Bondoux M, Luccarini JM, Peyrou V, Dodey P, Pruneau D, Massardier C, Paquet JL",,842013.0,DTCT0023221,10599265,DTCC01254414,1578316,50456
342,CHEMBL2087437,P46098,,HSJHANWKJLOWGS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599865,DTCC01254430,1558783,50457
343,CHEMBL2087438,P46098,,LOEWGPWXHKYVIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599867,DTCC01254432,1687977,50457
344,CHEMBL2087439,P46098,,UDNVGXVDJIKQKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599868,DTCC01254433,1429837,50457
345,CHEMBL2087440,P46098,,UQHUNGZFFQATJZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599869,DTCC01254434,102739,50457
346,CHEMBL2087441,P46098,,JWKYJUPITPBTSR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599870,DTCC01254435,1397699,50457
347,CHEMBL2087442,P46098,,UUULARAVAROYPO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599871,DTCC01254436,847577,50457
348,CHEMBL2087443,P46098,,BGJJEMSVLGIVLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599872,DTCC01254437,1202066,50457
349,CHEMBL2087443,P46098,,BGJJEMSVLGIVLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599346,DTCC01254437,1202066,50457
350,CHEMBL2087444,P46098,,VAEUZWBERFNXLX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599873,DTCC01254438,297411,50457
351,CHEMBL2087445,P46098,,YJOREKPBKODAPH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599874,DTCC01254439,1908971,50457
352,CHEMBL2087445,P46098,,YJOREKPBKODAPH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599347,DTCC01254439,1908971,50457
353,CHEMBL2087446,P46098,,GQCWFDPOTSZPCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599875,DTCC01254440,1106331,50457
354,CHEMBL2087447,P46098,,POWHTVORLJYXLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599697,DTCC01254441,1461939,50457
355,CHEMBL2087447,P46098,,POWHTVORLJYXLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599348,DTCC01254441,1461939,50457
356,CHEMBL2087448,P46098,,MIQNWMJNRQADMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599749,DTCC01254442,362627,50457
357,CHEMBL2087448,P46098,,MIQNWMJNRQADMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599350,DTCC01254442,362627,50457
358,CHEMBL2087449,P46098,,DWJPLBZSCNLIAR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599698,DTCC01254443,459021,50457
359,CHEMBL2087450,P46098,,AEZVYNVHNCDBQX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599876,DTCC01254445,1461940,50457
360,CHEMBL2087451,P46098,,MUFOLRMJGLDINZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599877,DTCC01254446,912667,50457
361,CHEMBL2087452,P46098,,BRVURYNCYHYNFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599878,DTCC01254447,102740,50457
362,CHEMBL2087453,P46098,,RPLWNHKGFXWLSL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599879,DTCC01254448,685678,50457
363,CHEMBL2087453,P46098,,RPLWNHKGFXWLSL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599351,DTCC01254448,685678,50457
364,CHEMBL2087454,P46098,,XJQFQLWVHXSRMJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599880,DTCC01254449,1461941,50457
365,CHEMBL2087455,P46098,,QENDQZCSFXDDOX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599881,DTCC01254450,1299908,50457
366,CHEMBL2087456,P46098,,LZQMVVGBOPZASC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599882,DTCC01254451,1106332,50457
367,CHEMBL2087456,P46098,,LZQMVVGBOPZASC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599352,DTCC01254451,1106332,50457
368,CHEMBL2087457,P46098,,PNHTUMMCJLWVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599883,DTCC01254452,2071504,50457
369,CHEMBL2087457,P46098,,PNHTUMMCJLWVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599353,DTCC01254452,2071504,50457
370,CHEMBL2087458,P46098,,UTZCOSNAHHZOGH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599884,DTCC01254453,1138685,50457
371,CHEMBL2087459,P46098,,VDQDOBJGSUGYMM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191.0,DTCT0023221,10599885,DTCC01254454,717999,50457
372,CHEMBL2104153,P46098,CYAMEMAZINE,SLFGIOIONGJGRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12527336.0,KI,=,2943.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738143,DTCC01257488,2106533,69666
373,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282.0,IC50,=,10.0,NM,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488293.0,DTCT0023221,2775812,DTCC01260981,175805,30579
374,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139.0,IC50,=,9.4,NM,,,,,,,,,,,,,,Displacement of radiolabeled MDL 72222 from human 5HT3 receptor,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008.0,51.0,22.0,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494485.0,DTCT0023221,2604410,DTCC01260981,166145,32034
375,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139.0,KI,=,6.6,NM,,,,,,,,,,,,,,Displacement of radiolabeled MDL 72222 from human 5HT3 receptor,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008.0,51.0,22.0,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494485.0,DTCT0023221,2584078,DTCC01260981,166145,32034
376,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,770.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885920,DTCC01260981,176407,34988
377,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,99.6,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887672,DTCC01260981,176407,34988
378,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21726069.0,KI,=,3.9,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human 5HT3 receptor,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011.0,54.0,15.0,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,761947.0,DTCT0023221,6053715,DTCC01260981,184540,45491
379,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23403082.0,IC50,=,11.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEK293 cells after 60 mins,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965430.0,DTCT0023221,12469495,DTCC01260981,188198,54795
380,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23403082.0,INHIBITION,=,3.0,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEK293 cells at 10 uM after 60 mins relative to control,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965635.0,DTCT0023221,12469563,DTCC01260981,188198,54795
381,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23403082.0,KI,=,2.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEK293 cells after 60 mins,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965430.0,DTCT0023221,12469429,DTCC01260981,188198,54795
382,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23466604.0,IC50,=,6.7,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013.0,63.0,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966037.0,DTCT0023221,12471227,DTCC01260981,188206,54801
383,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23466604.0,KI,=,4.7,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013.0,63.0,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966037.0,DTCT0023221,12471155,DTCC01260981,188206,54801
384,CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23582449.0,IC50,=,4.9,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013.0,21.0,10.0,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964168.0,DTCT0023221,12465310,DTCC01260981,188193,54817
385,CHEMBL2151437,P46098,AZD0328,OCKIPDMKGPYYJS-ZDUSSCGKSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,12.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851154.0,DTCT0023221,11361450,DTCC01284531,1514594,50968
386,CHEMBL2151439,P46098,,TXCYUSKWBHUVEP-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,2.8,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3 receptor expressed in Xenopus oocyte,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851141.0,DTCT0023221,11361480,DTCC01284532,1546615,50968
387,CHEMBL2151439,P46098,,TXCYUSKWBHUVEP-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,32.7,NM,,cell_based,,,,,,,,,,,,Antagonist activity at 5HT3 receptor expressed in N1E115 cells,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851140.0,DTCT0023221,11361481,DTCC01284532,1546615,50968
388,CHEMBL2151439,P46098,,TXCYUSKWBHUVEP-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,2.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361473,DTCC01284532,1546615,50968
389,CHEMBL2151440,P46098,,GUUAJKBOCMZUJW-IBGZPJMESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,60.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851135.0,DTCT0023221,11361487,DTCC01284533,770173,50968
390,CHEMBL2151441,P46098,,PIEZNFVNSICXLK-FUHWJXTLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,INHIBITION,=,20.0,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851023.0,DTCT0023221,11361602,DTCC01284534,1157455,50968
391,CHEMBL2151441,P46098,,PIEZNFVNSICXLK-FUHWJXTLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,20.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452778,DTCC01284534,1138922,51687
392,CHEMBL2151442,P46098,,WIEWCOLOPGXZDJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851023.0,DTCT0023221,11361606,DTCC01284535,1735816,50968
393,CHEMBL2151443,P46098,A-582941,GTMRUYCIJSNXGB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,150.0,NM,,,,,,,,,,,,,,Displacement of [3H]-BRL-43694 from human 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851187.0,DTCT0023221,11361438,DTCC00045081,1449663,50968
394,CHEMBL2151570,P46098,ABT-107,LUKNJAQKVPBDSC-SFHVURJKSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,INHIBITION,=,4.0,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851023.0,DTCT0023221,11361564,DTCC01284661,1449664,50968
395,CHEMBL2151572,P46098,ENCENICLINE,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,299.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361601,DTCC01284663,641412,50968
396,CHEMBL2151572,P46098,ENCENICLINE,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,51.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 nM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877192.0,DTCT0023221,11452732,DTCC01284663,621376,51687
397,CHEMBL2164350,P46098,,QJFWBEXGRNKZIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22738628.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012.0,22.0,14.0,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859967.0,DTCT0023221,11399011,DTCC01289819,19400,49664
398,CHEMBL2164354,P46098,,YUOLKUGHNOWKJF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22738628.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012.0,22.0,14.0,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859967.0,DTCT0023221,11398988,DTCC01289823,1494590,49664
399,CHEMBL2165447,P46098,,KZONDTNPVHWVKU-NSHDSACASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,EFFICACY,=,-0.1,%,,,,,,,,,,,,,,Displacement of [3H]LY-278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880502.0,DTCT0023221,11472029,DTCC01290805,912917,51811
400,CHEMBL2169890,P46098,,LDGNYEXMQRXXIW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,7.41,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422341,DTCC01291472,1332760,51459
401,CHEMBL2169964,P46098,,WWOMJAJTOOLHDS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,46.77,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422329,DTCC01291325,1008870,51459
402,CHEMBL2169965,P46098,,VMMHKLBVXJNMEM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,2.95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422327,DTCC01291326,1941466,51459
403,CHEMBL2169966,P46098,,CFMSRRKPZHTMEX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,1.62,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422324,DTCC01291327,1719485,51459
404,CHEMBL2169967,P46098,,RSUDGRCQQXSDOO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,407.38,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422323,DTCC01291328,556751,51459
405,CHEMBL2169968,P46098,,CIBFBHWSAKKIPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,537.03,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422322,DTCC01291329,1844701,51459
406,CHEMBL2169969,P46098,,VDFLDQVKOMEZEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,13.49,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422321,DTCC01291330,1365432,51459
407,CHEMBL2169970,P46098,,GRQDDYOXJKSBNX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,1.45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422319,DTCC01291331,135289,51459
408,CHEMBL2169971,P46098,,WJMAMTPJNQQNJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,5.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422318,DTCC01291332,750463,51459
409,CHEMBL2169972,P46098,,YMNXOJIOGVVKPL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,218.78,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422317,DTCC01291333,685867,51459
410,CHEMBL2169973,P46098,,JJKSXCUVAHBTLA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,204.17,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422316,DTCC01291334,880194,51459
411,CHEMBL2169974,P46098,,GBRCKQVRLPIGIR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,331.13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422315,DTCC01291335,1397859,51459
412,CHEMBL2169975,P46098,,FBESFXOTONWCII-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,467.74,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422345,DTCC01291336,395558,51459
413,CHEMBL2172192,P46098,,CHVVPMVMKPMDFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22664127.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 1 uM by radioligand displacement assay,Not Active,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,2012.0,22.0,13.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Vorobiev AA, Okun I",,863334.0,DTCT0023221,11411297,DTCC01293389,576450,51365
414,CHEMBL2177127,P46098,,IRMBVBDXXYXPEW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23098038.0,INHIBITION,<,20.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to 5HT3 at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012.0,55.0,22.0,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878139.0,DTCT0023221,11425895,DTCC01296149,2027620,51656
415,CHEMBL2179217,P46098,,ZPUAIXYROPYWKA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006002.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875715.0,DTCT0023221,11435578,DTCC01295975,641546,51583
416,CHEMBL2179222,P46098,,XRDVQWJPAZZLKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006002.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875715.0,DTCT0023221,11435577,DTCC01295978,1028954,51583
417,CHEMBL2179392,P46098,,RJIRTFWCWLPHDK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23098038.0,INHIBITION,<,20.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to 5HT3 at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012.0,55.0,22.0,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878139.0,DTCT0023221,11425875,DTCC01296145,900186,51656
418,CHEMBL2179395,P46098,,JXJCCQYPULQIKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23098038.0,INHIBITION,<,20.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to 5HT3 at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012.0,55.0,22.0,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878139.0,DTCT0023221,11425885,DTCC01296148,1385589,51656
419,CHEMBL2179529,P46098,AZD1446,GTUIQNHJSXQMKW-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22793665.0,INHIBITION,=,87.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 10 uM,,"Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective a4ß2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,21.0,"Mazurov AA, Miao L, Bhatti BS, Strachan JP, Akireddy S, Murthy S, Kombo D, Xiao YD, Hammond P, Zhang J, Hauser TA, Jordan KG, Miller CH, Speake JD, Gatto GJ, Yohannes D",,872693.0,DTCT0023221,11445495,DTCC01296279,1106534,51509
420,CHEMBL2179529,P46098,AZD1446,GTUIQNHJSXQMKW-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22793665.0,KI,=,700.0,NM,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor,,"Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective a4ß2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,21.0,"Mazurov AA, Miao L, Bhatti BS, Strachan JP, Akireddy S, Murthy S, Kombo D, Xiao YD, Hammond P, Zhang J, Hauser TA, Jordan KG, Miller CH, Speake JD, Gatto GJ, Yohannes D",,872691.0,DTCT0023221,11445493,DTCC01296279,1106534,51509
421,CHEMBL2179543,P46098,,AFIZEQKQIKDZQH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22793665.0,INHIBITION,=,40.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective a4ß2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,21.0,"Mazurov AA, Miao L, Bhatti BS, Strachan JP, Akireddy S, Murthy S, Kombo D, Xiao YD, Hammond P, Zhang J, Hauser TA, Jordan KG, Miller CH, Speake JD, Gatto GJ, Yohannes D",,872690.0,DTCT0023221,11445491,DTCC01296293,70629,51509
422,CHEMBL2179707,P46098,,IIDIAHIVYVSCHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23043420.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 at 100 uM,,"Discovery and Pharmacological Profile of New 1H-Indazole-3-carboxamide and 2H-Pyrrolo[3,4-c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands.",J. Med. Chem.,2012.0,55.0,22.0,"Furlotti G, Alisi MA, Apicella C, Capezzone de Joannon A, Cazzolla N, Costi R, Cuzzucoli Crucitti G, Garrone B, Iacovo A, Magarò G, Mangano G, Miele G, Ombrato R, Pescatori L, Polenzani L, Rosi F, Vitiello M, Di Santo R",,874294.0,DTCT0023221,11454329,DTCC01296453,90521,51610
423,CHEMBL2179839,P46098,,OQFNODATXJBYQO-RBUKOAKNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,15.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452781,DTCC01296580,621377,51687
424,CHEMBL2179862,P46098,,HTBCXNBZJPZOBH-FCHUYYIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,39.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452780,DTCC01296603,588999,51687
425,CHEMBL2179862,P46098,,HTBCXNBZJPZOBH-FCHUYYIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,KI,=,18600.0,NM,,,,,,,,,,,,,,Inhibition of human 5HT3R,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877364.0,DTCT0023221,11452773,DTCC01296603,588999,51687
426,CHEMBL2179866,P46098,,FONCJXWMQYTPRQ-WMLDXEAASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,14.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452779,DTCC00131463,1941516,51687
427,CHEMBL2179877,P46098,,HMBGJHCWZLRYIN-SIKLNZKXSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,12.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452777,DTCC00131474,1844742,51687
428,CHEMBL2179879,P46098,,YQRNOVVTYJEJEA-GHTZIAJQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,22.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452776,DTCC00131476,395618,51687
429,CHEMBL2180264,P46098,,OXKRFEWMSWPKKV-NQIIRXRSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,INHIBITION,=,20.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365.0,DTCT0023221,11452774,DTCC01296948,1202275,51687
430,CHEMBL2180835,P46098,,OUTWSZAPEGAWEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442258,DTCC01297487,1832542,51641
431,CHEMBL2180836,P46098,,KOTAZQOZDGBEDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442257,DTCC01297488,479953,51641
432,CHEMBL2180837,P46098,,NBIZFEZAYLVEGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,PIC50,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,Not Determined,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442215,DTCC01297489,835124,51641
433,CHEMBL2180838,P46098,,XXYWJJJEDMYQLQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,PIC50,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,Not Determined,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442214,DTCC01297490,1028975,51641
434,CHEMBL2180839,P46098,,OGPREQIZGSIMHW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,PIC50,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,Not Active,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442209,DTCC01297491,1417967,51641
435,CHEMBL2181166,P46098,,GDRLBCZDGQFDCZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,=,410.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436254,DTCC01297813,415869,51669
436,CHEMBL2181168,P46098,,BIAZRDQNRJRCRQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436191,DTCC01297815,479956,51669
437,CHEMBL2181169,P46098,,UWMNAFXETUEZJZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,=,1314.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436240,DTCC01297816,802446,51669
438,CHEMBL2181170,P46098,,JBPBJYKHTQKMKP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,=,641.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436251,DTCC01297817,1546755,51669
439,CHEMBL2181171,P46098,,MREMSPSMZSVSJS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,=,680.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436249,DTCC01297818,251880,51669
440,CHEMBL2181187,P46098,,OLINRUQQUFMPJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436192,DTCC01297835,415870,51669
441,CHEMBL2181188,P46098,,GGQFEMQQQLOYIH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,=,2470.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436232,DTCC01297836,350378,51669
442,CHEMBL2181189,P46098,,KMWRABRPTOODHP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207.0,KI,=,710.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012.0,55.0,22.0,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523.0,DTCT0023221,11436247,DTCC01297837,1028978,51669
443,CHEMBL2203551,P46098,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,EFFICACY,=,7.0,%,,,,,,,,,,,,,,Displacement of [3H]LY-278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880502.0,DTCT0023221,11472009,DTCC01298943,621402,51811
444,CHEMBL2203713,P46098,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22840695.0,INHIBITION,=,9.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL-43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10 uM after 120 mins,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012.0,55.0,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,882748.0,DTCT0023221,11459348,DTCC00131535,738126,51915
445,CHEMBL2204355,P46098,,CDEZIFKSLJMFDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,80.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460328,DTCC01299708,1656222,51828
446,CHEMBL2204356,P46098,,JTQUHGRGBNXQDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,67.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460327,DTCC01299709,1812500,51828
447,CHEMBL2204357,P46098,,HHVBUSGGPUQAOP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,29.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460326,DTCC01299710,1202308,51828
448,CHEMBL2204358,P46098,,ZTLVPNGMZUOVML-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,32.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460325,DTCC01299711,1170077,51828
449,CHEMBL2204359,P46098,,RJOWFEDJGNNCDF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,26.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460324,DTCC01299712,2007335,51828
450,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Agonist activity at human 5HT3A receptor expressed in xenopus oocytes by electrophysiological method in presence of ondansetron,Not Active,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880239.0,DTCT0023221,11460284,DTCC01299713,1748126,51828
451,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,EC50,=,2100.0,NM,,cell_based,,,,,,,,,,,Oocytes,Agonist activity at human 5HT3A receptor expressed in xenopus oocytes by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880243.0,DTCT0023221,11460191,DTCC01299713,1748126,51828
452,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,EFFICACY,=,64.0,%,,cell_based,,,,,,,,,,,Oocytes,Agonist activity at human 5HT3A receptor expressed in xenopus oocytes by electrophysiological method relative to 5HT,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880242.0,DTCT0023221,11460190,DTCC01299713,1748126,51828
453,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,IC50,=,12.0,NM,,cell_based,,,,,,,,,,,Oocytes,Antagonist activity at human 5HT3A receptor expressed in xenopus oocytes assessed as inhibition of 5HT-induced effect by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880244.0,DTCT0023221,11460195,DTCC01299713,1748126,51828
454,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,INHIBITION,=,100.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor at 1 uM,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880225.0,DTCT0023221,11459023,DTCC01299713,1748126,51828
455,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,3.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880262.0,DTCT0023221,11460287,DTCC01299713,1748126,51828
456,CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,23.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460323,DTCC01299713,1748126,51828
457,CHEMBL2204361,P46098,,AYFCXRDVVSZQJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,12.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460322,DTCC01299714,1527000,51828
458,CHEMBL2204362,P46098,,PQZKTTYJTULMNA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,17.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460321,DTCC01299715,1397958,51828
459,CHEMBL2204363,P46098,,CAVNQHZFZKMWIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,7.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460320,DTCC01299716,944409,51828
460,CHEMBL2204364,P46098,,SCMJERWDLBFTKH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,160.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460184,DTCC01299717,880270,51828
461,CHEMBL2204365,P46098,,CUKFWEYSWJQRNA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,150.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11459052,DTCC01299718,1300165,51828
462,CHEMBL2205031,P46098,,JSQWHKSZJJCLBC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,45.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11459051,DTCC01300293,1267718,51828
463,CHEMBL2205032,P46098,,IJONBIKCSKCKEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,670.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11459050,DTCC01300294,428143,51828
464,CHEMBL2205033,P46098,,RLFBHQCZNZAQCK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,130.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11459049,DTCC01300295,1430091,51828
465,CHEMBL2205034,P46098,,HJUJYONTBWEAKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,27.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11459048,DTCC01300296,2039942,51828
466,CHEMBL2205035,P46098,,NHOSAEPFSIDHPV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,270.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11459047,DTCC01300297,362885,51828
467,CHEMBL2205036,P46098,,DGKFZZQCWFNWRZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,310.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460384,DTCC01300298,1267719,51828
468,CHEMBL2205037,P46098,,OIMAWSBVYIVFBR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,190.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460383,DTCC01300299,589029,51828
469,CHEMBL2205038,P46098,,QFTFRCOFPNGFPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,500.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460382,DTCC01300300,1559060,51828
470,CHEMBL2205039,P46098,,MUIUIEFHOZRYHZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,440.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460381,DTCC01300301,847847,51828
471,CHEMBL2205040,P46098,,BNICWFRCIZHJEK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,260.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460380,DTCC01300302,1365525,51828
472,CHEMBL2205041,P46098,,RZJQKGRFQHFVDL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,64.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460379,DTCC01300303,944415,51828
473,CHEMBL2205042,P46098,,AAOXNOFJAOMEGO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,36.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460378,DTCC01300304,135366,51828
474,CHEMBL2205043,P46098,,XUMDENDMRHWGGR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,36.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460377,DTCC01300305,589030,51828
475,CHEMBL2205044,P46098,,XJSIHFKFXLFZEG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,53.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460376,DTCC01300306,1909229,51828
476,CHEMBL2205045,P46098,,TYKBKDLIAKRVRZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,56.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460375,DTCC01300307,330301,51828
477,CHEMBL2205046,P46098,,YTJNKAUGQNPJTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,140.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460374,DTCC01300308,1267720,51828
478,CHEMBL2205047,P46098,,JBYIRSHDOBNQGW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,450.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460373,DTCC01300309,1202316,51828
479,CHEMBL2205048,P46098,,SIKLZAAJSXLXIN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,62.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460335,DTCC01300310,17960,51828
480,CHEMBL2205049,P46098,,YTAWEBKOATVAHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,64.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460334,DTCC00131593,1719575,51828
481,CHEMBL2205050,P46098,,MLLYZTIIRALMMQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,52.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460333,DTCC00131594,232056,51828
482,CHEMBL2205051,P46098,,FSPHPGLLPWMVAT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,32.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460332,DTCC01300311,685957,51828
483,CHEMBL2205052,P46098,,QUHLMVHMAHPVMC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,86.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460331,DTCC01300312,685958,51828
484,CHEMBL2205053,P46098,,JNDJUERZLVTHAV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,110.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460330,DTCC01300313,589031,51828
485,CHEMBL2205054,P46098,,VHKBDODTXKHVJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,33.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460329,DTCC01300314,1332854,51828
486,CHEMBL2205360,P46098,,UGKUXKJKFRZEQP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435.0,INHIBITION,=,7.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012.0,20.0,23.0,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884965.0,DTCT0023221,11458697,DTCC01300594,317632,51993
487,CHEMBL2205360,P46098,,UGKUXKJKFRZEQP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435.0,KI,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor after 1.5 hrs by scintillation counting analysis,Not Determined,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012.0,20.0,23.0,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884851.0,DTCT0023221,11458646,DTCC01300594,317632,51993
488,CHEMBL2205361,P46098,,CTMDNCSJPPQMLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435.0,INHIBITION,=,2.9,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012.0,20.0,23.0,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884965.0,DTCT0023221,11458698,DTCC01300595,1449840,51993
489,CHEMBL2205361,P46098,,CTMDNCSJPPQMLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435.0,KI,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor after 1.5 hrs by scintillation counting analysis,Not Determined,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012.0,20.0,23.0,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884851.0,DTCT0023221,11458647,DTCC01300595,1449840,51993
490,CHEMBL2205362,P46098,,RQJPWNOKFLOHKI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435.0,INHIBITION,=,64.2,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012.0,20.0,23.0,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884965.0,DTCT0023221,11458677,DTCC01300596,1546783,51993
491,CHEMBL2205362,P46098,,RQJPWNOKFLOHKI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435.0,KI,=,7612.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012.0,20.0,23.0,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884851.0,DTCT0023221,11458651,DTCC01300596,1546783,51993
492,CHEMBL2205811,P46098,,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11474528,DTCC01301027,1267730,51935
493,CHEMBL2205812,P46098,,TWMXGXSGGIIQDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11474510,DTCC01301028,556858,51935
494,CHEMBL2205813,P46098,,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11474490,DTCC01301029,1688236,51935
495,CHEMBL2205814,P46098,,KULMFBVVFDTVNX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11474457,DTCC01301030,1623988,51935
496,CHEMBL2205816,P46098,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11474430,DTCC01301032,880294,51935
497,CHEMBL2205816,P46098,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584706,DTCC01301032,881049,55935
498,CHEMBL2205817,P46098,,GFQHCUYWLHSGJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11474406,DTCC01301033,912942,51935
499,CHEMBL2205823,P46098,,WWXCWTRLUXMAHX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475950,DTCC01301039,1780156,51935
500,CHEMBL2205824,P46098,,LIKZWSUAMNZHAE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475925,DTCC01301040,1688238,51935
501,CHEMBL2205825,P46098,,GYKFQDQFKGGVKD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475898,DTCC01301041,750568,51935
502,CHEMBL2205827,P46098,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475874,DTCC01301043,1812524,51935
503,CHEMBL2205827,P46098,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584708,DTCC01301043,1813367,55935
504,CHEMBL2205829,P46098,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475850,DTCC01301045,330310,51935
505,CHEMBL2205829,P46098,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584705,DTCC01301045,331095,55935
506,CHEMBL2205832,P46098,,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475822,DTCC01301048,589038,51935
507,CHEMBL2205833,P46098,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475784,DTCC01301049,2039955,51935
508,CHEMBL2205833,P46098,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584707,DTCC01301049,2040747,55935
509,CHEMBL2205836,P46098,,PSBBAGWMKGXQRW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079.0,DTCT0023221,11475753,DTCC01301052,1041425,51935
510,CHEMBL2206397,P46098,RO-4992479,NIRASHDWADNQJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22795332.0,INHIBITION,=,-6.0,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM by CEREP assay,,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,2012.0,22.0,16.0,"Galley G, Stalder H, Goergler A, Hoener MC, Norcross RD",,881961.0,DTCT0023221,11478596,DTCC00045622,835169,51910
511,CHEMBL2207376,P46098,,MJYQMQCVUXOIFY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912.0,INHIBITION,=,19.92,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896.0,DTCT0023221,11493441,DTCC01302559,750581,52134
512,CHEMBL2207382,P46098,,MBFLODNVCSXSKE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912.0,INHIBITION,=,8.93,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896.0,DTCT0023221,11493440,DTCC01302565,1041441,52134
513,CHEMBL2207386,P46098,,AGKMPGSBLMAGAX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912.0,INHIBITION,=,18.82,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896.0,DTCT0023221,11493443,DTCC01302569,718295,52134
514,CHEMBL2207388,P46098,,CULSPSVPJXBZMJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912.0,INHIBITION,=,6.73,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896.0,DTCT0023221,11493442,DTCC01302571,814971,52134
515,CHEMBL220808,P46098,SARIZOTAN,HKFMQJUJWSFOLY-OAQYLSRUSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565.0,IC50,<,6.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008.0,51.0,3.0,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123.0,DTCT0023221,2280978,DTCC00439481,1296638,25139
516,CHEMBL223331,P46098,KKHT-10608,YKQRXGQZAGVEJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2400.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887680,DTCC00002546,1885925,34988
517,CHEMBL223331,P46098,KKHT-10608,YKQRXGQZAGVEJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,107.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887655,DTCC00002546,1885925,34988
518,CHEMBL223387,P46098,,XKRVOMXWYNEPTN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1400.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887682,DTCC00447015,37738,34988
519,CHEMBL223387,P46098,,XKRVOMXWYNEPTN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,103.1,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887657,DTCC00447015,37738,34988
520,CHEMBL223715,P46098,KKHT-10612,RLQXOTMOPGYNGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887684,DTCC00002548,1211131,34988
521,CHEMBL223715,P46098,KKHT-10612,RLQXOTMOPGYNGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,96.4,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887659,DTCC00002548,1211131,34988
522,CHEMBL223951,P46098,KKHT-10617,FIJJTIJVCAYUQE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2100.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887688,DTCC00002553,1536021,34988
523,CHEMBL223951,P46098,KKHT-10617,FIJJTIJVCAYUQE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,96.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887663,DTCC00002553,1536021,34988
524,CHEMBL224008,P46098,,ISRIWKVGGLFNBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2700.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887683,DTCC00111170,727227,34988
525,CHEMBL224008,P46098,,ISRIWKVGGLFNBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,107.4,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887658,DTCC00111170,727227,34988
526,CHEMBL224159,P46098,KKHT-10109,JXEWFPXPEYRYSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,19800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887674,DTCC00002555,1726697,34988
527,CHEMBL224159,P46098,KKHT-10109,JXEWFPXPEYRYSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,80.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887649,DTCC00002555,1726697,34988
528,CHEMBL224160,P46098,KKHT-11118,FXRGLPUKLPILJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885914,DTCC00002557,727237,34988
529,CHEMBL224160,P46098,KKHT-11118,FXRGLPUKLPILJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,104.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887666,DTCC00002557,727237,34988
530,CHEMBL224227,P46098,KKHT-20718,YMGCQAHDDYCKLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,11600.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885917,DTCC00002561,1950838,34988
531,CHEMBL224227,P46098,KKHT-20718,YMGCQAHDDYCKLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,85.7,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887669,DTCC00002561,1950838,34988
532,CHEMBL224246,P46098,KKHT-20918,IWAHUQRZIUVMSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,5700.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885919,DTCC00002563,1697132,34988
533,CHEMBL224246,P46098,KKHT-20918,IWAHUQRZIUVMSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,98.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887671,DTCC00002563,1697132,34988
534,CHEMBL224310,P46098,KKHT-20218,WLYLIKBNGQZDFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1300.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885915,DTCC00002556,856886,34988
535,CHEMBL224310,P46098,KKHT-20218,WLYLIKBNGQZDFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,52.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887667,DTCC00002556,856886,34988
536,CHEMBL224389,P46098,KKHT-10603,NVNVERQZWUUANS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1900.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887677,DTCC00002559,1083040,34988
537,CHEMBL224389,P46098,KKHT-10603,NVNVERQZWUUANS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,107.9,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887652,DTCC00002559,1083040,34988
538,CHEMBL224641,P46098,KKHT-20713,CVIIPJUPHIOKNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,5900.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885916,DTCC00002564,1950849,34988
539,CHEMBL224641,P46098,KKHT-20713,CVIIPJUPHIOKNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,86.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887668,DTCC00002564,1950849,34988
540,CHEMBL224648,P46098,KKHT-10118,KINBZTGMJRQTER-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,15800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887675,DTCC00002558,1789145,34988
541,CHEMBL224648,P46098,KKHT-10118,KINBZTGMJRQTER-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,78.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887650,DTCC00002558,1789145,34988
542,CHEMBL224701,P46098,KKHT-10606,DPMQWTNICFCLFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1600.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887678,DTCC00002560,1017971,34988
543,CHEMBL224701,P46098,KKHT-10606,DPMQWTNICFCLFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,100.6,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887653,DTCC00002560,1017971,34988
544,CHEMBL224766,P46098,KKHT-10615,DWGFHYJCLFQFTA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2200.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887687,DTCC00002552,1821673,34988
545,CHEMBL224766,P46098,KKHT-10615,DWGFHYJCLFQFTA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,103.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887662,DTCC00002552,1821673,34988
546,CHEMBL224778,P46098,KKHT-10609,PYCLIFABZLPONX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1900.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887681,DTCC00002547,1276680,34988
547,CHEMBL224778,P46098,KKHT-10609,PYCLIFABZLPONX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,104.6,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887656,DTCC00002547,1276680,34988
548,CHEMBL225484,P46098,KKHT-10607,JRKIQFPYQPIURM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2100.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887679,DTCC00002544,823981,34988
549,CHEMBL225484,P46098,KKHT-10607,JRKIQFPYQPIURM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,100.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887654,DTCC00002544,823981,34988
550,CHEMBL225485,P46098,KKHT-11018,FKCDNDBJVOQPJB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,13600.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887690,DTCC00002545,953339,34988
551,CHEMBL225485,P46098,KKHT-11018,FKCDNDBJVOQPJB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,104.0,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887665,DTCC00002545,953339,34988
552,CHEMBL225543,P46098,KKHT-10613,NNJAFUNKEIDAAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2000.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887685,DTCC00002549,339411,34988
553,CHEMBL225543,P46098,KKHT-10613,NNJAFUNKEIDAAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,98.8,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887660,DTCC00002549,339411,34988
554,CHEMBL225600,P46098,KKHT-10614,FALASSBEVXPICK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2200.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887686,DTCC00002550,791496,34988
555,CHEMBL225600,P46098,KKHT-10614,FALASSBEVXPICK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,103.7,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887661,DTCC00002550,791496,34988
556,CHEMBL225601,P46098,KKHT-10618,BKSKSEWIBBBRSQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,3300.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887689,DTCC00002554,1885927,34988
557,CHEMBL225601,P46098,KKHT-10618,BKSKSEWIBBBRSQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,106.4,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887664,DTCC00002554,1885927,34988
558,CHEMBL226335,P46098,RUTIN,IKGXIBQEEMLURG-NVPNHPEKSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14750338,DTCC00448737,2109891,69275
559,CHEMBL22778,P46098,UH-301,FNKBVTBXFLSTPB-LBPRGKRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561.0,KI,=,2690.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14743178,DTCC01739164,2108309,68785
560,CHEMBL2298806,P46098,,OTPPYWCIUOIPCN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5248.07,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013.0,22.0,2.0,,,932184.0,DTCT0023221,11738843,DTCC01333520,1094659,51606
561,CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125510,DTCC00457685,795055,23555
562,CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125511,DTCC00457685,795055,23555
563,CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,23000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125188,DTCC00457685,795055,23555
564,CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,25118.86,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125189,DTCC00457685,795055,23555
565,CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125492,DTCC00457692,244448,23555
566,CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125493,DTCC00457692,244448,23555
567,CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125170,DTCC00457692,244448,23555
568,CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125171,DTCC00457692,244448,23555
569,CHEMBL230951,P46098,L-HOMOCYSTEATE,VBOQYPQEPHKASR-VKHMYHEASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14730879,DTCC00002972,2104237,69159
570,CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125522,DTCC00457678,2052137,23555
571,CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125523,DTCC00457678,2052137,23555
572,CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,15000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125201,DTCC00457678,2052137,23555
573,CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,15848.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125202,DTCC00457678,2052137,23555
574,CHEMBL2309589,P46098,,GSAVAAKDTVSQKT-MUJYYYPQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,1.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211383,DTCC01334813,1504291,37125
575,CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125490,DTCC00457693,127806,23555
576,CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125491,DTCC00457693,127806,23555
577,CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125168,DTCC00457693,127806,23555
578,CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125169,DTCC00457693,127806,23555
579,CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125519,DTCC00457680,924516,23555
580,CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,4400.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125518,DTCC00457680,924516,23555
581,CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,2511.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125198,DTCC00457680,924516,23555
582,CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,2700.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125197,DTCC00457680,924516,23555
583,CHEMBL232104,P46098,,BRIVIXLMMUIBJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17606674.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,Not Active,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,2007.0,51.0,10.0,"Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Hornéy C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH",,498966.0,DTCT0023221,2717305,DTCC00461356,1166865,34114
584,CHEMBL2322133,P46098,,FBGLUXQASNAMOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23265874.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Binding affinity to C-terminal-His6-tagged 5HT3A receptor (unknown origin) expressed in HEK293 cells assessed as decrease in fluorescence at 10 to 500 nM after 2 hrs by fluorimetric analysis in presence of granisetron,Not Active,Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.,Bioorg. Med. Chem. Lett.,2013.0,23.0,3.0,"Silva-Lopez EI, Barden AO, Brozik JA",,940561.0,DTCT0023221,11790396,DTCC01340489,1656625,53514
585,CHEMBL2322133,P46098,,FBGLUXQASNAMOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23265874.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Binding affinity to C-terminal-His6-tagged 5HT3A receptor (unknown origin) expressed in HEK293 cells assessed as decrease in fluorescence at 10 to 500 nM after 2 hrs by fluorimetric analysis,Active,Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.,Bioorg. Med. Chem. Lett.,2013.0,23.0,3.0,"Silva-Lopez EI, Barden AO, Brozik JA",,940562.0,DTCT0023221,11790397,DTCC01340489,1656625,53514
586,CHEMBL2322133,P46098,,FBGLUXQASNAMOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23265874.0,KD,=,83.0,NM,,cell_based,,,,,,,,,,,HEK293,Binding affinity to C-terminal-His6-tagged 5HT3A receptor (unknown origin) expressed in HEK293 cells after 2 hrs by fluorimetric analysis,,Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.,Bioorg. Med. Chem. Lett.,2013.0,23.0,3.0,"Silva-Lopez EI, Barden AO, Brozik JA",,940560.0,DTCT0023221,11790395,DTCC01340489,1656625,53514
587,CHEMBL2326501,P46098,,KRCLPAGVJVBLJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23237837.0,INHIBITION,=,7.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 1 uM,,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,2013.0,23.0,2.0,"Butini S, Gemma S, Brindisi M, Maramai S, Minetti P, Celona D, Napolitano R, Borsini F, Cabri W, Fezza F, Merlini L, Dallavalle S, Campiani G, Maccarrone M",,939655.0,DTCT0023221,11784459,DTCC01344807,1353507,53501
588,CHEMBL2332488,P46098,,RQAGIIPBHMAHTO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23414838.0,IC50,=,19000.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor (unknown origin),,Discovery of a novel series of quinolone a7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"McDonald IM, Mate RA, Zusi FC, Huang H, Post-Munson DJ, Ferrante MA, Gallagher L, Bertekap RL, Knox RJ, Robertson BJ, Harden DG, Morgan DG, Lodge NJ, Dworetzky SI, Olson RE, Macor JE",,943354.0,DTCT0023221,11831081,DTCC01346119,1515397,54050
589,CHEMBL2335706,P46098,MARISTACHONE A,VGUIDVOAJKITDB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23268694.0,INHIBITION,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) at 10 uM,Not Active,Unprecedented Polyketides from a Marine Sponge-Associated Stachylidium sp.,J. Nat. Prod.,2013.0,76.0,3.0,"Almeida C, Eguereva E, Kehraus S, König GM",,942212.0,DTCT0023221,11820894,DTCC01349130,964975,53803
590,CHEMBL238805,P46098,,ZXWKLBTWUHVMTO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17765553.0,INHIBITION,=,6.8,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 expressed in COS7 cells at 10 uM,,"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.",Bioorg. Med. Chem.,2007.0,15.0,21.0,"Welch JT, Lim DS",,449347.0,DTCT0023221,2188275,DTCC00473634,844044,23869
591,CHEMBL238806,P46098,,VUYJMSFPKOVHFI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17765553.0,INHIBITION,=,14.6,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 expressed in COS7 cells at 10 uM,,"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.",Bioorg. Med. Chem.,2007.0,15.0,21.0,"Welch JT, Lim DS",,449347.0,DTCT0023221,2188265,DTCC00473636,1037684,23869
592,CHEMBL2391147,P46098,,ZTGRWYMPQCQTHD-ONGXEEELSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23582449.0,INHIBITION,=,-1.0,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 10 uM by radioligand displacement assay relative to control,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013.0,21.0,10.0,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964357.0,DTCT0023221,12465381,DTCC01378839,220399,54817
593,CHEMBL2391541,P46098,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23602445.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor expressed in HEK293T cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965131.0,DTCT0023221,12465428,DTCC01379235,1386484,54821
594,CHEMBL2392692,P46098,,PVTFEAGMCGMRRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23664879.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 1 uM relative to control,,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,2013.0,23.0,12.0,"Thalji RK, McAtee JJ, Belyanskaya S, Brandt M, Brown GD, Costell MH, Ding Y, Dodson JW, Eisennagel SH, Fries RE, Gross JW, Harpel MR, Holt DA, Israel DI, Jolivette LJ, Krosky D, Li H, Lu Q, Mandichak T, Roethke T, Schnackenberg CG, Schwartz B, Shewchuk LM, Xie W, Behm DJ, Douglas SA, Shaw AL, Marino JP",,965581.0,DTCT0023221,12464859,DTCC01380390,1353885,54882
595,CHEMBL239434,P46098,,YGBSUVPUXAMOTQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17765553.0,INHIBITION,=,-6.1,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 expressed in COS7 cells at 10 uM,,"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.",Bioorg. Med. Chem.,2007.0,15.0,21.0,"Welch JT, Lim DS",,449347.0,DTCT0023221,2188291,DTCC00473635,8671,23869
596,CHEMBL2397268,P46098,,JAKRIQWSQWQJHM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23627311.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of serotonin 5-HT3 receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay,,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,2013.0,56.0,13.0,"Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS, Traynelis SF, Liotta DC",,968919.0,DTCT0023221,12483490,DTCC01381880,1353904,54936
597,CHEMBL2401750,P46098,,LPYIFDLQYWSXGD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,100000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504356,DTCC01384536,1009644,55103
598,CHEMBL2402887,P46098,,SMJJKUKILIABKV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504377,DTCC01384518,2008041,55103
599,CHEMBL2402888,P46098,,APHNFVMFNAFHIP-SKDQJUDHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,19952.62,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504376,DTCC01384519,1592082,55103
600,CHEMBL2402889,P46098,,ZMWMLWGNIHSFEN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,63095.73,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504375,DTCC01384520,815642,55103
601,CHEMBL2402890,P46098,,RGFKOYDSKUBPIE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504372,DTCC01384521,1202977,55103
602,CHEMBL2402891,P46098,,XSOUQQFRYGKIGJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504370,DTCC01384522,622091,55103
603,CHEMBL2402892,P46098,,GKXVRBQVTDCQMA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504369,DTCC01384523,718937,55103
604,CHEMBL2402893,P46098,,RCBBDNFCXSBDIT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,39810.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504368,DTCC01384524,103708,55103
605,CHEMBL2402894,P46098,,RXKLPZCVAQKBQA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,7943.28,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504367,DTCC01384525,622092,55103
606,CHEMBL2402895,P46098,,OPWPTXBWGBOQAM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,15848.93,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504366,DTCC01384526,1877707,55103
607,CHEMBL2402896,P46098,,LTNICOZLLWAENB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,1258.93,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504365,DTCC01384527,525389,55103
608,CHEMBL2402897,P46098,,HXAMYUTYZROIIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,100000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504364,DTCC01384528,428804,55103
609,CHEMBL2402898,P46098,,VGWMVWNOQKELRE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504363,DTCC01384529,718938,55103
610,CHEMBL2402899,P46098,,JHISKEZJFUUGOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,39810.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504362,DTCC01384530,1009643,55103
611,CHEMBL2402900,P46098,,INMZEMMKDSQLJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504361,DTCC01384531,1942199,55103
612,CHEMBL2402901,P46098,,HKJSZEAARPYKSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504360,DTCC01384532,1656889,55103
613,CHEMBL2402902,P46098,,SWAXUQYHWXHRRQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,63095.73,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504359,DTCC01384533,428805,55103
614,CHEMBL2402903,P46098,,HRBNJCZQEOOCBP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,100000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504358,DTCC01384534,71333,55103
615,CHEMBL2402904,P46098,,MZOITCJKGUIQEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of serotonin 5-HT3A receptor (unknown origin) at 1 uM,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971577.0,DTCT0023221,12504308,DTCC01384535,589690,55103
616,CHEMBL2402904,P46098,,MZOITCJKGUIQEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,100000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504357,DTCC01384535,589690,55103
617,CHEMBL2413154,P46098,,MEKSQRMXWZHFIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17221184.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727705,DTCC01388348,2103458,69253
618,CHEMBL2418364,P46098,,RIYSYRWQPZAUDK-CAZKFNJPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23932792.0,INHIBITION,=,90.0,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor by radioligand binding assay,,"Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1.",Bioorg. Med. Chem. Lett.,2013.0,23.0,18.0,"Manka JT, Rodriguez AL, Morrison RD, Venable DF, Cho HP, Blobaum AL, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA",,979647.0,DTCT0023221,12546515,DTCC01391044,1644771,55622
619,CHEMBL2426072,P46098,,ZQRQLCVEOGQBJA-BUHFOSPRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23909910.0,INHIBITION,=,95.0,%,,cell_based,,,,,,,,,,,Oocytes,Inhibition of serotonin 5-HT3A receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as inhibition of serotonin-induced current at 3 uM by two-electrode voltage clamp method,,Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.,J. Med. Chem.,2013.0,56.0,16.0,"Acker TM, Khatri A, Vance KM, Slabber C, Bacsa J, Snyder JP, Traynelis SF, Liotta DC",,983724.0,DTCT0023221,12584029,DTCC01395097,1909990,55762
620,CHEMBL2426097,P46098,,PXQFOMCFQUXMBP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23909910.0,INHIBITION,=,95.0,%,,cell_based,,,,,,,,,,,Oocytes,Inhibition of serotonin 5-HT3A receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as inhibition of serotonin-induced current at 3 uM by two-electrode voltage clamp method,,Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.,J. Med. Chem.,2013.0,56.0,16.0,"Acker TM, Khatri A, Vance KM, Slabber C, Bacsa J, Snyder JP, Traynelis SF, Liotta DC",,983724.0,DTCT0023221,12584192,DTCC01395123,1877816,55762
621,CHEMBL2429890,P46098,,VGYQUDBPYFLBLJ-PTCVETCVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584697,DTCC01398005,1268545,55935
622,CHEMBL2431120,P46098,,SWEOAXMICIJCQC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,ACS Med. Chem. Lett.,2013.0,4.0,9.0,,,986342.0,DTCT0023221,12586272,DTCC01397077,771298,55848
623,CHEMBL2432038,P46098,,OKCSFONJDXUZOU-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584696,DTCC01398006,913793,55935
624,CHEMBL2432039,P46098,,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584695,DTCC01398007,1845582,55935
625,CHEMBL2432040,P46098,,MPBJQDFYALBXED-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584727,DTCC01398008,1139742,55935
626,CHEMBL2432041,P46098,,MSTPNDDVMWUDFF-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584726,DTCC01398009,71453,55935
627,CHEMBL2432042,P46098,,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584725,DTCC01398010,589816,55935
628,CHEMBL2432043,P46098,,LKFSLMWAVKMONG-KPCGFGSOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584724,DTCC01398011,2040745,55935
629,CHEMBL2432044,P46098,,IDXFKHDXIHNWAI-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584723,DTCC01398012,2040746,55935
630,CHEMBL2432045,P46098,,ZWCQZHOWEDKJBN-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584704,DTCC01398013,1657028,55935
631,CHEMBL2432046,P46098,,KNBHNNRMMAKKFI-SEDVZXITSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584702,DTCC01398014,1009784,55935
632,CHEMBL2432048,P46098,,KBAKPEFQDPCCTP-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584701,DTCC01398016,1495532,55935
633,CHEMBL2432049,P46098,,DUZKXKAAUHDBQA-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584699,DTCC01398017,298486,55935
634,CHEMBL2432051,P46098,,CPLYGLAQLNAQOI-SEDVZXITSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584698,DTCC01398019,71454,55935
635,CHEMBL2432052,P46098,,SGFPDDMJMPKKTB-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584722,DTCC01398020,783458,55935
636,CHEMBL2432053,P46098,,DEOOAAFCKARVDM-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584721,DTCC01398021,751332,55935
637,CHEMBL2432054,P46098,,QQUOSDRKLSIRED-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584720,DTCC01398022,945256,55935
638,CHEMBL2432055,P46098,,VNGQWOKKSKAESQ-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584719,DTCC01398023,2040748,55935
639,CHEMBL2432056,P46098,,JHFKLSFCMAHSDK-LLOIJXFCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584717,DTCC01398024,103846,55935
640,CHEMBL2432057,P46098,,QHQJBDOHEUWLBB-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584716,DTCC01398025,71455,55935
641,CHEMBL2432058,P46098,,MJOVYQVAQIHDSE-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584715,DTCC01398026,2008169,55935
642,CHEMBL2432059,P46098,,YLVXPEMITKSDOS-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584713,DTCC01398027,2008170,55935
643,CHEMBL2432060,P46098,,CKFQOWSPJPMWEK-IINHSQADSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584712,DTCC01398028,1235634,55935
644,CHEMBL2432061,P46098,,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584711,DTCC01398029,1720366,55935
645,CHEMBL2432062,P46098,,SSQDVMAIIMMISV-SEDVZXITSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584710,DTCC01398030,1780918,55935
646,CHEMBL2432063,P46098,,BMHWWKPJPARTBN-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322.0,DTCT0023221,12584709,DTCC01398031,331096,55935
647,CHEMBL2436555,P46098,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337.0,KI,=,34.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin) expressed in mouse/rat NG108-15 cells after 30 mins by by liquid scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988339.0,DTCT0023221,12618341,DTCC01399574,71471,56006
648,CHEMBL2436555,P46098,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337.0,KI,=,80.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in African green monkey COS cells after 90 mins by scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988332.0,DTCT0023221,12618334,DTCC01399574,71471,56006
649,CHEMBL2436555,P46098,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337.0,PKI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in African green monkey COS cells after 90 mins by scintillation counting analysis,Not Determined,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988332.0,DTCT0023221,12618278,DTCC01399574,71471,56006
650,CHEMBL243712,P46098,AMISULPRIDE,NTJOBXMMWNYJFB-UHFFFAOYSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19337725.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14728346,DTCC00458164,2103595,69290
651,CHEMBL2440659,P46098,,AXVLPJHYYFHCHK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24074843.0,INHIBITION,>,35.0,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-GR-65630 from human recombinant 5-HT3 receptor expressed in HEK293 cells at 10 uM relative to control,,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Felts AS, Rodriguez AL, Morrison RD, Venable DF, Manka JT, Bates BS, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA",,990310.0,DTCT0023221,12632825,DTCC01401025,1592232,56261
652,CHEMBL2442940,P46098,,INPPXFAIFVJMMD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050790.0,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to human serotonin 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,"Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.",J. Med. Chem.,2013.0,56.0,20.0,"Fukaya T, Ishiyama T, Baba S, Masumoto S",,991150.0,DTCT0023221,12640927,DTCC01403311,103900,56238
653,CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125526,DTCC00457676,1410573,23555
654,CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125527,DTCC00457676,1410573,23555
655,CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,19000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125205,DTCC00457676,1410573,23555
656,CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,19952.62,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125206,DTCC00457676,1410573,23555
657,CHEMBL2448556,P46098,,DDHAJFBBJWHSBR-XYYAHUGASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,96.85,%,,cell_based,,,,,,,,,,,,Inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 0.1 uM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337831.0,DTCT0023221,13611755,DTCC01404267,1030723,57930
658,CHEMBL244946,P46098,,WIHMMKGUBDZGEG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17867665.0,INHIBITION,=,7.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2007.0,50.0,21.0,"Micheli F, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Curcuruto O, Damiani F, Fabio RD, Donati D, Gentile G, Gribble A, Hamprecht D, Tedesco G, Terreni S, Tarsi L, Lightfoot A, Stemp G, Macdonald G, Smith A, Pecoraro M, Petrone M, Perini O, Piner J, Rossi T, Worby A, Pilla M, Valerio E, Griffante C, Mugnaini M, Wood M, Scott C, Andreoli M, Lacroix L, Schwarz A, Gozzi A, Bifone A, Ashby CR, Hagan JJ, Heidbreder C",,446429.0,DTCT0023221,2158192,DTCC00459015,1312948,23588
659,CHEMBL246955,P46098,,XYYGFCDTBHAUSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17127059.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007.0,17.0,4.0,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453461.0,DTCT0023221,2219194,DTCC00477235,1361791,24220
660,CHEMBL250450,P46098,ISOQUERCETIN,OVSQVDMCBVZWGM-QSOFNFLRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14750916,DTCC00486067,2109951,69275
661,CHEMBL250699,P46098,A-803467,VHKBTPQDHDSBSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17483457.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from 5HT3 receptor,,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,20.0,"Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS",,466569.0,DTCT0023221,2351663,DTCC00003813,310509,25480
662,CHEMBL251005,P46098,,GKGCLPKLLFABEQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17892934.0,INHIBITION,<,40.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Discovery of 5-HT6 receptor ligands based on virtual HTS.,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Tasler S, Kraus J, Wuzik A, Müller O, Aschenbrenner A, Cubero E, Pascual R, Quintana-Ruiz JR, Dordal A, Mercè R, Codony X",,458167.0,DTCT0023221,2253167,DTCC00482475,1684849,24728
663,CHEMBL251254,P46098,HYPEROSIDE,OVSQVDMCBVZWGM-DTGCRPNFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14748600,DTCC00487046,2109632,69275
664,CHEMBL252766,P46098,,WOYCDVDURLTMAW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18078311.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]PIB from 5HT3 receptor at 10 uM,,"Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.",J. Med. Chem.,2008.0,51.0,1.0,"Cai L, Liow JS, Zoghbi SS, Cuevas J, Baetas C, Hong J, Shetty HU, Seneca NM, Brown AK, Gladding R, Temme SS, Herman MM, Innis RB, Pike VW",,460342.0,DTCT0023221,2268443,DTCC00485075,1070293,24989
665,CHEMBL253597,P46098,,DHZBNHMEIOBPAE-JVVVGQRLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18067245.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 at 10 uM,,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,2008.0,51.0,1.0,"Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW",,460113.0,DTCT0023221,2267459,DTCC00485513,1458632,24978
666,CHEMBL254352,P46098,,FVRUVTWIWLDBRH-RGEXLXHISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,19.0,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433.0,DTCT0023221,2351558,DTCC00491379,294152,25479
667,CHEMBL255898,P46098,BARETTIN,YYFNNPXWRXQUPR-JVXNRYDGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17067154.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [9-methyl-3H]BRL-43694 from human 5HT3A receptor expressed in HEK293 cells,,Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands.,J. Nat. Prod.,2006.0,69.0,10.0,"Hedner E, Sjögren M, Frändberg PA, Johansson T, Göransson U, Dahlström M, Jonsson P, Nyberg F, Bohlin L",,526858.0,DTCT0023221,2738959,DTCC00490533,1147126,29670
668,CHEMBL257155,P46098,,HXRJTORFQVDPEI-LGMDPLHJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,19.0,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433.0,DTCT0023221,2351505,DTCC00492328,326762,25479
669,CHEMBL257940,P46098,,WZHXVKWOVBWNIB-RHDGDCLCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18160282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Discovery of novel orally active ureido NPY Y5 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,3.0,"Li G, Stamford AW, Huang Y, Cheng KC, Cook J, Farley C, Gao J, Ghibaudi L, Greenlee WJ, Guzzi M, van Heek M, Hwa JJ, Kelly J, Mullins D, Parker EM, Wainhaus S, Zhang X",,468034.0,DTCT0023221,2301301,DTCC00499075,424837,25590
670,CHEMBL260374,P46098,THIOPERAMIDE,QKDDJDBFONZGBW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8564266.0,KI,=,120.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729293,DTCC00494403,2103825,69351
671,CHEMBL260565,P46098,,PKWXICSBZZLGCF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,251.19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090036,DTCC00494478,2039045,45760
672,CHEMBL26533,P46098,,PRZPXKIXNNNNCD-DJICYOIISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,1652026.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,,Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity.,J. Med. Chem.,1991.0,34.0,8.0,"Raghupathi RK, Rydelek-Fitzgerald L, Teitler M, Glennon RA",,3063.0,DTCT0023221,1036222,DTCC00162519,1391981,11257
673,CHEMBL266591,P46098,,WYWNEDARFVJQSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10715164.0,KI,=,1200.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000.0,43.0,5.0,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,3466.0,DTCT0023221,878057,DTCC00133882,969180,16105
674,CHEMBL267615,P46098,,ZEYRDXUWJDGTLD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331.0,IC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005.0,15.0,19.0,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408.0,DTCT0023221,1847909,DTCC00133863,919058,19721
675,CHEMBL268800,P46098,2-METHYL-5-METHOXYTRYPTAMINE,TYAPSMFCSAKSOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10715164.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000.0,43.0,5.0,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,3467.0,DTCT0023221,887068,DTCC01738625,1648833,16105
676,CHEMBL268800,P46098,2-METHYL-5-METHOXYTRYPTAMINE,TYAPSMFCSAKSOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12825922.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,"Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).",J. Med. Chem.,2003.0,46.0,14.0,,,3413.0,DTCT0023221,513854,DTCC01738625,1661576,17380
677,CHEMBL270595,P46098,,OXEFHEYEQUISKC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820298.0,DTCT0023221,10344317,DTCC00502273,1928089,48255
678,CHEMBL274119,P46098,RACEMETHIONINE,FFEARJCKVFRZRR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14733423,DTCC00135493,2104905,69159
679,CHEMBL274525,P46098,ABT-418,ILLGYRJAYAAAEW-QMMMGPOBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7518514.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14746468,DTCC00137246,2107062,69433
680,CHEMBL27453,P46098,3-(4-CHLOROPHENYL)PYRROLIDINE,MGGZDDQAOZEEDU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,794.33,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090031,DTCC01739293,1655267,45760
681,CHEMBL275528,P46098,PHENCYCLIDINE,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,273.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737498,DTCC00136780,2106327,68446
682,CHEMBL275528,P46098,PHENCYCLIDINE,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,2671.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737499,DTCC00136780,2106327,68446
683,CHEMBL276500,P46098,,HTSNFXAICLXZMA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,2.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14742441,DTCC00135202,2108053,68446
684,CHEMBL276500,P46098,,HTSNFXAICLXZMA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,398.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14742440,DTCC00135202,2108053,68446
685,CHEMBL27846,P46098,(R)ZACOPRIDE,FEROPKNOYKURCJ-ZDUSSCGKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5.01,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3475.0,DTCT0023221,528406,DTCC00165567,660106,1973
686,CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,28.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14759465,DTCC00152325,2111536,68446
687,CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,28.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14760114,DTCC00152325,2111536,68446
688,CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,57.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14759466,DTCC00152325,2111536,68446
689,CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,57.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14760115,DTCC00152325,2111536,68446
690,CHEMBL287045,P46098,SDZ-205557,FFNWMBDISAYHDC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,125.89,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613779,DTCC01739544,1726589,33265
691,CHEMBL288591,P46098,,HOMWNUXPSJQSSU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,0.457,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422325,DTCC00180202,944319,51459
692,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,1.45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211368,DTCC00177095,241562,37125
693,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20724042.0,KI,=,3.98,NM,,,,,,,,,,,,,,Binding affinity to 5HT3A receptor,,Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.,Eur. J. Med. Chem.,2010.0,45.0,11.0,"Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC",,685540.0,DTCT0023221,3563562,DTCC00177095,230479,41807
694,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-2.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035404,DTCC00177095,247805,42619
695,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,0.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825.0,DTCT0023221,5035415,DTCC00177095,247805,42619
696,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1.45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614109,DTCC00177095,231445,47216
697,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813.0,EC50,=,320.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human wild type 5-HT3A receptor expressed in HEK293 cells by FLIPR assay,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278461.0,DTCT0023221,12951269,DTCC00177095,253074,56549
698,CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813.0,KD,=,0.53,NM,,cell_based,,,,,,,,,,,,Binding affinity to human wild type 5-HT3A receptor expressed in HEK293 cells after 24 hrs by liquid scintillation counting analysis,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278482.0,DTCT0023221,12951289,DTCC00177095,253074,56549
699,CHEMBL28992,P46098,,FEROPKNOYKURCJ-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.182,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3476.0,DTCT0023221,537947,DTCC00165493,530906,1973
700,CHEMBL28992,P46098,,FEROPKNOYKURCJ-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5011.87,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,4.0,,,3475.0,DTCT0023221,537949,DTCC00165493,530906,1973
701,CHEMBL290938,P46098,,TZUKARBKFHPFDV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,12.0,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,782919,DTCC00181495,1467787,10391
702,CHEMBL292066,P46098,,NZXGDKLTTHIYTB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,19.21,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1260724,DTCC00212687,1034998,4387
703,CHEMBL292779,P46098,L-775606,ZUTQCPBDRJBADG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9357515.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,"Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.",J. Med. Chem.,1997.0,40.0,22.0,"MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG",,3459.0,DTCT0023221,729031,DTCC01740766,1240895,14385
704,CHEMBL293405,P46098,,SYMHUEFSSMBHJA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14713992,DTCC00215839,2099448,68163
705,CHEMBL293468,P46098,,RWXRJSRJIITQAK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,2818.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736606,DTCC00216870,2106032,68446
706,CHEMBL293468,P46098,,RWXRJSRJIITQAK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,6310.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736605,DTCC00216870,2106032,68446
707,CHEMBL299052,P46098,,VHGCDTVCOLNTBX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12431845.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14731360,DTCC00202425,2104388,68736
708,CHEMBL3,P46098,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125158,DTCC00132283,43212,23555
709,CHEMBL302743,P46098,,UBXGZTRRRHVEAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,5.21,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1270197,DTCC00218758,2000639,4387
710,CHEMBL304534,P46098,,RGLVXEXQIZDZCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,7.96,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1255910,DTCC00219214,1617533,4387
711,CHEMBL305582,P46098,,ADYMTDFOOCWUHC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,7.43,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1265601,DTCC00219247,1741821,4387
712,CHEMBL30713,P46098,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23602445.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor expressed in HEK293T cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965131.0,DTCT0023221,12465429,DTCC01739501,1995571,54821
713,CHEMBL3084430,P46098,,CBHIMCIVCXZMRS-DNZQSCRFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,0.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614110,DTCC01407403,1844178,47216
714,CHEMBL3084431,P46098,,JCHBKINXCIYGSB-MPIKPJSNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,199.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614111,DTCC01407404,1201715,47216
715,CHEMBL3084432,P46098,,SDFVJNYZXNDMQD-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614125,DTCC01407405,943780,47216
716,CHEMBL3084432,P46098,,SDFVJNYZXNDMQD-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy in presence of 10 uM ondansetron,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800921.0,DTCT0023221,7614132,DTCC01407405,943780,47216
717,CHEMBL3084432,P46098,,SDFVJNYZXNDMQD-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614112,DTCC01407405,943780,47216
718,CHEMBL3084433,P46098,,WEDXHKBFMNCGFH-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614126,DTCC01407406,781918,47216
719,CHEMBL3084433,P46098,,WEDXHKBFMNCGFH-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,7.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614113,DTCC01407406,781918,47216
720,CHEMBL3084434,P46098,,MHNNUCFPEURPIX-OJXFFNQFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614127,DTCC01407407,17908,47216
721,CHEMBL3084434,P46098,,MHNNUCFPEURPIX-OJXFFNQFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy in presence of 10 uM ondansetron,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800921.0,DTCT0023221,7614133,DTCC01407407,17908,47216
722,CHEMBL3084434,P46098,,MHNNUCFPEURPIX-OJXFFNQFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614114,DTCC01407407,17908,47216
723,CHEMBL3084435,P46098,,VJEBGMIAGKMECI-LDLYASANSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614115,DTCC01407408,1169429,47216
724,CHEMBL3084436,P46098,,QSIGSEDSPXQCKE-CXAYTTCISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,142.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614116,DTCC01407409,749966,47216
725,CHEMBL3084437,P46098,,MYXOSHHXRWCJCA-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,6300.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614117,DTCC01407410,1299535,47216
726,CHEMBL3084438,P46098,,TXJVVQVHDLOBCQ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614128,DTCC01407411,1267069,47216
727,CHEMBL3084438,P46098,,TXJVVQVHDLOBCQ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,8.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614118,DTCC01407411,1267069,47216
728,CHEMBL3084439,P46098,,XPDKHWGJPIAGSI-BKFWDETESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614129,DTCC01407412,1779573,47216
729,CHEMBL3084439,P46098,,XPDKHWGJPIAGSI-BKFWDETESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614119,DTCC01407412,1779573,47216
730,CHEMBL3084440,P46098,,VMAWYVBPAWZAGD-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614130,DTCC01407413,2039344,47216
731,CHEMBL3084440,P46098,,VMAWYVBPAWZAGD-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy in presence of 10 uM ondansetron,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800921.0,DTCT0023221,7614134,DTCC01407413,2039344,47216
732,CHEMBL3084440,P46098,,VMAWYVBPAWZAGD-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614120,DTCC01407413,2039344,47216
733,CHEMBL3084441,P46098,,KKQAFQIZABQOOY-JOZNFPNDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920.0,DTCT0023221,7614131,DTCC01407414,17909,47216
734,CHEMBL3084441,P46098,,KKQAFQIZABQOOY-JOZNFPNDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614121,DTCC01407414,17909,47216
735,CHEMBL3084442,P46098,,STOPSEQYAMSLCO-QEIWAGNOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,157.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614122,DTCC01407415,1655595,47216
736,CHEMBL3084443,P46098,,BWUVAZMPSVZMLB-CXAYTTCISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,1300.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614123,DTCC01407416,263828,47216
737,CHEMBL3084444,P46098,,KMQUSSWWYBEKHN-PKQPGRETSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135.0,KI,=,208.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012.0,22.0,2.0,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919.0,DTCT0023221,7614124,DTCC01407417,17916,47216
738,CHEMBL3084582,P46098,,OBSQXMOZMFTQSH-CNDDSTCGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,316.23,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613777,DTCC01407558,1950755,33265
739,CHEMBL3084719,P46098,,MGVAXVSGNNKWEZ-QEIWAGNOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Binding affinity to human 5HT3A receptor in HEK293 cells assessed as cell labeling by confocal microscopy in presence of quipazine,Active,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612616.0,DTCT0023221,3211384,DTCC01407695,437629,37125
740,CHEMBL3084719,P46098,,MGVAXVSGNNKWEZ-QEIWAGNOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,2.8,NM,,cell_based,,,,,,,,,,,HEK293,Binding affinity to human 5HT3A receptor in HEK293 cells assessed as cell labeling by confocal microscopy,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612615.0,DTCT0023221,3211385,DTCC01407695,437629,37125
741,CHEMBL3084759,P46098,,HMQQYASRCXSQBR-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,73.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553826,DTCC01407732,469936,41528
742,CHEMBL3084760,P46098,,FVAIFXRTWOJMOT-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,58.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553827,DTCC01407733,1375811,41528
743,CHEMBL3084761,P46098,,RXDWERDONCYTQT-PHZGNYQRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,40.0,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553828,DTCC01407734,534677,41528
744,CHEMBL3084762,P46098,,RBULLMHVZYBTHL-LUKYLMHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,12.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553830,DTCC01407735,1019137,41528
745,CHEMBL3084763,P46098,,RBULLMHVZYBTHL-VQHPVUNQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,92.6,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553831,DTCC01407736,502564,41528
746,CHEMBL3084764,P46098,,QFWHMNCBGAIEHD-XLAORIBOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,4.6,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553832,DTCC01407737,1408220,41528
747,CHEMBL3084765,P46098,,BIKQMUIIBHYLFG-OKYOBFRVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,3.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553833,DTCC01407738,1116763,41528
748,CHEMBL3084766,P46098,,VMTCKBHBISQSTL-FTEYMNFISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,5.0,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553834,DTCC01407739,1504836,41528
749,CHEMBL3084767,P46098,,SDYKMQKYPRJEJM-HAGHYFMRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,3.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553835,DTCC01407740,1952039,41528
750,CHEMBL3084768,P46098,,XLQKCOZKZDBOOM-DCXXXQMHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,2.0,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553836,DTCC01407741,307828,41528
751,CHEMBL3084769,P46098,,HHKROCCRVVBZNW-KFGODFMUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,0.6,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553837,DTCC01407742,986896,41528
752,CHEMBL3084770,P46098,,UIKMHGOYAXJLIA-VPAKFMSCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553839,DTCC01407743,406077,41528
753,CHEMBL3084771,P46098,,PHTYRUNMQXLWGU-PECIQYQJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,35.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553840,DTCC01407744,340534,41528
754,CHEMBL3084772,P46098,,ZTOYBNWVJQYBOX-PHZGNYQRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,72.2,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553842,DTCC01407745,1472478,41528
755,CHEMBL3084773,P46098,,QWZXRDUZUQKTLV-LUKYLMHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,16.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553843,DTCC01407746,1375815,41528
756,CHEMBL3084774,P46098,,BTAHQEQRFWNWKD-PECIQYQJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,37.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553844,DTCC01407747,469939,41528
757,CHEMBL3084775,P46098,,BTAHQEQRFWNWKD-ZKXLYKBJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,59.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553845,DTCC01407748,502569,41528
758,CHEMBL3084776,P46098,,BTAHQEQRFWNWKD-KFGODFMUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,2.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553846,DTCC01407749,663789,41528
759,CHEMBL3084777,P46098,,OZOLNJQERDKPFN-OSYLJGHBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,14.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553848,DTCC01407750,1919165,41528
760,CHEMBL3084778,P46098,,SFVKVHVOODTRCH-QKDCVEJESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,8.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553850,DTCC01407751,1440098,41528
761,CHEMBL3084779,P46098,,ORIFHGMCBRVMDD-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,15.1,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553820,DTCC01407752,1822826,41528
762,CHEMBL3084780,P46098,,ILEZUEGFQWZUOZ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,16.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553821,DTCC01407753,1019143,41528
763,CHEMBL3084781,P46098,,GGTVJORIYQKWBH-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,18.0,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553822,DTCC01407754,792698,41528
764,CHEMBL3084782,P46098,,VDBKJDOCZOVAPB-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,18.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553823,DTCC01407755,566924,41528
765,CHEMBL3084783,P46098,,ZXDOWRQWHIUDFJ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,40.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553824,DTCC01407756,1310666,41528
766,CHEMBL3084784,P46098,,KVRNIHXCXMCIQM-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,94.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553825,DTCC01407757,858151,41528
767,CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125488,DTCC01408495,1987064,23555
768,CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125489,DTCC01408495,1987064,23555
769,CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125166,DTCC01408495,1987064,23555
770,CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125167,DTCC01408495,1987064,23555
771,CHEMBL3093186,P46098,,RVXJKDQROPYYOF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128816.0,KI,=,1200.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3,,Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Fontenelle CQ, Wang Z, Fossey C, Cailly T, Linclau B, Fabis F",,1278511.0,DTCT0023221,12952365,DTCC01412791,363859,56552
772,CHEMBL3093187,P46098,,YKBQHBXRXWGQIZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128816.0,KI,=,2600.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3,,Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Fontenelle CQ, Wang Z, Fossey C, Cailly T, Linclau B, Fabis F",,1278511.0,DTCT0023221,12952364,DTCC01412792,233035,56552
773,CHEMBL3094311,P46098,,NHUZHVAPAIJQRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,23.1,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962165,DTCC01413925,1127501,56656
774,CHEMBL3094312,P46098,,KKYAPAJUTFYVRD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,10.4,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962123,DTCC01413926,351566,56656
775,CHEMBL3094313,P46098,,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,-10.6,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962081,DTCC01413927,933254,56656
776,CHEMBL3094314,P46098,,NLGKYLSBSOGION-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,-11.9,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962039,DTCC01413928,901389,56656
777,CHEMBL3094316,P46098,,RSZFCDGHJLBYEB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,-16.5,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12963267,DTCC01413930,1708845,56656
778,CHEMBL3094317,P46098,,VCEAPZBMHGKMHI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,-17.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12963225,DTCC01413931,1256448,56656
779,CHEMBL3094318,P46098,,CYPDLWIUOMSUJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,-13.8,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962292,DTCC01413932,1737126,56656
780,CHEMBL3094319,P46098,,YYONFKYBFNEIKC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,-4.2,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962250,DTCC01413933,965453,56656
781,CHEMBL3094320,P46098,,UZVSKGBBGCJIRV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903.0,INHIBITION,=,13.7,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115.0,DTCT0023221,12962208,DTCC01413934,1644990,56656
782,CHEMBL3099899,P46098,,VDWKDBPHAPPUBO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24215892.0,INHIBITION,=,-3.0,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM relative to control,,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,2013.0,23.0,24.0,"Mercer SP, Roecker AJ, Garson S, Reiss DR, Meacham Harrell C, Murphy KL, Bruno JG, Bednar RA, Lemaire W, Cui D, Cabalu TD, Tang C, Prueksaritanont T, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ",,1282878.0,DTCT0023221,12972963,DTCC01415896,1737150,56711
783,CHEMBL3104091,P46098,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847.0,DTCT0023221,12984227,DTCC01417357,351604,56928
784,CHEMBL3104092,P46098,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847.0,DTCT0023221,12984203,DTCC01417358,1030177,56928
785,CHEMBL3104093,P46098,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159.0,KI,=,501.19,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847.0,DTCT0023221,12984162,DTCC01417359,577788,56928
786,CHEMBL3104093,P46098,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159.0,KI,=,529.0,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847.0,DTCT0023221,12984084,DTCC01417359,577788,56928
787,CHEMBL310604,P46098,HOMOCYSTEINE,FFFHZYDWPBMWHY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14744009,DTCC00239847,2108578,69159
788,CHEMBL31354,P46098,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14730791,DTCC00166968,2104228,68785
789,CHEMBL31354,P46098,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21520940.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011.0,54.0,10.0,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747437.0,DTCT0023221,5943669,DTCC00166968,509294,44583
790,CHEMBL313631,P46098,,YXPIBYSOCFGTHG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12361399.0,KI,>,10000.0,NM,,,,,,,,,,,,,,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.,J. Med. Chem.,2002.0,45.0,21.0,"Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA",,3474.0,DTCT0023221,1236399,DTCC00252054,886449,17003
791,CHEMBL3186763,P46098,,DCAMTBFFNOHDAW-DYTRJAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25244572.0,INHIBITION,=,1.64,%,,,,,,,,,,,,,,Displacement of [3H]GR-65630 from human 5HT3 receptor at 10 uM,,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,2014.0,57.0,20.0,"Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE",,1439053.0,DTCT0023221,14011986,DTCC01442275,2029987,59962
792,CHEMBL3215892,P46098,,MTATYSOUXXNXHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912.0,INHIBITION,=,17.99,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896.0,DTCT0023221,11493439,DTCC01463309,1041440,52134
793,CHEMBL3216651,P46098,,KWSJSWCQZPEIPC-LQVXLWKRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997.0,60.0,4.0,"Lewin G, Schaeffer C, Dacquet C",,549546.0,DTCT0023221,2539168,DTCC01464065,1788318,27062
794,CHEMBL3217984,P46098,,YVENIGOVHPMTDH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,630.96,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329312.0,DTCT0023221,13582410,DTCC01464882,1030631,39761
795,CHEMBL3233402,P46098,,QOUMVERMRHELNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,36.86,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830.0,DTCT0023221,13611749,DTCC01472420,1030719,57930
796,CHEMBL3233667,P46098,,IVCAEPYRFIZWLG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,19.75,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830.0,DTCT0023221,13611750,DTCC01472687,1128021,57930
797,CHEMBL3233668,P46098,,ILVAWRRDRHCBOI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,14.28,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830.0,DTCT0023221,13611751,DTCC01472688,1062965,57930
798,CHEMBL3233675,P46098,,JFMXQIZKNMCOKW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,17.22,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830.0,DTCT0023221,13611752,DTCC01472695,1613339,57930
799,CHEMBL3233676,P46098,,WICBFQOIMPMYDE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,13.75,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830.0,DTCT0023221,13611753,DTCC01472696,1096002,57930
800,CHEMBL3233679,P46098,,SZNATCJGGOZJDA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057.0,INHIBITION,=,16.56,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014.0,78.0,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830.0,DTCT0023221,13611754,DTCC01472699,1387348,57930
801,CHEMBL3235480,P46098,,JIGWWGDIEUWCOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,=,230.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624528,DTCC01474511,1075182,57970
802,CHEMBL3235481,P46098,,TYQSTXACTJXVQJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624529,DTCC01474512,200660,57970
803,CHEMBL3235482,P46098,,RCCDDPHPJBBTOH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,=,505.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624530,DTCC01474513,622645,57970
804,CHEMBL3235483,P46098,,BKRDDYIAVADMIJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624531,DTCC01474514,1140168,57970
805,CHEMBL3235484,P46098,,WITLOMKPGROHOE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624532,DTCC01474515,396907,57970
806,CHEMBL3235485,P46098,,CTXSDFAIKXRHJK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624533,DTCC01474516,1010204,57970
807,CHEMBL3235486,P46098,,WBOQGKDOKBETNS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624534,DTCC01474517,881447,57970
808,CHEMBL3235487,P46098,,BJNBJBFZIZJIQH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624535,DTCC01474518,1495969,57970
809,CHEMBL3235488,P46098,,FVYGPOGSXRAZEB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013.0,56.0,19.0,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278.0,DTCT0023221,13624536,DTCC01474519,1560308,57970
810,CHEMBL3261478,P46098,,IYUQYZMILCFRJI-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,67.6,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709617,DTCC01486915,1657540,58772
811,CHEMBL3261478,P46098,,IYUQYZMILCFRJI-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,74.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678613,DTCC01486915,1659870,65052
812,CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,ACTIVITY,=,7.0,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969.0,DTCT0023221,13709628,DTCC01486916,233435,58772
813,CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971.0,DTCT0023221,13709638,DTCC01486916,233435,58772
814,CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,3.1,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709618,DTCC01486916,233435,58772
815,CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,4.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678614,DTCC01486916,235814,65052
816,CHEMBL3261480,P46098,,VVNHBZRFRXWLFQ-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,0.2,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709619,DTCC01486917,2008702,58772
817,CHEMBL3261480,P46098,,VVNHBZRFRXWLFQ-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678616,DTCC01486917,2011264,65052
818,CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,ACTIVITY,=,19.0,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969.0,DTCT0023221,13709629,DTCC01486918,881571,58772
819,CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971.0,DTCT0023221,13709639,DTCC01486918,881571,58772
820,CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,8.1,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709620,DTCC01486918,881571,58772
821,CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,8.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678619,DTCC01486918,883997,65052
822,CHEMBL3261482,P46098,,WLINCFBAKQHMPZ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,ACTIVITY,=,30.0,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969.0,DTCT0023221,13709630,DTCC01486919,1042780,58772
823,CHEMBL3261482,P46098,,WLINCFBAKQHMPZ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971.0,DTCT0023221,13709640,DTCC01486919,1042780,58772
824,CHEMBL3261482,P46098,,WLINCFBAKQHMPZ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,6.4,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709621,DTCC01486919,1042780,58772
825,CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,ACTIVITY,=,28.0,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969.0,DTCT0023221,13709631,DTCC01486920,1625395,58772
826,CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971.0,DTCT0023221,13709641,DTCC01486920,1625395,58772
827,CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,0.5,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709622,DTCC01486920,1625395,58772
828,CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678620,DTCC01486920,1627864,65052
829,CHEMBL3261484,P46098,,RBNIAPFMQOKNBD-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,0.8,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709623,DTCC01486921,622758,58772
830,CHEMBL3261485,P46098,,XDJFTOOYWJXAAZ-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,ACTIVITY,=,87.0,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969.0,DTCT0023221,13709632,DTCC01486922,1496096,58772
831,CHEMBL3261485,P46098,,XDJFTOOYWJXAAZ-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971.0,DTCT0023221,13709643,DTCC01486922,1496096,58772
832,CHEMBL3261485,P46098,,XDJFTOOYWJXAAZ-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,13.5,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709624,DTCC01486922,1496096,58772
833,CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,ACTIVITY,=,83.0,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969.0,DTCT0023221,13709633,DTCC01486923,1203608,58772
834,CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971.0,DTCT0023221,13709644,DTCC01486923,1203608,58772
835,CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,5.7,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709625,DTCC01486923,1203608,58772
836,CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,7.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678629,DTCC01486923,1206052,65052
837,CHEMBL3261487,P46098,,FOVPMEXFLUOBRL-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431.0,KI,=,701.0,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,11.0,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968.0,DTCT0023221,13709626,DTCC01486924,1592727,58772
838,CHEMBL3261487,P46098,,FOVPMEXFLUOBRL-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,701.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678630,DTCC01486924,1595242,65052
839,CHEMBL3262125,P46098,,OIZPYIZBDYGMNM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,95.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710405,DTCC01487568,1930784,58852
840,CHEMBL3262129,P46098,,DQNDQNJPABVUOS-BTQNPOSSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,100.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710406,DTCC01487572,675632,58852
841,CHEMBL3262132,P46098,,ZWCUBSOPHPGVRD-UTONKHPSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,43.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710407,DTCC01487575,643454,58852
842,CHEMBL3262135,P46098,,WVUAJTKMQULXHI-BTQNPOSSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,99.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710408,DTCC01487579,902089,58852
843,CHEMBL3262143,P46098,,ABWJEIIFONCFKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,99.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710409,DTCC01487587,1159462,58852
844,CHEMBL3262144,P46098,,MXHSBCKYMYQTPI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,91.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710410,DTCC01487588,319472,58852
845,CHEMBL3262156,P46098,,CBIFADZHFPXCGB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,39.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710411,DTCC01487600,2029531,58852
846,CHEMBL3262162,P46098,,GYVJDAOHVCIKJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,23.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710412,DTCC01487606,1387509,58852
847,CHEMBL3262164,P46098,,GYVJDAOHVCIKJN-RSAXXLAASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,7.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710413,DTCC01487608,740031,58852
848,CHEMBL3262168,P46098,,YXVBKPDMQWCFGZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,40.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710414,DTCC01487612,1930785,58852
849,CHEMBL3262171,P46098,,DSBWLGAVGSZBLW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,80.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710415,DTCC01487615,1709548,58852
850,CHEMBL3262172,P46098,,GGWDKUQZZHJDPZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,47.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710416,DTCC01487616,869820,58852
851,CHEMBL3262174,P46098,,ULCUTKYYKKNHQX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197.0,INHIBITION,=,16.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019.0,DTCT0023221,13710417,DTCC01487618,1224063,58852
852,CHEMBL3262390,P46098,,MRARYZFWVQTTTE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360.0,INHIBITION,=,1.0,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014.0,80.0,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437.0,DTCT0023221,13715641,DTCC01487836,1224067,58782
853,CHEMBL3262393,P46098,,LGZBUKYZDPMWQV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360.0,INHIBITION,=,15.0,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014.0,80.0,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437.0,DTCT0023221,13715622,DTCC01487839,1709550,58782
854,CHEMBL3262407,P46098,,DJAHTVFQLSUHKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360.0,INHIBITION,=,5.0,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014.0,80.0,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437.0,DTCT0023221,13715570,DTCC01487853,1322115,58782
855,CHEMBL3262432,P46098,,QDZASJHLCZFYMF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360.0,INHIBITION,=,6.0,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014.0,80.0,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437.0,DTCT0023221,13715589,DTCC01487879,92453,58782
856,CHEMBL3287723,P46098,,AOYJKNKRKBOUAP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24735492.0,INHIBITION,=,-15.3,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 10 uM by radioligand displacement assay,,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,2014.0,57.0,10.0,"Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND",,1361692.0,DTCT0023221,13779798,DTCC01498697,200946,59335
857,CHEMBL329179,P46098,,OJGZHBJNBKIPHW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,1.94,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,778477,DTCC00255790,1532546,10391
858,CHEMBL3310035,P46098,,RQPAEAIGXOANQF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human serotonin 5-HT3 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta counting analysis,Not Active,,J. Nat. Prod.,2014.0,77.0,5.0,,,1450763.0,DTCT0023221,13892096,DTCC01510285,655458,57486
859,CHEMBL3310802,P46098,,PLIHWCCORFZAAL-WLHGVMLRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24856064.0,INHIBITION,=,-10.0,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 3 uM by radioligand binding assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014.0,24.0,14.0,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1448341.0,DTCT0023221,13918399,DTCC01511043,385195,60676
860,CHEMBL3311308,P46098,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24881566.0,EC50,>,50118.72,NM,,,,,,,,,,,,,,Agonist activity at human 5-HT3 receptor by FLIPR/summary (Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014.0,24.0,14.0,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455271.0,DTCT0023221,13918415,DTCC01511540,558563,60691
861,CHEMBL3311308,P46098,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24881566.0,EC50,>,50118.72,NM,,,,,,,,,,,,,,Agonist activity at human 5-HT3 receptor by FLIPR(Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014.0,24.0,14.0,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455272.0,DTCT0023221,13918416,DTCC01511540,558563,60691
862,CHEMBL3326982,P46098,,JUVUVFRLXMQWRG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25127461.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 (unknown origin),,Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.,Bioorg. Med. Chem.,2014.0,22.0,17.0,"Kim Y, Tae J, Lee K, Rhim H, Choo IH, Cho H, Park WK, Keum G, Choo H",,1453282.0,DTCT0023221,13967403,DTCC01518856,1593250,61216
863,CHEMBL3326993,P46098,,IAKYDYYOYGXWAX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25127461.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 (unknown origin),,Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.,Bioorg. Med. Chem.,2014.0,22.0,17.0,"Kim Y, Tae J, Lee K, Rhim H, Choo IH, Cho H, Park WK, Keum G, Choo H",,1453282.0,DTCT0023221,13967385,DTCC01518867,590853,61216
864,CHEMBL3334797,P46098,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25164761.0,INHIBITION,=,-5.2,%,,,,,,,,,,,,,,Inhibition of human 5HT3 at 10 uM by [3H]RL43694 binding assay relative to control,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014.0,86.0,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1457920.0,DTCT0023221,13968464,DTCC01521941,1996944,59781
865,CHEMBL33884,P46098,GR-113808,MOZPSIXKYJUTKI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613764,DTCC01739618,662552,33265
866,CHEMBL34291,P46098,SC-53116,GAYSOZKZPOVDSB-HZMBPMFUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12540230.0,KI,=,152.0,NM,,,,,,,,,,,,,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,5-HT4 receptor ligands: applications and new prospects.,J. Med. Chem.,2003.0,46.0,3.0,"Langlois M, Fischmeister R",,3468.0,DTCT0023221,1069306,DTCC01739643,938793,17663
867,CHEMBL356359,P46098,PIBOSEROD,KVCSJPATKXABRQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613769,DTCC00329795,1632627,33265
868,CHEMBL3577955,P46098,,PWDBREUBRYUEGC-BTJKTKAUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496643.0,DTCT0023221,14434908,DTCC01646031,903869,62611
869,CHEMBL3577956,P46098,,ABJWJGMTLYSISP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496643.0,DTCT0023221,14434909,DTCC01646032,386606,62611
870,CHEMBL3577957,P46098,,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496643.0,DTCT0023221,14434910,DTCC01646033,1550378,62611
871,CHEMBL3608450,P46098,,XYYAWEJOUNEPTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,8.0,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522382,DTCC01659060,2010933,63285
872,CHEMBL3608451,P46098,,CZFCLBXCYDIEPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,-2.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522383,DTCC01659061,1044967,63285
873,CHEMBL3609140,P46098,,WMUMDPMAVBGKFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,0.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522384,DTCC01659756,1336478,63285
874,CHEMBL3609141,P46098,,KZDZYBKXTRADGE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,11.6,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522385,DTCC01659758,366417,63285
875,CHEMBL3609142,P46098,,FESBEMCDUCWSRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,0.8,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522386,DTCC01659759,366418,63285
876,CHEMBL3609143,P46098,,CYJCXWNNMRXTFZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,7.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522387,DTCC01659760,1691636,63285
877,CHEMBL3609144,P46098,,PFRJZRVFRYEUFK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,8.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522388,DTCC01659761,1530549,63285
878,CHEMBL3609145,P46098,,VOXGFSUNUJCBDG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,-7.4,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522389,DTCC01659762,883678,63285
879,CHEMBL3609146,P46098,,GCHJSHYKQQLMEH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,4.1,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522390,DTCC01659763,171062,63285
880,CHEMBL3609147,P46098,,IKCBNRBKMJGBBJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,-4.1,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522391,DTCC01659764,1303757,63285
881,CHEMBL3609148,P46098,,OOEBRLFRLPWAPM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772.0,INHIBITION,=,-13.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512430.0,DTCT0023221,14522392,DTCC01659765,202966,63285
882,CHEMBL3613642,P46098,,KORKKQLDGMHNKO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26235950.0,INHIBITION,=,-3.0,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor assessed as inhibition of control specific binding at 10 uM,,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,2015.0,25.0,18.0,"Wei ZL, Nguyen MT, O'Mahony DJ, Acevedo A, Zipfel S, Zhang Q, Liu L, Dourado M, Chi C, Yip V, DeFalco J, Gustafson A, Emerling DE, Kelly MG, Kincaid J, Vincent F, Duncton MA",,1514562.0,DTCT0023221,14536057,DTCC01662099,495991,63547
883,CHEMBL363124,P46098,,YQSXXLHEQOZMOT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004.0,14.0,16.0,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007.0,DTCT0023221,1764696,DTCC00387183,1295600,18177
884,CHEMBL363124,P46098,,YQSXXLHEQOZMOT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013.0,22.0,2.0,,,932184.0,DTCT0023221,11740305,DTCC00387183,1320700,51606
885,CHEMBL3633757,P46098,,AJIMVLSQIMXLNV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26475518.0,KI,>,900.0,NM,,,,,,,,,,,,,,Displacement of [3H]-LY278584 from recombinant human 5-HT3 receptor after 1.5 hrs by Microbeta scintillation counting analysis,,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,2015.0,25.0,22.0,"Ponnala S, Kapadia N, Madapa S, Alberts IL, Harding WW",,1527271.0,DTCT0023221,14599739,DTCC01670761,1077577,64247
886,CHEMBL3639782,P46098,,GDMKKRJGHYVUND-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635633,DTCC01712080,2063717,64307
887,CHEMBL364005,P46098,,BPPGPYJBCVXILI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331.0,IC50,=,34.0,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005.0,15.0,19.0,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408.0,DTCT0023221,1847955,DTCC00405036,1113810,19721
888,CHEMBL365323,P46098,,SSOHJAKQLOENEM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648.0,KI,=,49.8,NM,,,,,,,,,,,,,,Inhibition of human 5HT3R,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012.0,55.0,22.0,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877364.0,DTCT0023221,11452772,DTCC00404345,492456,51687
889,CHEMBL366563,P46098,,LEVWYRKDKASIDU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727100,DTCC00370225,2103226,69159
890,CHEMBL3673238,P46098,,UYSKPMCDNLQXLI-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678615,DTCC01705847,980602,65052
891,CHEMBL3673239,P46098,,ZFBWQZNTQCGSCO-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,416.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678617,DTCC01705848,1498536,65052
892,CHEMBL3673240,P46098,,ZFBWQZNTQCGSCO-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,205.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678618,DTCC01705849,1173788,65052
893,CHEMBL3673241,P46098,,WLINCFBAKQHMPZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,6.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678621,DTCC01705850,592767,65052
894,CHEMBL3673242,P46098,,CSONPSGXWWHUTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,14.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678622,DTCC01705851,1945420,65052
895,CHEMBL3673243,P46098,,RBNIAPFMQOKNBD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678623,DTCC01705852,399531,65052
896,CHEMBL3673244,P46098,,XWUPGTBREYOJFJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678624,DTCC01705853,1401775,65052
897,CHEMBL3673245,P46098,,YLPZXKURYOEIQJ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,32.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678625,DTCC01705854,463250,65052
898,CHEMBL3673246,P46098,,LGLCKEXISVFUDS-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,130.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678626,DTCC01705855,139122,65052
899,CHEMBL3673247,P46098,,NRGNXBSNUWZEIJ-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,406.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678627,DTCC01705856,1912946,65052
900,CHEMBL3673248,P46098,,KACRUIFNMDGLQB-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,206.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678628,DTCC01705857,235813,65052
901,CHEMBL3673249,P46098,,HFEFUMDVHZMGPE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,8.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678631,DTCC01705858,1271554,65052
902,CHEMBL3673250,P46098,,FKHIPVXDHNZSRM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,30.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678632,DTCC01705859,657624,65052
903,CHEMBL3673251,P46098,,DUFOURYPCWYIEE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678633,DTCC01705860,1238778,65052
904,CHEMBL3673252,P46098,,FQYWZZQVOSFYHI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,24.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678635,DTCC01705861,1498537,65052
905,CHEMBL3673252,P46098,,FQYWZZQVOSFYHI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,217.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678634,DTCC01705861,1498537,65052
906,CHEMBL3673253,P46098,,MUFQWBWNQHXWKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,73.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678636,DTCC01705862,268430,65052
907,CHEMBL3673254,P46098,,TVQVUCVKRZJIOB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,241.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678638,DTCC01705863,366747,65052
908,CHEMBL3673254,P46098,,TVQVUCVKRZJIOB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,579.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015.0,,,,,1528463.0,DTCT0023221,14678637,DTCC01705863,366747,65052
909,CHEMBL3679390,P46098,,ZTVHPOWKVOPISB-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635621,DTCC01712061,645857,64307
910,CHEMBL3679391,P46098,,ATTAPIQZQXPNMZ-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635625,DTCC01712062,968400,64307
911,CHEMBL3679392,P46098,,ATTAPIQZQXPNMZ-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635620,DTCC01712063,774425,64307
912,CHEMBL3679393,P46098,,ZTVHPOWKVOPISB-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635615,DTCC01712064,710068,64307
913,CHEMBL3679394,P46098,,WTFBVGQGFZBITI-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635622,DTCC01712065,742387,64307
914,CHEMBL3679395,P46098,,UCBSZTBOXRRYMN-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635623,DTCC01712066,872180,64307
915,CHEMBL3679396,P46098,,UCBSZTBOXRRYMN-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635617,DTCC01712067,516578,64307
916,CHEMBL3679397,P46098,,WTASBJPDMWMMEL-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,3.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635624,DTCC01712068,710069,64307
917,CHEMBL3679398,P46098,,WTASBJPDMWMMEL-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635616,DTCC01712069,420116,64307
918,CHEMBL3679399,P46098,,HPMOOCNWTGBYIG-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635618,DTCC01712070,223888,64307
919,CHEMBL3679400,P46098,,NJXILISOPRFRLR-NRFANRHFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635626,DTCC01712071,159693,64307
920,CHEMBL3679401,P46098,,YKQUIJWABGQLEP-FQEVSTJZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,29.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635627,DTCC01712072,1680207,64307
921,CHEMBL3679402,P46098,,YKQUIJWABGQLEP-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,7.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635619,DTCC01712073,1966340,64307
922,CHEMBL3679403,P46098,,LNCMYWGGZAEHIK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,13.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635614,DTCC01712074,127073,64307
923,CHEMBL3679404,P46098,,NXSYJBVNYHBHHG-FQEVSTJZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,68.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635628,DTCC01712075,1804500,64307
924,CHEMBL3679405,P46098,,GTOVOFHFJNASEM-NRFANRHFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,57.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635629,DTCC01712076,94858,64307
925,CHEMBL3679406,P46098,,PBZWPISSKGJWPR-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635630,DTCC01712077,1130572,64307
926,CHEMBL3679407,P46098,,BZPUAHCKXAJNIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,34.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635631,DTCC01712078,516579,64307
927,CHEMBL3679408,P46098,,WHLXDRXTKZLGFK-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,3.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635638,DTCC01712079,1771944,64307
928,CHEMBL3679408,P46098,,WHLXDRXTKZLGFK-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,4.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635632,DTCC01712079,1771942,64307
929,CHEMBL3679409,P46098,,USMXSRUHBDFPEM-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635634,DTCC01712081,1486619,64307
930,CHEMBL3679410,P46098,,ZAHAKXSHZSSPOF-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635635,DTCC01712082,1771943,64307
931,CHEMBL3679411,P46098,,MEYSSICNMCKUSB-JOCHJYFZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635636,DTCC01712083,1868817,64307
932,CHEMBL3679412,P46098,,WHLXDRXTKZLGFK-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,108.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635637,DTCC01712084,1583093,64307
933,CHEMBL3679413,P46098,,IANJVKHDSMUIRT-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635640,DTCC01712085,1130573,64307
934,CHEMBL3679414,P46098,,RBGMTAOTVOHILH-HSZRJFAPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635641,DTCC01712086,256099,64307
935,CHEMBL3679415,P46098,,WHVZPNITVJSAMC-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,49.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635642,DTCC01712087,904452,64307
936,CHEMBL3679416,P46098,,IANJVKHDSMUIRT-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,8.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635643,DTCC01712088,1740132,64307
937,CHEMBL3679417,P46098,,RBGMTAOTVOHILH-QHCPKHFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,13.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635644,DTCC01712089,1868818,64307
938,CHEMBL3679418,P46098,,LSNUXVIISZOERE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,267.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635645,DTCC01712090,159694,64307
939,CHEMBL3679419,P46098,,JTKYQKMRKDHHPR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,59.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635646,DTCC01712091,1161837,64307
940,CHEMBL3679420,P46098,,IQMIOVIDFWQLDA-JOCHJYFZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,25.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013.0,,,,,1527764.0,DTCT0023221,14635639,DTCC01712092,548620,64307
941,CHEMBL3740472,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26363507.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Agonist activity at human recombinant 5HT3 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,2015.0,103.0,,"Nirogi R, Mohammed AR, Shinde AK, Bogaraju N, Gagginapalli SR, Ravella SR, Kota L, Bhyrapuneni G, Muddana NR, Benade V, Palacharla RC, Jayarajan P, Subramanian R, Goyal VK.",,1540913.0,DTCT0023221,16676,DTCC00065101,1648360,65482
942,CHEMBL3740472,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26363507.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Antagonist activity at human recombinant 5HT3 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,2015.0,103.0,,"Nirogi R, Mohammed AR, Shinde AK, Bogaraju N, Gagginapalli SR, Ravella SR, Kota L, Bhyrapuneni G, Muddana NR, Benade V, Palacharla RC, Jayarajan P, Subramanian R, Goyal VK.",,1540933.0,DTCT0023221,16696,DTCC00065101,1648360,65482
943,CHEMBL3741992,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26460788.0,INHIBITION,<,30.0,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM,,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,2015.0,58.0,21.0,"Lopez-Tapia F, Walker KA, Brotherton-Pleiss C, Caroon J, Nitzan D, Lowrie L, Gleason S, Zhao SH, Berger J, Cockayne D, Phippard D, Suttmann R, Fitch WL, Bourdet D, Rege P, Huang X, Broadbent S, Dvorak C, Zhu J, Wagner P, Padilla F, Loe B, Jahangir A, Alker A.",,1541658.0,DTCT0023221,20304,DTCC00065423,1804813,65488
944,CHEMBL374351,P46098,KKHT-10103,WHHXYDWPIRKEHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,57000.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887673,DTCC00002551,921018,34988
945,CHEMBL374351,P46098,KKHT-10103,WHHXYDWPIRKEHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,34.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887648,DTCC00002551,921018,34988
946,CHEMBL3746146,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26580980.0,KI,=,3.0,NM,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human 5-HT3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"Design of 7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.",Eur. J. Med. Chem.,2016.0,107.0,,"Ouach A, Pin F, Bertrand E, Vercouillie J, Gulhan Z, Mothes C, Deloye JB, Guilloteau D, Suzenet F, Chalon S, Routier S.",,1546368.0,DTCT0023221,33154,DTCC00068812,1013253,65644
947,CHEMBL3746799,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26580980.0,KI,=,52.0,NM,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human 5-HT3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"Design of 7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.",Eur. J. Med. Chem.,2016.0,107.0,,"Ouach A, Pin F, Bertrand E, Vercouillie J, Gulhan Z, Mothes C, Deloye JB, Guilloteau D, Suzenet F, Chalon S, Routier S.",,1546368.0,DTCT0023221,33156,DTCC00069049,884371,65644
948,CHEMBL3747344,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26580980.0,KI,=,3.0,NM,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human 5-HT3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"Design of 7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.",Eur. J. Med. Chem.,2016.0,107.0,,"Ouach A, Pin F, Bertrand E, Vercouillie J, Gulhan Z, Mothes C, Deloye JB, Guilloteau D, Suzenet F, Chalon S, Routier S.",,1546368.0,DTCT0023221,33155,DTCC00069041,915885,65644
949,CHEMBL3759860,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26761776.0,INHIBITION,=,50.0,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin) at 1 to 2 uM by radioligand binding assay,,Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.,Eur. J. Med. Chem.,2016.0,109.0,,"Park JS, Im W, Choi S, Park SJ, Jung JM, Baek KS, Son HP, Sharma S, Kim IS, Jung YH.",,1552730.0,DTCT0023221,69217,DTCC00074937,432317,66015
950,CHEMBL3763166,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26653033.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor (unknown origin) at 10 uM,,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,2016.0,59.0,1.0,"Lin SY, Yeh TK, Kuo CC, Song JS, Cheng MF, Liao FY, Chao MW, Huang HL, Chen YL, Yang CY, Wu MH, Hsieh CL, Hsiao W, Peng YH, Wu JS, Lin LM, Sun M, Chao YS, Shih C, Wu SY, Pan SL, Hung MS, Ueng SH.",,1553775.0,DTCT0023221,91902,DTCC00075195,807224,66086
951,CHEMBL376324,P46098,,BJPAAUARTYANJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16971122.0,IC50,=,275.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Inhibitors of unactivated p38 MAP kinase.,Bioorg. Med. Chem. Lett.,2006.0,16.0,23.0,"Bullington J, Argentieri D, Averill K, Carter D, Cavender D, Fahmy B, Fan X, Hall D, Heintzelman G, Jackson P, Leung WP, Li X, Ling P, Olini G, Razler T, Reuman M, Rupert K, Russell R, Siekierka J, Wadsworth S, Wolff R, Xiang B, Zhang YM",,424582.0,DTCT0023221,2013813,DTCC00440693,1102639,21793
952,CHEMBL3763779,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005.0,INHIBITION,=,24.0,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016.0,110.0,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571.0,DTCT0023221,81424,DTCC00075509,74889,66201
953,CHEMBL3764133,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005.0,INHIBITION,=,41.0,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016.0,110.0,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571.0,DTCT0023221,81344,DTCC00075511,1752263,66201
954,CHEMBL3764335,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005.0,INHIBITION,=,41.0,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016.0,110.0,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571.0,DTCT0023221,81434,DTCC00075512,658061,66201
955,CHEMBL3764650,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005.0,INHIBITION,=,18.0,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016.0,110.0,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571.0,DTCT0023221,81425,DTCC00075510,367196,66201
956,CHEMBL376596,P46098,KKHT-20818,PRICKWSOIKQPFF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,4800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885918,DTCC00002562,1983565,34988
957,CHEMBL376596,P46098,KKHT-20818,PRICKWSOIKQPFF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,99.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887670,DTCC00002562,1983565,34988
958,CHEMBL3770106,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016.0,59.0,2.0,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239.0,DTCT0023221,99386,DTCC00078103,256545,66255
959,CHEMBL3770342,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016.0,59.0,2.0,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239.0,DTCT0023221,99388,DTCC00078107,678484,66255
960,CHEMBL3770981,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016.0,59.0,2.0,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239.0,DTCT0023221,99387,DTCC00078106,1519401,66255
961,CHEMBL3771331,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016.0,59.0,2.0,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239.0,DTCT0023221,99389,DTCC00078113,1837319,66255
962,CHEMBL3775436,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801.0,INHIBITION,=,29.4,%,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016.0,24.0,8.0,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559533.0,DTCT0023221,118987,DTCC00081018,517082,66408
963,CHEMBL3775769,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801.0,INHIBITION,=,12.3,%,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016.0,24.0,8.0,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559533.0,DTCT0023221,119852,DTCC00081020,774921,66408
964,CHEMBL378349,P46098,,AFLJKKMTBWNZFE-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,188.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361460,DTCC00427657,835012,50968
965,CHEMBL378349,P46098,,AFLJKKMTBWNZFE-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,174.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361459,DTCC00427657,835012,50968
966,CHEMBL378471,P46098,,CXDMUUBLDHSHNL-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,580.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361470,DTCC00427682,1800122,50968
967,CHEMBL378471,P46098,,CXDMUUBLDHSHNL-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,663.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361469,DTCC00427682,1800122,50968
968,CHEMBL379302,P46098,,LGWFAAILRNJWJB-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,962.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361465,DTCC00427560,931900,50968
969,CHEMBL379302,P46098,,LGWFAAILRNJWJB-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,310.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361464,DTCC00427560,931900,50968
970,CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125496,DTCC00417396,730707,23555
971,CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125497,DTCC00417396,730707,23555
972,CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125174,DTCC00417396,730707,23555
973,CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125175,DTCC00417396,730707,23555
974,CHEMBL3823832,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,INHIBITION,=,64.0,%,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,,In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents,MedChemComm,2016.0,7.0,6.0,"Shao L, Campbell UC, Fang QK, Powell NA, Campbell JE, Jones PG, Hanania T, Alexandrov V, Morganstern I, Sabath E, Zhong HM, Large TH, Spear KL",,1586709.0,DTCT0023221,303633,DTCC00099681,1722211,67430
975,CHEMBL38288,P46098,WAY-100135,UMTDAKAAYOXIKU-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14744737,DTCC01739668,2108809,68785
976,CHEMBL38465,P46098,,SDWUPSHVUBKGKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,1.8,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,773157,DTCC00181296,140856,10391
977,CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125512,DTCC00457684,1247690,23555
978,CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125513,DTCC00457684,1247690,23555
979,CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,5700.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125190,DTCC00457684,1247690,23555
980,CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125191,DTCC00457684,1247690,23555
981,CHEMBL388047,P46098,,NPZKVFNHJRDGHI-SQHUXFNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125186,DTCC00457686,342835,23555
982,CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,2500.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125507,DTCC00457687,244447,23555
983,CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125508,DTCC00457687,244447,23555
984,CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,1900.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125184,DTCC00457687,244447,23555
985,CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,1995.26,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125185,DTCC00457687,244447,23555
986,CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125501,DTCC00457690,537046,23555
987,CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125502,DTCC00457690,537046,23555
988,CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125178,DTCC00457690,537046,23555
989,CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125179,DTCC00457690,537046,23555
990,CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,11000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125301,DTCC00457674,795054,23555
991,CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,12589.25,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125302,DTCC00457674,795054,23555
992,CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,3100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125162,DTCC00457674,795054,23555
993,CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,3162.28,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125163,DTCC00457674,795054,23555
994,CHEMBL388401,P46098,KKHT-10318,VJRGAGPCQUZOLU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,7500.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887676,DTCC00002566,1276678,34988
995,CHEMBL388401,P46098,KKHT-10318,VJRGAGPCQUZOLU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,VMAX,=,103.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445.0,DTCT0023221,2887651,DTCC00002566,1276678,34988
996,CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125514,DTCC00457683,892666,23555
997,CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125515,DTCC00457683,892666,23555
998,CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,25118.86,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125193,DTCC00457683,892666,23555
999,CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,28000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125192,DTCC00457683,892666,23555
1000,CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,495.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729698,DTCC00134069,2103971,68446
1001,CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729699,DTCC00134069,2103971,68446
1002,CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,EC50,=,457.09,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2126082,DTCC00134069,43214,23555
1003,CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,EC50,=,500.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2126080,DTCC00134069,43214,23555
1004,CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,141.0,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700639.0,DTCT0023221,5035405,DTCC00134069,47560,42619
1005,CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,EC50,=,178.0,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635.0,DTCT0023221,5035393,DTCC00134069,47560,42619
1006,CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125524,DTCC00457677,1760292,23555
1007,CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125525,DTCC00457677,1760292,23555
1008,CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125203,DTCC00457677,1760292,23555
1009,CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125204,DTCC00457677,1760292,23555
1010,CHEMBL392760,P46098,WAY-181187,RYBOXBBYCVOYNO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17948978.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,CHO,Inhibition of human 5HT3 receptor expressed in CHO cells at 100 nM,,"Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.",J. Med. Chem.,2007.0,50.0,23.0,"Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE",,451126.0,DTCT0023221,2203115,DTCC00003286,2020054,24044
1011,CHEMBL395368,P46098,,ZYALYWXELCWDBL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17127059.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007.0,17.0,4.0,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453461.0,DTCT0023221,2219138,DTCC00477229,67033,24220
1012,CHEMBL395609,P46098,,DIMAAAZZSSXDEH-DFBJGRDBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17127059.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007.0,17.0,4.0,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453461.0,DTCT0023221,2219193,DTCC00477237,682203,24220
1013,CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125528,DTCC00457675,147879,23555
1014,CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125529,DTCC00457675,147879,23555
1015,CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125208,DTCC00457675,147879,23555
1016,CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,11000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125207,DTCC00457675,147879,23555
1017,CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125520,DTCC00457679,1889425,23555
1018,CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125521,DTCC00457679,1889425,23555
1019,CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125199,DTCC00457679,1889425,23555
1020,CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125200,DTCC00457679,1889425,23555
1021,CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125516,DTCC00457681,601373,23555
1022,CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125517,DTCC00457681,601373,23555
1023,CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125195,DTCC00457681,601373,23555
1024,CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125196,DTCC00457681,601373,23555
1025,CHEMBL39677,P46098,ACRIDINE,DZBUGLKDJFMEHC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849459,DTCC00181372,1717187,34292
1026,CHEMBL397434,P46098,,ULIQGBPQLPCTAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718823,DTCC00455328,2101764,68163
1027,CHEMBL399045,P46098,,AKKGFQRBBVGLEB-KRXBUXKQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17869105.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM,Not Active,Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.,Bioorg. Med. Chem. Lett.,2007.0,17.0,21.0,"Xia M, Hou C, Pollack S, Brackley J, DeMong D, Pan M, Singer M, Matheis M, Olini G, Cavender D, Wachter M",,457775.0,DTCT0023221,2249928,DTCC00483460,115518,24680
1028,CHEMBL401541,P46098,,UDUQYNVUNNDSEJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17998160.0,KI,=,1051.0,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.,Bioorg. Med. Chem. Lett.,2008.0,18.0,1.0,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,463654.0,DTCT0023221,2290837,DTCC00502473,1378416,25254
1029,CHEMBL402143,P46098,,QCFZUTYIUYQTPW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2622640,DTCC00501513,1588595,33115
1030,CHEMBL402540,P46098,,FOBJQZLFHNQSAX-UYRXBGFRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,19.0,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433.0,DTCT0023221,2351557,DTCC00491376,747050,25479
1031,CHEMBL40260,P46098,,ATBPRFXCCZLQCU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434.0,KI,=,3.3,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990.0,33.0,10.0,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470.0,DTCT0023221,1056369,DTCC00181522,712139,10392
1032,CHEMBL402757,P46098,,NSEUBONDLOTDLU-XLNRJJMWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,19.0,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433.0,DTCT0023221,2351559,DTCC00491378,1523527,25479
1033,CHEMBL404232,P46098,APLYSINOPSIN,AZGOVLGMSGAOMP-FZYUQVBKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,3029.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643600,DTCC00490517,836269,56290
1034,CHEMBL404372,P46098,,XFMPGBXLGWZMQP-YFKPBYRVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18023344.0,KI,=,1062.3,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.,Bioorg. Med. Chem. Lett.,2008.0,18.0,1.0,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,464433.0,DTCT0023221,2291676,DTCC00502372,779086,25312
1035,CHEMBL407391,P46098,DIMETHYLADENINE,BVIAOQMSVZHOJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718000,DTCC00494965,2101324,68163
1036,CHEMBL41,P46098,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849461,DTCC00134078,1588862,34292
1037,CHEMBL414183,P46098,,FKFNPTZCZKTCNF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,12.59,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090038,DTCC00133197,1908320,45760
1038,CHEMBL41543,P46098,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849451,DTCC00180007,845294,34292
1039,CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125506,DTCC00457688,1889427,23555
1040,CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,4200.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125505,DTCC00457688,1889427,23555
1041,CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,5900.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125182,DTCC00457688,1889427,23555
1042,CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125183,DTCC00457688,1889427,23555
1043,CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125503,DTCC00457689,1474801,23555
1044,CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125504,DTCC00457689,1474801,23555
1045,CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,39810.72,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125181,DTCC00457689,1474801,23555
1046,CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,40000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125180,DTCC00457689,1474801,23555
1047,CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125499,DTCC00457691,1857141,23555
1048,CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125500,DTCC00457691,1857141,23555
1049,CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125176,DTCC00457691,1857141,23555
1050,CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125177,DTCC00457691,1857141,23555
1051,CHEMBL418854,P46098,,QHLRKDSRGUZHSH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10464021.0,KI,>,1000.0,NM,,,,,,,,,,,,,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,,"N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.",J. Med. Chem.,1999.0,42.0,17.0,"Birch AM, Bradley PA, Gill JC, Kerrigan F, Needham PL",,3125.0,DTCT0023221,1102501,DTCC00287129,1456479,15336
1052,CHEMBL419496,P46098,,NYNPDVHTKWVOLU-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361455,DTCC00251734,900076,50968
1053,CHEMBL42,P46098,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283.0,KI,=,186.21,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004.0,14.0,16.0,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007.0,DTCT0023221,1765154,DTCC00134115,6984,18177
1054,CHEMBL42,P46098,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,186.21,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013.0,22.0,2.0,,,932184.0,DTCT0023221,11738831,DTCC00134115,55750,51606
1055,CHEMBL42,P46098,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329312.0,DTCT0023221,13582405,DTCC00134115,58495,39761
1056,CHEMBL42055,P46098,E-FLUPENTIXOL,NJMYODHXAKYRHW-BLLMUTORSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849454,DTCC00185842,618780,34292
1057,CHEMBL421747,P46098,,DVTRMRRJKIYJHT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,791253,DTCC00255789,1980183,10391
1058,CHEMBL429317,P46098,AVL-3288,VMAKIACTLSBBIY-BOPFTXTBSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,19.0,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433.0,DTCT0023221,2351560,DTCC00492329,1523526,25479
1059,CHEMBL43048,P46098,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12761331.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14730587,DTCC00186878,2104160,68767
1060,CHEMBL443764,P46098,VUF-10249,QPKAPAVYCGEURE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,1.35,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422330,DTCC00004197,1073800,51459
1061,CHEMBL444985,P46098,,ZINGRQZUIVEPKX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19282174.0,KI,=,404.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3 receptor expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009.0,19.0,8.0,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564831.0,DTCT0023221,2620132,DTCC00570244,586439,33285
1062,CHEMBL445332,P46098,SALVINORIN A,OBSYBRPAKCASQB-AGQYDFLVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12192085.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14728234,DTCC00395210,2103589,69286
1063,CHEMBL453023,P46098,,IAORVHGBICJISE-STYPWORHSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997.0,60.0,4.0,"Lewin G, Schaeffer C, Dacquet C",,549546.0,DTCT0023221,2539167,DTCC00113358,597145,27062
1064,CHEMBL453996,P46098,,MUOXAGUZMVATIC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19282174.0,KI,=,311.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3 receptor expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009.0,19.0,8.0,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564831.0,DTCT0023221,2620029,DTCC00570174,1653671,33285
1065,CHEMBL454407,P46098,,VKXYLXZLODSKCD-QZTJIDSGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,251188.64,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473366,DTCC00517737,1841786,32916
1066,CHEMBL454890,P46098,VUF-10499,VCADIWSEVTZZOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,2.82,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422331,DTCC00005478,524648,51459
1067,CHEMBL459689,P46098,,NBYYGODJBZAJJF-WOJBJXKFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,25118.86,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473367,DTCC00517852,941322,32916
1068,CHEMBL459730,P46098,,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18754613.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,"Displacement of [3H]LY278,584 from human cloned 5HT3 receptor",,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,2008.0,51.0,18.0,"Donohue SR, Pike VW, Finnema SJ, Truong P, Andersson J, Gulyás B, Halldin C",,512507.0,DTCT0023221,2562803,DTCC00529017,2036926,31906
1069,CHEMBL459900,P46098,,KNSUADXKFTZSIZ-RTBURBONSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473368,DTCC00517853,164502,32916
1070,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434.0,KI,=,16.0,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990.0,33.0,10.0,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470.0,DTCT0023221,1075266,DTCC00134875,291514,10392
1071,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,16.2,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,784312,DTCC00134875,303211,10391
1072,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,9.62,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14735558,DTCC00134875,2105680,68446
1073,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,6383.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14735559,DTCC00134875,2105680,68446
1074,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14735560,DTCC00134875,2105680,68446
1075,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341.0,KI,=,3.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,22.0,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333.0,DTCT0023221,3553851,DTCC00134875,307832,41528
1076,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,-1.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638.0,DTCT0023221,5035403,DTCC00134875,313578,42619
1077,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988.0,ACTIVITY,=,0.0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825.0,DTCT0023221,5035414,DTCC00134875,313578,42619
1078,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,IC50,=,0.09,NM,,cell_based,,,,,,,,,,,Oocytes,Antagonist activity at human 5HT3A receptor expressed in xenopus oocytes assessed as inhibition of 5HT-induced effect by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880244.0,DTCT0023221,11460193,DTCC00134875,297651,51828
1079,CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,=,2.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460370,DTCC00134875,297651,51828
1080,CHEMBL461360,P46098,,CMOWYBWYCJHODO-VIFPVBQESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,2344.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422344,DTCC00515317,1300093,51459
1081,CHEMBL461729,P46098,,PCXDWBYAWMJZSM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,3548.13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422343,DTCC00515254,264389,51459
1082,CHEMBL462417,P46098,,OICQCECVOFFRAG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,11748.98,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422342,DTCC00515381,135290,51459
1083,CHEMBL464099,P46098,N-METHYLLAUROTETANINE,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25695425.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5-HT3 receptor expressed in HEKT cell membranes by radioligand binding assay,,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,2015.0,78.0,4.0,"Madapa S, Harding WW",,1499640.0,DTCT0023221,14438671,DTCC00005857,624816,62678
1084,CHEMBL467094,P46098,NANTENINE,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19963380.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human 5HT3 receptor,,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,2010.0,20.0,2.0,"Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW",,604273.0,DTCT0023221,3169930,DTCC00115128,663129,36881
1085,CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,NG108-15,Antagonist activity at 5HT3 receptor in hybrid NG108-15 cells assessed as inhibition of 5HT-induced current treated 1 min prior to agonist treatment by electrophysiology,Not Active,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564576.0,DTCT0023221,2613018,DTCC00570224,1082935,33265
1086,CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,=,6.92,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583.0,DTCT0023221,2613037,DTCC00570224,1082935,33265
1087,CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,=,385.0,NM,,cell_based,,,,,,,,,,,NG108-15,Antagonist activity at 5HT3 receptor in hybrid NG108-15 cells assessed as inhibition of 5HT-induced current by electrophysiology,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564575.0,DTCT0023221,2613019,DTCC00570224,1082935,33265
1088,CHEMBL471035,P46098,,IMESNXOOQNBNMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19282174.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3 receptor expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009.0,19.0,8.0,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564831.0,DTCT0023221,2620133,DTCC00570245,2004653,33285
1089,CHEMBL471663,P46098,,CZPMNOSNQHHGTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583.0,DTCT0023221,2613734,DTCC00569998,371836,33265
1090,CHEMBL471712,P46098,VUF-10331,BNASSGFQLMOZKG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,575.44,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422340,DTCC00005442,912852,51459
1091,CHEMBL472219,P46098,SC-53606,UVEYNCQCHBIENE-GTNSWQLSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,251.19,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613781,DTCC00009156,208469,33265
1092,CHEMBL473186,P46098,RS-127445,ZZZQXCUPAJFVBN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10455251.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736443,DTCC00005674,2105972,69444
1093,CHEMBL473302,P46098,VUF-10351,PELIXYXPUAFHOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,12.02,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422339,DTCC00005441,1656134,51459
1094,CHEMBL475331,P46098,VUF-10147,KJVGBWURWKYDCH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,0.0513,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422328,DTCC00005440,2007250,51459
1095,CHEMBL475965,P46098,,IFWGJAXMPXZADJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19146417.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009.0,52.0,3.0,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516660.0,DTCT0023221,2696301,DTCC00550152,1567645,32399
1096,CHEMBL476838,P46098,,CFYAUZPZSBAQNA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2622643,DTCC00551714,100166,33115
1097,CHEMBL476839,P46098,,MJKRYUCQHJLOIV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2622644,DTCC00551715,1103808,33115
1098,CHEMBL479,P46098,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849467,DTCC00137035,165159,34292
1099,CHEMBL479383,P46098,,IJHSPFFWIXGDBB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488430.0,DTCT0023221,2775990,DTCC00525641,1756334,30579
1100,CHEMBL479683,P46098,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24582985.0,INHIBITION,=,61.7,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by radioligand binding assay relative to control,,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014.0,24.0,6.0,"Williams DA, Zaidi SA, Zhang Y",,1297171.0,DTCT0023221,13068455,DTCC00537969,1127642,57600
1101,CHEMBL479683,P46098,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24582985.0,KI,=,2511.89,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014.0,24.0,6.0,"Williams DA, Zaidi SA, Zhang Y",,1296927.0,DTCT0023221,13068431,DTCC00537969,1127642,57600
1102,CHEMBL481153,P46098,,CJGNMVAAMQAWEF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23707254.0,KI,=,1900.0,NM,,,,,,,,,,,,,,Antagonist activity at serotonin 5HT3 receptor (unknown origin) by PDSP assay,,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,2013.0,23.0,13.0,"Darvesh S, Macdonald IR, Martin E",,969177.0,DTCT0023221,12499004,DTCC00526518,1624676,55086
1103,CHEMBL481280,P46098,,BUZBVOKDNAZIIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488430.0,DTCT0023221,2775982,DTCC00525642,1756335,30579
1104,CHEMBL481425,P46098,,LTMXOVNSECYFSK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19119012.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.",Bioorg. Med. Chem.,2009.0,17.0,3.0,"Chu W, Xu J, Zhou D, Zhang F, Jones LA, Wheeler KT, Mach RH",,515866.0,DTCT0023221,2694584,DTCC00532302,1243524,32320
1105,CHEMBL481863,P46098,JNJ-10392980,ZIQGASWXUSSORV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282.0,INHIBITION,=,25.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488314.0,DTCT0023221,2775753,DTCC00006309,207957,30579
1106,CHEMBL482496,P46098,,ZFUOLNAKPBFDIJ-VQBNBCTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18468904.0,KI,>,500.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.",Bioorg. Med. Chem.,2008.0,16.0,11.0,"Nichols DE, Frescas SP, Chemel BR, Rehder KS, Zhong D, Lewin AH",,556751.0,DTCT0023221,2543046,DTCC00559644,1906611,28891
1107,CHEMBL483749,P46098,,QPUXUSUONDVIKY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19338356.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009.0,52.0,7.0,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497693.0,DTCT0023221,2727994,DTCC00569050,273669,34004
1108,CHEMBL484952,P46098,,MTEFLXYKMHWTNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19338356.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009.0,52.0,7.0,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497693.0,DTCT0023221,2727995,DTCC00569111,759316,34004
1109,CHEMBL489060,P46098,VUF-10350,GLWWAUFFFXRHOL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,6.61,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422338,DTCC00005452,556753,51459
1110,CHEMBL489061,P46098,VUF-10508,YLCLVZULHOQJRR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,16595.87,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422336,DTCC00005453,1748050,51459
1111,CHEMBL489062,P46098,VUF-10349,GNITVWLUINGTBR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,1.12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422346,DTCC00005454,1106489,51459
1112,CHEMBL489271,P46098,VUF-10509,YTLUXTFQLXDBJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,2.69,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422333,DTCC00005457,1494619,51459
1113,CHEMBL489408,P46098,,GWHHZSAHAOWCRM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2623612,DTCC00551776,1297360,33115
1114,CHEMBL489664,P46098,VUF-10455,BQFFJFYYLYTLCC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,14.79,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422332,DTCC00005471,1462113,51459
1115,CHEMBL49,P46098,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460371,DTCC00135177,102981,51828
1116,CHEMBL490071,P46098,VUF-10329,CBXQAAQVKDTXJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,13.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422335,DTCC00005448,1909144,51459
1117,CHEMBL490072,P46098,VUF-10453,LCGYRMCRRGNDFQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,79.43,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422334,DTCC00005449,1494618,51459
1118,CHEMBL490073,P46098,VUF-10452,GGBKKIVDGBAYTK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,165.96,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422337,DTCC00005450,880196,51459
1119,CHEMBL490632,P46098,,PPXOTGGYVKBLCQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2623609,DTCC00551773,1906510,33115
1120,CHEMBL490633,P46098,,YTQJBBJHLKKOLR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2623610,DTCC00551774,1427399,33115
1121,CHEMBL490634,P46098,,VSDLSICGFMFZRC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2623611,DTCC00551775,1685574,33115
1122,CHEMBL490843,P46098,,BADPXOSJBUEVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19331415.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor,Active,"Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.",J. Med. Chem.,2009.0,52.0,8.0,"Ulens C, Akdemir A, Jongejan A, van Elk R, Bertrand S, Perrakis A, Leurs R, Smit AB, Sixma TK, Bertrand D, de Esch IJ",,563563.0,DTCT0023221,2625327,DTCC00552222,1071069,33123
1123,CHEMBL491861,P46098,,DZOFIEFQFCWGIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19331415.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor,Active,"Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.",J. Med. Chem.,2009.0,52.0,8.0,"Ulens C, Akdemir A, Jongejan A, van Elk R, Bertrand S, Perrakis A, Leurs R, Smit AB, Sixma TK, Bertrand D, de Esch IJ",,563563.0,DTCT0023221,2625335,DTCC00552280,1556319,33123
1124,CHEMBL492884,P46098,,NIJGWJIOMPHDBP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,KI,=,1258.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090043,DTCC00528056,588048,45760
1125,CHEMBL498770,P46098,IODOPHENPROPIT,UBHYDQAARZKHEZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8564266.0,KI,=,11.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14743399,DTCC00541500,2108370,69351
1126,CHEMBL499536,P46098,,HQYLURGLNKLOQJ-XHDPSFHLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,19952.62,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473370,DTCC00517855,1555907,32916
1127,CHEMBL499536,P46098,,HQYLURGLNKLOQJ-XHDPSFHLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KD,=,13000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361605,DTCC00517855,1578796,50968
1128,CHEMBL50,P46098,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729987,DTCC00135230,2104025,69275
1129,CHEMBL500,P46098,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561.0,KI,=,6610.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14744125,DTCC00139321,2108612,68785
1130,CHEMBL503427,P46098,,BSAYMXGAHRLDCA-RTBURBONSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,50118.72,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473369,DTCC00517854,132100,32916
1131,CHEMBL509387,P46098,(-)-TABERSONINE HCL,BFVXDLZRORZNHX-OCIDDWSYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997.0,60.0,4.0,"Lewin G, Schaeffer C, Dacquet C",,549546.0,DTCT0023221,2539166,DTCC00004852,1406207,27062
1132,CHEMBL509540,P46098,A-940894,KUZRWWLVBUPCRK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,INHIBITION,=,98.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3AR at 10 uM,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766549.0,DTCT0023221,6090049,DTCC00006426,1908323,45760
1133,CHEMBL510275,P46098,METHYLLYCACONITINE,XLTANAWLDBYGFU-BVFBBISOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125300,DTCC00538707,1021384,23555
1134,CHEMBL510275,P46098,METHYLLYCACONITINE,XLTANAWLDBYGFU-BVFBBISOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445992.0,DTCT0023221,2125161,DTCC00538707,1021384,23555
1135,CHEMBL511312,P46098,,RZFPSYUVZCCIFI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583.0,DTCT0023221,2613740,DTCC00569996,371835,33265
1136,CHEMBL511609,P46098,,HVWYYWIRLPBRTO-JSGCOSHPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17067154.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [9-methyl-3H]BRL-43694 from human 5HT3A receptor expressed in HEK293 cells,,Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands.,J. Nat. Prod.,2006.0,69.0,10.0,"Hedner E, Sjögren M, Frändberg PA, Johansson T, Göransson U, Dahlström M, Jonsson P, Nyberg F, Bohlin L",,526858.0,DTCT0023221,2738950,DTCC00506515,920108,29670
1137,CHEMBL511699,P46098,,XFBXGLNGAUZHSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041.0,KI,=,18.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012.0,55.0,20.0,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726.0,DTCT0023221,11422347,DTCC00515257,1300092,51459
1138,CHEMBL512332,P46098,METHYLAPLYSINOPSIN,GXBMTEAMDOVNLO-TVSYJCFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296.0,KI,=,1511.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013.0,21.0,22.0,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092.0,DTCT0023221,12643633,DTCC00507844,1095374,56290
1139,CHEMBL515472,P46098,,QCFZUTYIUYQTPW-JOCHJYFZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2622641,DTCC00551712,554033,33115
1140,CHEMBL516088,P46098,,HVJOIRMQZXEGPW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490.0,DTCT0023221,2622642,DTCC00551713,1264819,33115
1141,CHEMBL519240,P46098,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139.0,ACTIVITY,=,2.2,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM relative to control,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008.0,51.0,22.0,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494267.0,DTCT0023221,2604325,DTCC00008943,1621329,32034
1142,CHEMBL519240,P46098,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139.0,INHIBITION,=,98.0,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 10 uM,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008.0,51.0,22.0,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494189.0,DTCT0023221,2604246,DTCC00008943,1621329,32034
1143,CHEMBL519240,P46098,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,INHIBITION,=,98.0,%,,,,,,,,,,,,,,Inhibition of 5-HT3AR at 10 uM,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766549.0,DTCT0023221,6090047,DTCC00008943,1623090,45760
1144,CHEMBL519609,P46098,,FPUKGJMTLUQGFZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23707254.0,KI,=,3900.0,NM,,,,,,,,,,,,,,Antagonist activity at serotonin 5HT3 receptor (unknown origin) by PDSP assay,,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,2013.0,23.0,13.0,"Darvesh S, Macdonald IR, Martin E",,969177.0,DTCT0023221,12499021,DTCC00526517,1235500,55086
1145,CHEMBL520349,P46098,,OHOQFGDSEWQDAX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19338356.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009.0,52.0,7.0,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497693.0,DTCT0023221,2727996,DTCC00569166,1178835,34004
1146,CHEMBL526307,P46098,,AATPYXMXFBBKFO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19231180.0,KI,=,100000000.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,"Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.",Bioorg. Med. Chem. Lett.,2009.0,19.0,6.0,"Carter DS, Alam M, Cai H, Dillon MP, Ford AP, Gever JR, Jahangir A, Lin C, Moore AG, Wagner PJ, Zhai Y",,565951.0,DTCT0023221,2475726,DTCC00534803,726731,32941
1147,CHEMBL53929,P46098,OCTOPAMINE,QHGUCRYDKWKLMG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium at 10 nM by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478753.0,DTCT0023221,2354066,DTCC00196284,1426856,26306
1148,CHEMBL53929,P46098,OCTOPAMINE,QHGUCRYDKWKLMG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,EC50,=,24.0,NM,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478755.0,DTCT0023221,2354069,DTCC00196284,1426856,26306
1149,CHEMBL54,P46098,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,0.56,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727266,DTCC00135385,2103354,68446
1150,CHEMBL54,P46098,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,15.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727265,DTCC00135385,2103354,68446
1151,CHEMBL54,P46098,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849455,DTCC00135385,11934,34292
1152,CHEMBL541018,P46098,,RKGYJVASTMCSHZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849469,DTCC00582611,1717191,34292
1153,CHEMBL541993,P46098,,JDPGHZDOBUGUDU-LURJTMIESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18023344.0,KI,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,Not Determined,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.,Bioorg. Med. Chem. Lett.,2008.0,18.0,1.0,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,464433.0,DTCT0023221,2291693,DTCC00502334,228570,25312
1154,CHEMBL54720,P46098,,QYWDOJXSLBBWLE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,=,1.41,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]granisetron form 5HT3 receptor in hybrid NG180-15 cells,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564556.0,DTCT0023221,2613762,DTCC00197722,240858,33265
1155,CHEMBL549,P46098,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,Not Determined,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265.0,DTCT0023221,11460372,DTCC00144121,428144,51828
1156,CHEMBL54943,P46098,CYSTEINE,XUJNEKJLAYXESH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14732676,DTCC00201307,2103464,69159
1157,CHEMBL555146,P46098,,VGSYEFOBFMUWGO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22313227.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012.0,55.0,5.0,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818810.0,DTCT0023221,10474249,DTCC00380469,1106159,48153
1158,CHEMBL558226,P46098,SC-52491,DHGXYMAJZPNYQQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.2,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,,Bioorg. Med. Chem. Lett.,1997.0,7.0,17.0,,,3469.0,DTCT0023221,1022050,DTCC00022374,1196056,2213
1159,CHEMBL559456,P46098,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19359175.0,INHIBITION,<,15.0,%,,,,,,,,,,,,,,Inhibition of 5HT3R at 200 nM,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009.0,19.0,10.0,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575313.0,DTCT0023221,2876718,DTCC00582984,339382,34589
1160,CHEMBL559478,P46098,SSR180711,RXLOZRCLQMJJLC-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19576766.0,IC50,>,3160.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]LY278584 from human 5HT3 receptor expressed in HEK293 cells,,"Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,16.0,"O'Donnell CJ, Peng L, O'Neill BT, Arnold EP, Mather RJ, Sands SB, Shrikhande A, Lebel LA, Spracklin DK, Nedza FM",,582492.0,DTCT0023221,2914150,DTCC00583548,985720,35190
1161,CHEMBL559478,P46098,SSR180711,RXLOZRCLQMJJLC-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851023.0,DTCT0023221,11361603,DTCC00583548,996351,50968
1162,CHEMBL560,P46098,PENTAZOCINE,VOKSWYLNZZRQPF-GDIGMMSISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,15.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736560,DTCC00145614,2106015,68446
1163,CHEMBL560,P46098,PENTAZOCINE,VOKSWYLNZZRQPF-GDIGMMSISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,195.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736559,DTCC00145614,2106015,68446
1164,CHEMBL560,P46098,PENTAZOCINE,VOKSWYLNZZRQPF-GDIGMMSISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,857.7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736558,DTCC00145614,2106015,68446
1165,CHEMBL563848,P46098,,XWTAQEXSIBGWRM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,3993.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361541,DTCC00585061,2059386,50968
1166,CHEMBL564180,P46098,,PJQCANLCUDUPRF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849453,DTCC00584171,910364,34292
1167,CHEMBL564850,P46098,,MQZFLDZRBIKMGM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19576766.0,IC50,>,3160.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]LY278584 from human 5HT3 receptor expressed in HEK293 cells,,"Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,16.0,"O'Donnell CJ, Peng L, O'Neill BT, Arnold EP, Mather RJ, Sands SB, Shrikhande A, Lebel LA, Spracklin DK, Nedza FM",,582492.0,DTCT0023221,2914151,DTCC00586605,79685,35190
1168,CHEMBL565540,P46098,SEN-12333,GBMDUJQQSGOIFW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19515567.0,SELECTIVITY RATIO,,,,,cell_based,,,,,,,,,,,HEK293,Activity at human 5HT3 receptor expressed in human HEK293 cells assessed as effect on membrane potential by FLIPR assay,Not Active,SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist.,Bioorg. Med. Chem.,2009.0,17.0,14.0,"Haydar SN, Ghiron C, Bettinetti L, Bothmann H, Comery TA, Dunlop J, La Rosa S, Micco I, Pollastrini M, Quinn J, Roncarati R, Scali C, Valacchi M, Varrone M, Zanaletti R",,598743.0,DTCT0023221,3090598,DTCC00023271,1363188,36012
1169,CHEMBL565547,P46098,,QGJVXXSJZAPJME-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19646865.0,KI,=,3700.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.,Bioorg. Med. Chem. Lett.,2009.0,19.0,17.0,"Brennan PE, Whitlock GA, Ho DK, Conlon K, McMurray G",,599284.0,DTCT0023221,3109451,DTCC00602399,208957,36131
1170,CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434.0,KI,=,2.7,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990.0,33.0,10.0,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470.0,DTCT0023221,1056367,DTCC00204705,712138,10392
1171,CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,2.7,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,813759,DTCC00204705,723753,10391
1172,CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,2.82,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613775,DTCC00204705,727129,33265
1173,CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,5.3,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361609,DTCC00204705,737976,50968
1174,CHEMBL56900,P46098,LERISETRON,PWWDCRQZITYKDV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,0.36,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1255908,DTCC00204700,1423851,4387
1175,CHEMBL569270,P46098,,UTPGRZGMQVAYAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24147864.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by PDSP assay,,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,2013.0,56.0,22.0,"Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW",,1274798.0,DTCT0023221,12941488,DTCC00606473,1333771,56413
1176,CHEMBL569357,P46098,,HFOUMBDMIJJHCK-OSPHWJPCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,3100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114455,DTCC00604510,1039093,36218
1177,CHEMBL569585,P46098,,POJMJIIKSJRQPV-OZJYBUQCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,790.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114460,DTCC00604518,1589099,36218
1178,CHEMBL570487,P46098,,POJMJIIKSJRQPV-UBMARQKXSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1700.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114462,DTCC00604561,619033,36218
1179,CHEMBL570710,P46098,,SOEFWQWHKHCTLH-BIIVWMMYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1600.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114459,DTCC00604500,1874707,36218
1180,CHEMBL571799,P46098,,POJMJIIKSJRQPV-QZOFJNMOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598658.0,DTCT0023221,3115583,DTCC00604612,133045,36218
1181,CHEMBL571799,P46098,,POJMJIIKSJRQPV-QZOFJNMOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,159.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114464,DTCC00604612,133045,36218
1182,CHEMBL572038,P46098,,OHGAQBAXUOYIOB-CJAUYULYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,3500.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114453,DTCC00604452,165404,36218
1183,CHEMBL572248,P46098,,HFOUMBDMIJJHCK-BXKMTCNYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,2500.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114456,DTCC00604517,229795,36218
1184,CHEMBL572249,P46098,,SOEFWQWHKHCTLH-QJTHLVPVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1400.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114465,DTCC00604453,812625,36218
1185,CHEMBL582877,P46098,,ODCAEXNEGXTNBY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016.0,59.0,2.0,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239.0,DTCT0023221,99385,DTCC00599156,1226952,66255
1186,CHEMBL583681,P46098,,POJMJIIKSJRQPV-JQKXIHIISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,2800.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114458,DTCC00604591,327966,36218
1187,CHEMBL584743,P46098,,OHGAQBAXUOYIOB-AVRWGWEMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,4900.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114454,DTCC00604451,1810259,36218
1188,CHEMBL585567,P46098,,SOEFWQWHKHCTLH-YUXJLSHCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,18.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114463,DTCC00604574,393299,36218
1189,CHEMBL585925,P46098,,SOEFWQWHKHCTLH-ZSKASMGYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,390.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114461,DTCC00604524,1363220,36218
1190,CHEMBL590615,P46098,,CWYDYWFZPBTTIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538.0,DTCT0023221,3163675,DTCC00609878,176896,36082
1191,CHEMBL595449,P46098,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19646882.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009.0,17.0,17.0,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601696.0,DTCT0023221,3163162,DTCC00612138,1136637,36541
1192,CHEMBL596758,P46098,,HKZXJCJPMIJTDL-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,237.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211377,DTCC00622307,372592,37125
1193,CHEMBL596951,P46098,,CGNLROWYSDSBMN-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,0.17,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211369,DTCC00622184,1789798,37125
1194,CHEMBL596952,P46098,,OIVVFYLMLVRCHQ-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,26.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211370,DTCC00622185,241563,37125
1195,CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,484.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181593,DTCC00618948,910774,37429
1196,CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,484.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361553,DTCC00618948,931901,50968
1197,CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,1370.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361551,DTCC00618948,931901,50968
1198,CHEMBL597276,P46098,,KZCFXYPUJPOLMF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,Not Determined,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181596,DTCC00619021,1330645,37429
1199,CHEMBL597440,P46098,,ZLUOOMMZUAJVNO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,2480.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181594,DTCC00618949,1395715,37429
1200,CHEMBL597737,P46098,,ATCMRGMIYIPJQT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,>,7310.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181600,DTCC00618115,1842781,37429
1201,CHEMBL597843,P46098,,HIWIXUJADKOVEP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,579.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361542,DTCC00618887,446367,50968
1202,CHEMBL597984,P46098,,KMAHQUWVTWBRDK-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,59.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211382,DTCC00622380,1051063,37125
1203,CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,0.78,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738829,DTCC01740527,2106786,68446
1204,CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,20.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738826,DTCC01740527,2106786,68446
1205,CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,1259.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738827,DTCC01740527,2106786,68446
1206,CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,6918.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738825,DTCC01740527,2106786,68446
1207,CHEMBL598555,P46098,,YABLRALLVGHPFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,3310.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181599,DTCC00618111,1167964,37429
1208,CHEMBL598803,P46098,,KWVHDIHZHBHZBJ-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,375.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211371,DTCC00622236,1439532,37125
1209,CHEMBL598804,P46098,,FKNBNSUXUZHSKP-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,7.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211372,DTCC00622237,1789800,37125
1210,CHEMBL598805,P46098,,SXJUZHRNCSMYNX-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,3029.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211374,DTCC00622239,1211766,37125
1211,CHEMBL599011,P46098,,AJEBHUMZPBDLQF-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,0.67,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211379,DTCC00622309,1568545,37125
1212,CHEMBL599012,P46098,,UYPUNICVVJSXHT-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,71.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211380,DTCC00622310,1244760,37125
1213,CHEMBL599760,P46098,RO-85,WLMBSKSEPQCRJV-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20045645.0,ACTIVITY,>,50.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting,,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,2010.0,20.0,3.0,"Brotherton-Pleiss CE, Dillon MP, Ford AP, Gever JR, Carter DS, Gleason SK, Lin CJ, Moore AG, Thompson AW, Villa M, Zhai Y",,612484.0,DTCT0023221,3188545,DTCC00030157,1918622,37451
1214,CHEMBL600053,P46098,,BKYSPAJPVPEZOE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538.0,DTCT0023221,3163676,DTCC00609877,405425,36082
1215,CHEMBL602850,P46098,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538.0,DTCT0023221,3163677,DTCC00609826,1309981,36082
1216,CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,70.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181598,DTCC00618110,878089,37429
1217,CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,70.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361559,DTCC00618110,900077,50968
1218,CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,244.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361558,DTCC00618110,900077,50968
1219,CHEMBL603673,P46098,,IJQKBGDDQMPHRI-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,279.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211376,DTCC00622240,2049325,37125
1220,CHEMBL604083,P46098,,XHOQYFHYEDPLTL-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,749.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211378,DTCC00622308,986346,37125
1221,CHEMBL604798,P46098,CP-810123,BSNKYWSMUAGMDO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,5.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181595,DTCC00030113,1039298,37429
1222,CHEMBL605562,P46098,,XQKKWUYBGYIOKW-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,5306.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211373,DTCC00622238,437627,37125
1223,CHEMBL605772,P46098,,VZSXQQMZYQDDQE-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481.0,KI,=,0.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010.0,53.0,5.0,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614.0,DTCT0023221,3211381,DTCC00622311,2017195,37125
1224,CHEMBL608560,P46098,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538.0,DTCT0023221,3163678,DTCC00609825,1789660,36082
1225,CHEMBL611082,P46098,,CXJLWJAYGMWLRR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,KI,=,13.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361544,DTCC00618819,1094157,50968
1226,CHEMBL611369,P46098,,MJSSERWIBBMXQD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,779.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181592,DTCC00124272,1167975,37429
1227,CHEMBL61946,P46098,CARAMIPHEN,OFAIGZWCDGNZGT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14740713,DTCC00208292,2107484,68446
1228,CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,0.72,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739669,DTCC00207121,2107137,68446
1229,CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,27.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739668,DTCC00207121,2107137,68446
1230,CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,3981.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739667,DTCC00207121,2107137,68446
1231,CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,5523.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739666,DTCC00207121,2107137,68446
1232,CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19119012.0,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.",Bioorg. Med. Chem.,2009.0,17.0,3.0,"Chu W, Xu J, Zhou D, Zhang F, Jones LA, Wheeler KT, Mach RH",,515866.0,DTCT0023221,2694583,DTCC00207121,952786,32320
1233,CHEMBL63054,P46098,,ZSMRRZONCYIFNB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849463,DTCC00211900,1427680,34292
1234,CHEMBL63354,P46098,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14753780,DTCC00216407,2103540,69275
1235,CHEMBL63863,P46098,,LUAPLNWRHHWKLK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,1.43,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1281243,DTCC00219246,1713650,4387
1236,CHEMBL6437,P46098,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at SER3 receptor expressed in HEK293 cells assessed as inhibition of 10 nM octopamine-induced response by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478756.0,DTCT0023221,2354070,DTCC00132673,1362144,26306
1237,CHEMBL644,P46098,TRIMIPRAMINE,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849468,DTCC00154839,973976,34292
1238,CHEMBL65280,P46098,,QQJHRQZZCNYDMX-VPUSJEBWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10869410.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14743043,DTCC00213993,2108262,69668
1239,CHEMBL654,P46098,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337.0,KI,=,2900.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5-HT3A receptor expressed in HEK293 cells by liquid scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988340.0,DTCT0023221,12618343,DTCC00155023,1301042,56006
1240,CHEMBL66114,P46098,RS-39604,BKVIWGRFRKLFIO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7582507.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736053,DTCC01740814,2105854,69634
1241,CHEMBL66692,P46098,,GALAKJYLTKKOBQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,0.42,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1282499,DTCC00218537,64116,4387
1242,CHEMBL667,P46098,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,EC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,342044,DTCC00103957,1792774,23555
1243,CHEMBL66918,P46098,,DULFTXXWXGBQBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,KI,=,1.69,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480.0,DTCT0023221,1248997,DTCC00218476,873787,4387
1244,CHEMBL681,P46098,ETOMIDATE,NPUKDXXFDDZOKR-LLVKDONJSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5HT3A receptor expressed in Xenopus oocyte,Not Active,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010.0,53.0,17.0,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675557.0,DTCT0023221,3545612,DTCC00156281,1343196,41410
1245,CHEMBL681,P46098,ETOMIDATE,NPUKDXXFDDZOKR-LLVKDONJSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351.0,INHIBITION,=,1.3,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 300 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010.0,53.0,17.0,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675556.0,DTCT0023221,3545590,DTCC00156281,1343196,41410
1246,CHEMBL68131,P46098,SB-204070,AOOSJYIINXVNHV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,158.49,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613767,DTCC01740809,694838,33265
1247,CHEMBL68281,P46098,,DTBALPGNCWCVJP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,EC50,=,240.0,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3478.0,DTCT0023221,1261964,DTCC00218786,257824,4387
1248,CHEMBL68281,P46098,,DTBALPGNCWCVJP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154.0,EFFICACY,=,30.0,%,,,,,,,,,,,,,,Percent efficacy against 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001.0,11.0,16.0,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3479.0,DTCT0023221,1261965,DTCC00218786,257824,4387
1249,CHEMBL715,P46098,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,14642972.0,KI,=,417.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14757522,DTCC00160346,2111150,68458
1250,CHEMBL715,P46098,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329312.0,DTCT0023221,13582404,DTCC00160346,1516359,39761
1251,CHEMBL716,P46098,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329312.0,DTCT0023221,13582407,DTCC00160380,1737586,39761
1252,CHEMBL72,P46098,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849460,DTCC00137288,1104078,34292
1253,CHEMBL726,P46098,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849462,DTCC00162562,1717188,34292
1254,CHEMBL73234,P46098,CARBETAPENTANE,CFJMRBQWBDQYMK-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,7.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714746,DTCC00229187,2099798,68446
1255,CHEMBL73234,P46098,CARBETAPENTANE,CFJMRBQWBDQYMK-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,165.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714745,DTCC00229187,2099798,68446
1256,CHEMBL74656,P46098,REL-CISAPRIDE,DCSUBABJRXZOMT-RBBKRZOGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin),,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971567.0,DTCT0023221,12504298,DTCC00232098,71332,55103
1257,CHEMBL74656,P46098,REL-CISAPRIDE,DCSUBABJRXZOMT-RBBKRZOGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504374,DTCC00232098,71332,55103
1258,CHEMBL76370,P46098,TEGASEROD,IKBKZGMPCYNSLU-RGVLZGJSSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613771,DTCC00232682,856773,33265
1259,CHEMBL76370,P46098,TEGASEROD,IKBKZGMPCYNSLU-RGVLZGJSSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062.0,KI,=,2511.89,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013.0,23.0,14.0,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714.0,DTCT0023221,12504373,DTCC00232682,848532,55103
1260,CHEMBL773,P46098,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,EC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2126085,DTCC00168448,1539385,23555
1261,CHEMBL78838,P46098,,IQMRECYOUIKYGG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429.0,PKI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,Not Active,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545.0,DTCT0023221,6090025,DTCC00237145,102054,45760
1262,CHEMBL79261,P46098,,LYXKFNHUJJDTIA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561.0,KI,=,1100.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714039,DTCC00239269,2099468,68785
1263,CHEMBL8197,P46098,,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,8.41,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712502,DTCC00134926,2098709,68446
1264,CHEMBL8197,P46098,,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,4332.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712504,DTCC00134926,2098709,68446
1265,CHEMBL8197,P46098,,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712507,DTCC00134926,2098709,68446
1266,CHEMBL828,P46098,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849465,DTCC00179549,1717190,34292
1267,CHEMBL83954,P46098,RS-23597-190,RLSGBCUXLRMTPF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428.0,DTCT0023221,2613783,DTCC01741365,1885821,33265
1268,CHEMBL85,P46098,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849466,DTCC00138594,1362973,34292
1269,CHEMBL85,P46098,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329312.0,DTCT0023221,13582409,DTCC00138594,1387256,39761
1270,CHEMBL8514,P46098,BUTACLAMOL,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,944.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14711605,DTCC00135718,2098467,68446
1271,CHEMBL8514,P46098,BUTACLAMOL,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,3464.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14711608,DTCC00135718,2098467,68446
1272,CHEMBL8618,P46098,NAN-190,SJDOMIRMMUGQQK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561.0,KI,=,316.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14711195,DTCC00135647,2098369,68785
1273,CHEMBL86304,P46098,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451.0,INHIBITION,<=,50.0,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009.0,44.0,6.0,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131.0,DTCT0023221,2849457,DTCC00246764,812424,34292
1274,CHEMBL93240,P46098,METITEPINE,RLJFTICUTYVZDG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at SER3 receptor expressed in HEK293 cells assessed as inhibition of 10 nM octopamine-induced response by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478756.0,DTCT0023221,2354071,DTCC00260212,1458837,26306
1275,CHEMBL93240,P46098,METITEPINE,RLJFTICUTYVZDG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at SER3 receptor expressed in HEK293 cells assessed as inhibition of 100 nM octopamine-induced response by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007.0,450.0,7169.0,"Petrascheck M, Ye X, Buck LB",,478757.0,DTCT0023221,2354055,DTCC00260212,1458837,26306
1276,CHEMBL93919,P46098,,NADMOKMSPBJASV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824.0,KI,=,0.42,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990.0,33.0,10.0,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465.0,DTCT0023221,796811,DTCC00255816,1403478,10391
1277,CHEMBL96,P46098,GAMMA-AMINOBUTYRIC ACID,BTCSSZJGUNDROE-UHFFFAOYSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,EC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2126084,DTCC00141298,698398,23555
1278,CHEMBL98883,P46098,,LGQCVMYAEFTEFN-VUCTXSBTSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,50.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708010,DTCC00267199,2097582,68446
1279,CHEMBL98883,P46098,,LGQCVMYAEFTEFN-VUCTXSBTSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,1906.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708013,DTCC00267199,2097582,68446
1280,CHEMBL98883,P46098,,LGQCVMYAEFTEFN-VUCTXSBTSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708014,DTCC00267199,2097582,68446
1281,,P46098,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14747001,DTCC01744004,2109188,69275
1282,,P46098,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14749638,DTCC01744004,2109188,69275
1283,,P46098,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14751390,DTCC01744004,2110075,69159
1284,,P46098,D-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-GSVOUGTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14755075,DTCC01745877,2104421,69159
1285,,P46098,D-HOMOCYSTEINE SULFINIC ACID,PDNJLMZEGXHSCU-GSVOUGTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14752977,DTCC01746621,2110340,69159
1286,,P46098,D-HOMOCYSTEINE THIOLACTONE,KIWQWJKWBHZMDT-GSVOUGTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14751342,DTCC01746491,2110074,69159
1287,,P46098,DL-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14731407,DTCC01745876,2104415,69159
1288,,P46098,EED226,DYIRSNMPIZZNBK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,28135235.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14725779,DTCC01744057,2096701,67941
1289,,P46098,MDL 100907,HXTGXYRHXAGCFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15999145.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14750491,DTCC01745097,2109914,69464
1290,,P46098,PU01,WPEBMRNXFWCMHU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,490.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712396,DTCC01744709,2098682,68163
1291,,P46098,PU03,ZITSATWAZDKOBF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,2800.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720093,DTCC01744876,2101991,68163
1292,,P46098,PU04,KRBFLOBPUMORJO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14705766,DTCC01744148,2097015,68163
1293,,P46098,PU06,IDRHDKGNUNKODU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14722190,DTCC01745080,2102510,68163
1294,,P46098,PU07,IVHTZIIPDCREHO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724072,DTCC01745334,2102800,68163
1295,,P46098,PY01,WPPPKVSENOHDIG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,3400.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712405,DTCC01744711,2098685,68163
1296,,P46098,PY02,BWGIECJEQVGDRP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14726506,DTCC01745665,2103165,68163
1297,,P46098,PY05,PKNNCDGLZOSLJS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708124,DTCC01744454,2097628,68163
1298,,P46098,SR144528,SUGVYNSRNKFXQM-ACSDJOOWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9454810.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14754357,DTCC01745818,2103995,69395
1299,,P46098,SURECN14521175,QLOOWOVVZLBYHU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,14709324.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14753603,DTCC01745721,2103342,69198
1300,,P46098,TH02,YPAKIZUIDJVWEU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,14000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14719709,DTCC01744827,2101934,68163
1301,,P46098,TH03,IULBXDZWXBXGNP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724094,DTCC01745336,2102802,68163
1302,,P46098,TH04,JBGBKQZMARTYMJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14721631,DTCC01745004,2102428,68163
1303,,P46098,TH05,OIOMPFBFUIBOFU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14707513,DTCC01744398,2097466,68163
1304,,P46098,TH06,YQZJKNSLWYSIQK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14719746,DTCC01744836,2101944,68163
1305,,P46098,TH09,GKQNHLVTVYRVPU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14723619,DTCC01745268,2102728,68163
1306,,P46098,TH10,FHGYGOURWHLFKB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724448,DTCC01745401,2102876,68163
1307,,P46098,TH11,BYOFGWKOPRCCDL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14726034,DTCC01745604,2103098,68163
1308,,P46098,TH12,BKOSOHWFMPLYRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14726337,DTCC01745648,2103147,68163
1309,,P46098,TH13,HOASDGCNODVMOU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724566,DTCC01745416,2102894,68163
